BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1457116 O=C(O)c1ccccc1CN1CCN(c2nc3ccccc3s2)CC1 InChI=1S/C19H19N3O2S/c23-18(24)15-6-2-1-5-14(15)13-21-9-11-22(12-10-21)19-20-16-7-3-4-8-17(16)25-19/h1-8H,9-13H2,(H,23,24) LLTPYQZAFYOGRA-UHFFFAOYSA-N 703524 2-[[4-(1,3-benzo- thiazol-2-yl)piper- azin-1-yl]methyl]- benzoic acid::US20240368133, Compound A-01 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 33600 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703524 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703524&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443716 507747473 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457117 CCS(=O)(=O)NC(=O)c1ccccc1CN1CCN(c2nc3ccccc3s2)CC1 InChI=1S/C21H24N4O3S2/c1-2-30(27,28)23-20(26)17-8-4-3-7-16(17)15-24-11-13-25(14-12-24)21-22-18-9-5-6-10-19(18)29-21/h3-10H,2,11-15H2,1H3,(H,23,26) NSVRXVLSHSMPHE-UHFFFAOYSA-N 703525 2-[[4-(1,3-benzo- thiazol-2-yl)piper- azin-1-yl]methyl]- N-ethylsulfonyl- benzamide::US20240368133, Compound A-02 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 6210 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703525 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703525&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212200 507747474 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457118 c1ccc(-c2nn[nH]n2)c(CN2CCN(c3nc4ccccc4s3)CC2)c1 InChI=1S/C19H19N7S/c1-2-6-15(18-21-23-24-22-18)14(5-1)13-25-9-11-26(12-10-25)19-20-16-7-3-4-8-17(16)27-19/h1-8H,9-13H2,(H,21,22,23,24) AYJCHNFIMILLBX-UHFFFAOYSA-N 703526 2-[4-[[2-(2H- tetrazol-5-yl)phen- yl]-methyl]piper- azin-1-yl]-1,3- benzothiazole::US20240368133, Compound A-03 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 15900 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703526 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703526&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 169608772 507747475 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457119 CCS(=O)(=O)NC(=O)c1ccccc1N1CCN(Cc2nc3ccccc3s2)CC1 InChI=1S/C21H24N4O3S2/c1-2-30(27,28)23-21(26)16-7-3-5-9-18(16)25-13-11-24(12-14-25)15-20-22-17-8-4-6-10-19(17)29-20/h3-10H,2,11-15H2,1H3,(H,23,26) ZHPVBOYLRGRJNL-UHFFFAOYSA-N 703527 2-[4-(1,3-benzo- thiazol-2-ylmeth- yl)piperazin-1-yl]- N-ethylsulfonyl- benzamide::US20240368133, Compound A-04 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 22800 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703527 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703527&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 169609332 507747476 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457120 c5ccc(N3CCN(Cc2nc1ccccc1s2)CC3)c(c4nn[nH]n4)c5 InChI=1S/C19H19N7S/c1-3-7-16(14(5-1)19-21-23-24-22-19)26-11-9-25(10-12-26)13-18-20-15-6-2-4-8-17(15)27-18/h1-8H,9-13H2,(H,21,22,23,24) OVPLDUIIXKGXTP-UHFFFAOYSA-N 703528 2-[[4-[2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]-1,3-benzo- thiazole::US20240368133, Compound A-05 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 34100 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703528 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703528&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 169609282 507747477 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457121 c5ccc(N3CCC(Cc2nc1ccccc1s2)CC3)c(c4nn[nH]n4)c5 InChI=1S/C20H20N6S/c1-3-7-17(15(5-1)20-22-24-25-23-20)26-11-9-14(10-12-26)13-19-21-16-6-2-4-8-18(16)27-19/h1-8,14H,9-13H2,(H,22,23,24,25) INKVQZJQAUZJOH-UHFFFAOYSA-N 703529 2-[[1-[2-(2H- tetrazol-5-yl)phen- yl]-4-piperidyl]- methyl]-1,3-benzo- thiazole::US20240368133, Compound A-06 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 16500 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703529 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703529&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 169609277 507747478 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457122 O=[N+]([O-])c1ccc2nc(N3CCN(Cc4ccccc4-c4nn[nH]n4)CC3)sc2c1 InChI=1S/C19H18N8O2S/c28-27(29)14-5-6-16-17(11-14)30-19(20-16)26-9-7-25(8-10-26)12-13-3-1-2-4-15(13)18-21-23-24-22-18/h1-6,11H,7-10,12H2,(H,21,22,23,24) JRCVSBXSFOCPMS-UHFFFAOYSA-N 703530 6-nitro-2-[4-[[2- (2H-tetrazol-5-yl)- phenyl]methyl]- piperazin-1-yl]-1,3- benzothiazole::US20240368133, Compound A-07 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 28800 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703530 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703530&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443894 507747479 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457123 CCOC(=O)NS(=O)(=O)c1ccc(C(F)(F)F)cc1N1CCN(Cc2nc3ccccc3n2C)CC1 InChI=1S/C23H26F3N5O4S/c1-3-35-22(32)28-36(33,34)20-9-8-16(23(24,25)26)14-19(20)31-12-10-30(11-13-31)15-21-27-17-6-4-5-7-18(17)29(21)2/h4-9,14H,3,10-13,15H2,1-2H3,(H,28,32) BYORFRFOHVYBLR-UHFFFAOYSA-N 703531 ethyl N-[2-[4-[(1- methylbenzimid- azol-2-yl)methyl]- piperazin-1-yl]-4- (trifluoromethyl)- phenyl]sulfonyl- carbamate::US20240368133, Compound A-08 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 6820 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703531 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703531&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171779851 507747480 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457124 CCCCOC(=O)NS(=O)(=O)c1ccc(C(F)(F)F)cc1N1CCN(Cc2nc3ccccc3n2C)CC1 InChI=1S/C25H30F3N5O4S/c1-3-4-15-37-24(34)30-38(35,36)22-10-9-18(25(26,27)28)16-21(22)33-13-11-32(12-14-33)17-23-29-19-7-5-6-8-20(19)31(23)2/h5-10,16H,3-4,11-15,17H2,1-2H3,(H,30,34) HPYLEWGHDCANII-UHFFFAOYSA-N 703532 butyl N-[2-[4-[(1- methylbenzimid- azol-2-yl)methyl]- piperazin-1-yl]-4- (trifluoromethyl)- phenyl]sulfonyl- carbamate::US20240368133, Compound A-09 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 2180 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703532 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703532&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 169609259 507747481 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457125 CCCCNC(=O)NS(=O)(=O)c1ccc(C(F)(F)F)cc1N1CCN(Cc2nc3ccccc3n2C)CC1 InChI=1S/C25H31F3N6O3S/c1-3-4-11-29-24(35)31-38(36,37)22-10-9-18(25(26,27)28)16-21(22)34-14-12-33(13-15-34)17-23-30-19-7-5-6-8-20(19)32(23)2/h5-10,16H,3-4,11-15,17H2,1-2H3,(H2,29,31,35) SCISZPMVSUUSMT-UHFFFAOYSA-N 703533 1-butyl-3-[2-[4-[(1- methylbenzimid- azol-2-yl)methyl]- piperazin-1-yl]-4- (trifluoromethyl)- phenyl]sulfonyl- urea::US20240368133, Compound A-10 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 3360 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703533 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703533&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 169609290 507747482 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457126 CCCCOC(=O)NS(=O)c1ccc(C)cc1N1CCN(Cc2nc3ccccc3n2C)CC1 InChI=1S/C25H33N5O3S/c1-4-5-16-33-25(31)27-34(32)23-11-10-19(2)17-22(23)30-14-12-29(13-15-30)18-24-26-20-8-6-7-9-21(20)28(24)3/h6-11,17H,4-5,12-16,18H2,1-3H3,(H,27,31) FLFLETBETIJBMS-UHFFFAOYSA-N 703534 butyl N-[4-methyl- 2-[4-[(1-methyl- benzimidazol-2-yl)- methyl]piperazin- 1-yl]phenyl]sulfon- ylcarbamate::US20240368133, Compound A-11 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 959 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703534 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703534&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172484127 507747483 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457127 CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1N1CCN(Cc2nc3ccccc3n2C)CC1 InChI=1S/C25H34N6O3S/c1-4-5-12-26-25(32)28-35(33,34)23-11-10-19(2)17-22(23)31-15-13-30(14-16-31)18-24-27-20-8-6-7-9-21(20)29(24)3/h6-11,17H,4-5,12-16,18H2,1-3H3,(H2,26,28,32) PURBGUWQDDCNIP-UHFFFAOYSA-N 703535 1-butyl-3-[4-meth- yl-2-[4-[(1-methyl- benzimidazol-2-yl)- methyl]piperazin-1- yl]phenyl]sulfonyl- urea::US20240368133, Compound A-12 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 1270 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703535 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703535&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 169609289 507747484 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457128 CCS(=O)(=O)NC(=O)c1ccccc1N1CCN(Cc2nc3ccccc3n2C)CC1 InChI=1S/C22H27N5O3S/c1-3-31(29,30)24-22(28)17-8-4-6-10-19(17)27-14-12-26(13-15-27)16-21-23-18-9-5-7-11-20(18)25(21)2/h4-11H,3,12-16H2,1-2H3,(H,24,28) MZPUTNSVUKKPGO-UHFFFAOYSA-N 703536 N-ethylsulfonyl-2- [4-[(1-methylbenz- imidazol-2-yl)meth- yl]piperazin-1-yl]- benzamide::US20240368133, Compound A-13 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 13600 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703536 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703536&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 169608771 507747485 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457129 CCS(=O)(=O)NC(=O)c1ccc(OC(C)C)cc1N1CCN(Cc2nc3ccccc3n2C)CC1 InChI=1S/C25H33N5O4S/c1-5-35(32,33)27-25(31)20-11-10-19(34-18(2)3)16-23(20)30-14-12-29(13-15-30)17-24-26-21-8-6-7-9-22(21)28(24)4/h6-11,16,18H,5,12-15,17H2,1-4H3,(H,27,31) NNBDWJKSRBSLCB-UHFFFAOYSA-N 703537 N-ethylsulfonyl-4- isopropoxy-2-[4- [(1-methylbenz- imidazol-2-yl)meth- yl]piperazin-1-yl]- benzamide::US20240368133, Compound A-14 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 4820 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703537 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703537&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 169609268 507747486 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457130 Cn1c(CN2CCN(c3ccccc3-c3nn[nH]n3)CC2)nc2ccccc21 InChI=1S/C20H22N8/c1-26-18-9-5-3-7-16(18)21-19(26)14-27-10-12-28(13-11-27)17-8-4-2-6-15(17)20-22-24-25-23-20/h2-9H,10-14H2,1H3,(H,22,23,24,25) KDDMGVJTWQNENM-UHFFFAOYSA-N 703538 1-methyl-2-[4-[2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]benz- imidazole::US20240368133, Compound A-15 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 42900 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703538 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703538&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 169608604 507747487 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457131 Cc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4n3C)CC2)c1 InChI=1S/C21H24N8/c1-15-7-8-16(21-23-25-26-24-21)19(13-15)29-11-9-28(10-12-29)14-20-22-17-5-3-4-6-18(17)27(20)2/h3-8,13H,9-12,14H2,1-2H3,(H,23,24,25,26) WAYWAWKHSXHGAX-UHFFFAOYSA-N 703539 1-methyl-2-[[4-[5- methyl-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]benzimid- azole::US20240368133, Compound A-16 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 21700 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703539 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703539&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212142 507747488 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457132 Cn1c(CN2CCN(c3cc(C(F)(F)F)ccc3-c3nn[nH]n3)CC2)nc2ccccc21 InChI=1S/C21H21F3N8/c1-30-17-5-3-2-4-16(17)25-19(30)13-31-8-10-32(11-9-31)18-12-14(21(22,23)24)6-7-15(18)20-26-28-29-27-20/h2-7,12H,8-11,13H2,1H3,(H,26,27,28,29) SZOLKRXREXYWJU-UHFFFAOYSA-N 703540 1-methyl-2-[[4-[2- (2H-tetrazol-5-yl)- 5-(trifluoromethyl)- phenyl]piperazin-1- yl]methyl]benzimid- azole::US20240368133, Compound A-17 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 14300 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703540 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703540&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 169610176 507747489 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457133 C/C=C/c1ccc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4n3C)CC2)c1 InChI=1S/C23H26N8/c1-3-6-17-9-10-18(23-25-27-28-26-23)21(15-17)31-13-11-30(12-14-31)16-22-24-19-7-4-5-8-20(19)29(22)2/h3-10,15H,11-14,16H2,1-2H3,(H,25,26,27,28) DSJPUMASZCIDQQ-UHFFFAOYSA-N 703541 1-methyl-2-[[4-[5- [(E)-prop-1-enyl]-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]benz- imidazole::US20240368133, Compound A-18 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 3850 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703541 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703541&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 169609352 507747490 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457134 CCCc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4n3C)CC2)c1 InChI=1S/C23H28N8/c1-3-6-17-9-10-18(23-25-27-28-26-23)21(15-17)31-13-11-30(12-14-31)16-22-24-19-7-4-5-8-20(19)29(22)2/h4-5,7-10,15H,3,6,11-14,16H2,1-2H3,(H,25,26,27,28) ZDKFGDQGEPGOSO-UHFFFAOYSA-N 703542 1-methyl-2-[[4-[5- propyl-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]benzimid- azole::US20240368133, Compound A-19 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 1170 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703542 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703542&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 169608599 507747491 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457135 CC(C)Cc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4n3C)CC2)c1 InChI=1S/C24H30N8/c1-17(2)14-18-8-9-19(24-26-28-29-27-24)22(15-18)32-12-10-31(11-13-32)16-23-25-20-6-4-5-7-21(20)30(23)3/h4-9,15,17H,10-14,16H2,1-3H3,(H,26,27,28,29) AMJXFNRPXIVNKH-UHFFFAOYSA-N 703543 2-[[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin-1- yl]methyl]-1-meth- yl-benzimidazole::US20240368133, Compound A-20 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 510 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703543 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703543&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 169609389 507747492 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457136 CC(C)=Cc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4n3C)CC2)c1 InChI=1S/C24H28N8/c1-17(2)14-18-8-9-19(24-26-28-29-27-24)22(15-18)32-12-10-31(11-13-32)16-23-25-20-6-4-5-7-21(20)30(23)3/h4-9,14-15H,10-13,16H2,1-3H3,(H,26,27,28,29) ZKWNCTZOUCUQCJ-UHFFFAOYSA-N 703544 1-methyl-2-[[4-[5- (2-methylprop-1- enyl)-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]benzimid- azole::US20240368133, Compound A-21 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 488 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703544 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703544&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212156 507747493 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457137 COc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4n3C)CC2)c1 InChI=1S/C21H24N8O/c1-27-18-6-4-3-5-17(18)22-20(27)14-28-9-11-29(12-10-28)19-13-15(30-2)7-8-16(19)21-23-25-26-24-21/h3-8,13H,9-12,14H2,1-2H3,(H,23,24,25,26) FMTJQQZAPAYQDT-UHFFFAOYSA-N 703545 2-[[4-[5-methoxy-2- (2H-tetrazol-5-yl)- phenyl]piperazin-1- yl]methyl]-1-meth- yl-benzimidazole::US20240368133, Compound A-22 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 19700 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703545 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703545&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 169608602 507747494 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457138 CCOc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4n3C)CC2)c1 InChI=1S/C22H26N8O/c1-3-31-16-8-9-17(22-24-26-27-25-22)20(14-16)30-12-10-29(11-13-30)15-21-23-18-6-4-5-7-19(18)28(21)2/h4-9,14H,3,10-13,15H2,1-2H3,(H,24,25,26,27) LYCHJTKNIZYCNL-UHFFFAOYSA-N 703546 2-[[4-[5-ethoxy-2- (2H-tetrazol-5-yl)- phenyl]piperazin-1- yl]methyl]-1-meth- yl-benzimidazole::US20240368133, Compound A-23 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 2370 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703546 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703546&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 169609408 507747495 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457139 CC(C)Oc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4n3C)CC2)c1 InChI=1S/C23H28N8O/c1-16(2)32-17-8-9-18(23-25-27-28-26-23)21(14-17)31-12-10-30(11-13-31)15-22-24-19-6-4-5-7-20(19)29(22)3/h4-9,14,16H,10-13,15H2,1-3H3,(H,25,26,27,28) HGARTCAJAXOLCI-UHFFFAOYSA-N 703547 2-[4-[5-isopropoxy- 2-(2H-tetrazol-5- yl)phenyl]piperazin- 1-yl]methyl]-1- methyl-benzimid- azole::US20240368133, Compound A-24 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 7140 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703547 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703547&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 169609371 507747496 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457140 CC(C)Oc1ccc(-c2nn[nH]n2)c(N2CCC(Cc3nc4ccccc4n3C)CC2)c1 InChI=1S/C24H29N7O/c1-16(2)32-18-8-9-19(24-26-28-29-27-24)22(15-18)31-12-10-17(11-13-31)14-23-25-20-6-4-5-7-21(20)30(23)3/h4-9,15-17H,10-14H2,1-3H3,(H,26,27,28,29) IPLQEDLQDCIEJW-UHFFFAOYSA-N 703548 2-[[1-[5-isopropoxy- 2-(2H-tetrazol-5- yl)phenyl]-4- piperidyl]methyl]- 1-methyl-benzimid- azole::US20240368133, Compound A-25 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 8310 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703548 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703548&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 169609419 507747497 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457141 O=c4[nH]c(CN3CCN(c1ccccc1c2nn[nH]n2)CC3)nc5ccccc45 InChI=1S/C20H20N8O/c29-20-14-5-1-3-7-16(14)21-18(22-20)13-27-9-11-28(12-10-27)17-8-4-2-6-15(17)19-23-25-26-24-19/h1-8H,9-13H2,(H,21,22,29)(H,23,24,25,26) KITZHFRYQPETKG-UHFFFAOYSA-N 703549 2-[[4-[2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]-3H-quin- azolin-4-one::US20240368133, Compound A-26 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 111000 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703549 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703549&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 169608608 507747498 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457142 Cc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4c(=O)[nH]3)CC2)c1 InChI=1S/C21H22N8O/c1-14-6-7-16(20-24-26-27-25-20)18(12-14)29-10-8-28(9-11-29)13-19-22-17-5-3-2-4-15(17)21(30)23-19/h2-7,12H,8-11,13H2,1H3,(H,22,23,30)(H,24,25,26,27) ZMEXDNHUZBWFHP-UHFFFAOYSA-N 703550 2-[[4-[5-methyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-3H- quinazolin-4-one::US20240368133, Compound A-27 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 35900 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703550 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703550&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212148 507747499 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457143 O=c5[nH]c(CN4CCN(c2cc(C1CC1)ccc2c3nn[nH]n3)CC4)nc6ccccc56 InChI=1S/C23H24N8O/c32-23-17-3-1-2-4-19(17)24-21(25-23)14-30-9-11-31(12-10-30)20-13-16(15-5-6-15)7-8-18(20)22-26-28-29-27-22/h1-4,7-8,13,15H,5-6,9-12,14H2,(H,24,25,32)(H,26,27,28,29) CMTOUVQZUGVHED-UHFFFAOYSA-N 703551 2-[[4-[5-cycloprop- yl-2-(2H-tetrazol-5- yl)phenyl]piperazin- 1-yl]methyl]-3H- quinazolin-4-one::US20240368133, Compound A-28 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 3560 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703551 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703551&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171780053 507747500 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457144 O=c1[nH]c(CN2CCN(c3cc(C(F)(F)F)ccc3-c3nn[nH]n3)CC2)nc2ccccc12 InChI=1S/C21H19F3N8O/c22-21(23,24)13-5-6-15(19-27-29-30-28-19)17(11-13)32-9-7-31(8-10-32)12-18-25-16-4-2-1-3-14(16)20(33)26-18/h1-6,11H,7-10,12H2,(H,25,26,33)(H,27,28,29,30) UVRGZCZHQLQNID-UHFFFAOYSA-N 703552 2-[[4-[2-(2H- tetrazol-5-yl)-5- (trifluoromethyl)- phenyl]piperazin- 1-yl]methyl]-3H- quinazolin-4-one::US20240368133, Compound A-29 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 42400 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703552 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703552&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212150 507747501 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457145 CC(C)=Cc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4c(=O)[nH]3)CC2)c1 InChI=1S/C24H26N8O/c1-16(2)13-17-7-8-19(23-27-29-30-28-23)21(14-17)32-11-9-31(10-12-32)15-22-25-20-6-4-3-5-18(20)24(33)26-22/h3-8,13-14H,9-12,15H2,1-2H3,(H,25,26,33)(H,27,28,29,30) OEVNNJLRZPNEKU-UHFFFAOYSA-N 703553 2-[[4-[5-(2-methyl- prop-1-enyl)-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-3H- quinazolin-4-one::US20240368133, Compound A-30 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 114000 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703553 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703553&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212203 507747502 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457146 CC(C)Cc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4c(=O)[nH]3)CC2)c1 InChI=1S/C24H28N8O/c1-16(2)13-17-7-8-19(23-27-29-30-28-23)21(14-17)32-11-9-31(10-12-32)15-22-25-20-6-4-3-5-18(20)24(33)26-22/h3-8,14,16H,9-13,15H2,1-2H3,(H,25,26,33)(H,27,28,29,30) GAYOWXXPQDRBFW-UHFFFAOYSA-N 703554 2-[[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-3H- quinazolin-4-one::US20240368133, Compound A-31 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 2070 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703554 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703554&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171779865 507747503 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457147 CC(C)Oc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4c(=O)[nH]3)CC2)c1 InChI=1S/C23H26N8O2/c1-15(2)33-16-7-8-18(22-26-28-29-27-22)20(13-16)31-11-9-30(10-12-31)14-21-24-19-6-4-3-5-17(19)23(32)25-21/h3-8,13,15H,9-12,14H2,1-2H3,(H,24,25,32)(H,26,27,28,29) HXKYYYMPAFNLHU-UHFFFAOYSA-N 703555 2-[4-[5-isopropoxy- 2-(2H-tetrazol-5- yl)phenyl]piperazin- 1-yl]methyl]-3H- quinazolin-4-one::US20240368133, Compound A-32 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 14700 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703555 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703555&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212206 507747504 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457148 CCc1ccc(C(=O)NS(=O)(=O)CC)c(N2CCN(Cc3nc4ccccc4s3)CC2)c1 InChI=1S/C23H28N4O3S2/c1-3-17-9-10-18(23(28)25-32(29,30)4-2)20(15-17)27-13-11-26(12-14-27)16-22-24-19-7-5-6-8-21(19)31-22/h5-10,15H,3-4,11-14,16H2,1-2H3,(H,25,28) LFSWQDHXNYKPSO-UHFFFAOYSA-N 703556 2-[4-(1,3-benzo- thiazol-2-ylmethyl)- piperazin-1-yl]-4- ethyl-N-ethylsulfon- yl-benzamide::US20240368133, Compound A-33 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 3070 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703556 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703556&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443705 507747505 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457149 CCS(=O)(=O)NC(=O)c1ccc(C(C)C)cc1N1CCN(Cc2nc3ccccc3s2)CC1 InChI=1S/C24H30N4O3S2/c1-4-33(30,31)26-24(29)19-10-9-18(17(2)3)15-21(19)28-13-11-27(12-14-28)16-23-25-20-7-5-6-8-22(20)32-23/h5-10,15,17H,4,11-14,16H2,1-3H3,(H,26,29) RVYGRFRYAUNHRW-UHFFFAOYSA-N 703557 2-[4-(1,3-benzo- thiazol-2-ylmethyl)- piperazin-1-yl]-N- ethylsulfonyl-4-iso- propyl-benzamide::US20240368133, Compound A-34 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 484 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703557 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703557&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443744 507747506 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457150 CCS(=O)(=O)NC(=O)c1ccc(C2CC2)cc1N1CCN(Cc2nc3ccccc3s2)CC1 InChI=1S/C24H28N4O3S2/c1-2-33(30,31)26-24(29)19-10-9-18(17-7-8-17)15-21(19)28-13-11-27(12-14-28)16-23-25-20-5-3-4-6-22(20)32-23/h3-6,9-10,15,17H,2,7-8,11-14,16H2,1H3,(H,26,29) DLSDWPNWRABIQA-UHFFFAOYSA-N 703558 2-[4-(1,3-benzo- thiazol-2-ylmethyl)- piperazin-1-yl]-4- cyclopropyl-N-eth- ylsulfonyl-benz- amide::US20240368133, Compound A-35 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 602 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703558 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703558&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443922 507747507 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457151 CCS(=O)(=O)NC(=O)c1ccc(CC(C)C)cc1N1CCN(Cc2nc3ccccc3s2)CC1 InChI=1S/C25H32N4O3S2/c1-4-34(31,32)27-25(30)20-10-9-19(15-18(2)3)16-22(20)29-13-11-28(12-14-29)17-24-26-21-7-5-6-8-23(21)33-24/h5-10,16,18H,4,11-15,17H2,1-3H3,(H,27,30) PRRRGYSNMJONNY-UHFFFAOYSA-N 703559 2-[4-(1,3-benzo- thiazol-2-ylmethyl)- piperazin-1-yl]-N- ethylsulfonyl-4- isobutyl-benzamide::US20240368133, Compound A-36 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 1420 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703559 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703559&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443893 507747508 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457152 CCS(=O)(=O)NC(=O)c1ccc(OC)cc1N1CCN(Cc2nc3ccccc3s2)CC1 InChI=1S/C22H26N4O4S2/c1-3-32(28,29)24-22(27)17-9-8-16(30-2)14-19(17)26-12-10-25(11-13-26)15-21-23-18-6-4-5-7-20(18)31-21/h4-9,14H,3,10-13,15H2,1-2H3,(H,24,27) QKDRRRGNCZMBHT-UHFFFAOYSA-N 703560 2-[4-(1,3-benzo- thiazol-2-ylmethyl)- piperazin-1-yl]-N- ethylsulfonyl-4- methoxy-benzamide::US20240368133, Compound A-37 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 6580 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703560 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703560&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443723 507747509 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457153 CCOc1ccc(C(=O)NS(=O)(=O)CC)c(N2CCN(Cc3nc4ccccc4s3)CC2)c1 InChI=1S/C23H28N4O4S2/c1-3-31-17-9-10-18(23(28)25-33(29,30)4-2)20(15-17)27-13-11-26(12-14-27)16-22-24-19-7-5-6-8-21(19)32-22/h5-10,15H,3-4,11-14,16H2,1-2H3,(H,25,28) QSKBNIRZFMWKEO-UHFFFAOYSA-N 703561 2-[4-(1,3-benzo- thiazol-2-ylmethyl)- piperazin-1-yl]-4- ethoxy-N-ethyl- sulfonyl-benzamide::US20240368133, Compound A-38 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 2400 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703561 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703561&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443467 507747510 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457154 CCS(=O)(=O)NC(=O)c1ccc(OC(C)C)cc1CN1CCN(c2nc3ccccc3s2)CC1 InChI=1S/C24H30N4O4S2/c1-4-34(30,31)26-23(29)20-10-9-19(32-17(2)3)15-18(20)16-27-11-13-28(14-12-27)24-25-21-7-5-6-8-22(21)33-24/h5-10,15,17H,4,11-14,16H2,1-3H3,(H,26,29) UBMWHYKCWQPBFW-UHFFFAOYSA-N 703562 2-[[4-(1,3-benzo- thiazol-2-yl)piper- azin-1-yl]methyl]- N-ethylsulfonyl-4- isopropoxy-benz- amide::US20240368133, Compound A-39 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 2810 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703562 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703562&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443859 507747511 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457155 CCS(=O)(=O)NC(=O)c1ccc(OC(C)C)cc1N1CCN(Cc2nc3ccccc3s2)CC1 InChI=1S/C24H30N4O4S2/c1-4-34(30,31)26-24(29)19-10-9-18(32-17(2)3)15-21(19)28-13-11-27(12-14-28)16-23-25-20-7-5-6-8-22(20)33-23/h5-10,15,17H,4,11-14,16H2,1-3H3,(H,26,29) BXVNGEGLPDZKLD-UHFFFAOYSA-N 703563 2-[4-(1,3-benzo- thiazol-2-ylmethyl)- piperazin-1-yl]-N- ethylsulfonyl-4- isopropoxy-benz- amide::US20240368133, Compound A-40 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 5870 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703563 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703563&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443755 507747512 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457156 CCS(=O)(=O)NC(=O)c1ccc(OC2CC2)cc1N1CCN(Cc2nc3ccccc3s2)CC1 InChI=1S/C24H28N4O4S2/c1-2-34(30,31)26-24(29)19-10-9-18(32-17-7-8-17)15-21(19)28-13-11-27(12-14-28)16-23-25-20-5-3-4-6-22(20)33-23/h3-6,9-10,15,17H,2,7-8,11-14,16H2,1H3,(H,26,29) ADQPYVOOAUWHBU-UHFFFAOYSA-N 703564 2-[4-(1,3-benzo- thiazol-2-ylmethyl)- piperazin-1-yl]-4- (cyclopropoxy)-N- ethylsulfonyl-benz- amide::US20240368133, Compound A-41 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 2540 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703564 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703564&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443570 507747513 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457157 CCCOc1ccc(C(=O)NS(=O)(=O)CC)c(N2CCN(Cc3nc4ccccc4s3)CC2)c1 InChI=1S/C24H30N4O4S2/c1-3-15-32-18-9-10-19(24(29)26-34(30,31)4-2)21(16-18)28-13-11-27(12-14-28)17-23-25-20-7-5-6-8-22(20)33-23/h5-10,16H,3-4,11-15,17H2,1-2H3,(H,26,29) DCOVRGFZJRCJDF-UHFFFAOYSA-N 703565 2-[4-(1,3-benzo- thiazol-2-ylmeth- yl)piperazin-1-yl]- N-ethylsulfonyl-4- propoxy-benzamide::US20240368133, Compound A-42 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 17700 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703565 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703565&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443946 507747514 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457158 CCS(=O)(=O)NC(=O)c1ccc(OCC(C)C)cc1N1CCN(Cc2nc3ccccc3s2)CC1 InChI=1S/C25H32N4O4S2/c1-4-35(31,32)27-25(30)20-10-9-19(33-17-18(2)3)15-22(20)29-13-11-28(12-14-29)16-24-26-21-7-5-6-8-23(21)34-24/h5-10,15,18H,4,11-14,16-17H2,1-3H3,(H,27,30) DNBJAAZPFCICER-UHFFFAOYSA-N 703566 2-[4-(1,3-benzo- thiazol-2-ylmeth- yl)piperazin-1-yl]- N-ethylsulfonyl-4- isobutoxy-benz- amide::US20240368133, Compound A-43 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 4380 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703566 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703566&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443886 507747515 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457159 CCNc1ccc(C(=O)NS(=O)(=O)CC)c(N2CCN(Cc3nc4ccccc4s3)CC2)c1 InChI=1S/C23H29N5O3S2/c1-3-24-17-9-10-18(23(29)26-33(30,31)4-2)20(15-17)28-13-11-27(12-14-28)16-22-25-19-7-5-6-8-21(19)32-22/h5-10,15,24H,3-4,11-14,16H2,1-2H3,(H,26,29) YVYYDNRQBORTGU-UHFFFAOYSA-N 703567 2-[4-(1,3-benzo- thiazol-2-ylmethyl)- piperazin-1-yl]-4- (ethylamino)-N- ethylsulfonyl-benz- amide::US20240368133, Compound A-44 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 7180 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703567 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703567&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443732 507747516 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457160 CCc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4s3)CC2)c1 InChI=1S/C21H23N7S/c1-2-15-7-8-16(21-23-25-26-24-21)18(13-15)28-11-9-27(10-12-28)14-20-22-17-5-3-4-6-19(17)29-20/h3-8,13H,2,9-12,14H2,1H3,(H,23,24,25,26) SLGKSHCWFZUZAX-UHFFFAOYSA-N 703568 2-[[4-[5-ethyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-1,3- benzothiazole::US20240368133, Compound A-45 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 2540 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703568 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703568&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443728 507747517 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457161 CC(C)c1ccc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4s3)CC2)c1 InChI=1S/C22H25N7S/c1-15(2)16-7-8-17(22-24-26-27-25-22)19(13-16)29-11-9-28(10-12-29)14-21-23-18-5-3-4-6-20(18)30-21/h3-8,13,15H,9-12,14H2,1-2H3,(H,24,25,26,27) GPQDSQCGLRWBFS-UHFFFAOYSA-N 703569 2-[4-[5-isopropyl- 2-(2H-tetrazol-5- yl)phenyl]piperazin- 1-yl]methyl]-1,3- benzothiazole::US20240368133, Compound A-46 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 1790 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703569 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703569&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443481 507747518 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457162 c6ccc5sc(CN4CCN(c2cc(C1CC1)ccc2c3nn[nH]n3)CC4)nc5c6 InChI=1S/C22H23N7S/c1-2-4-20-18(3-1)23-21(30-20)14-28-9-11-29(12-10-28)19-13-16(15-5-6-15)7-8-17(19)22-24-26-27-25-22/h1-4,7-8,13,15H,5-6,9-12,14H2,(H,24,25,26,27) JJDBRVBVTKITBV-UHFFFAOYSA-N 703570 2-[[4-[5-cycloprop- yl-2-(2H-tetrazol-5- yl)phenyl]piperazin- 1-yl]methyl]-1,3- benzothiazole::US20240368133, Compound A-47 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 1070 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703570 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703570&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212211 507747519 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457163 CC(C)Cc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4s3)CC2)c1 InChI=1S/C23H27N7S/c1-16(2)13-17-7-8-18(23-25-27-28-26-23)20(14-17)30-11-9-29(10-12-30)15-22-24-19-5-3-4-6-21(19)31-22/h3-8,14,16H,9-13,15H2,1-2H3,(H,25,26,27,28) QQSNIEJIUAYEPP-UHFFFAOYSA-N 703571 2-[[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-1,3- benzothiazole::US20240368133, Compound A-48 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 628 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703571 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703571&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443945 507747520 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457164 CC(C)Cc1ccc(-c2c[nH]nn2)c(N2CCN(c3nc4ccccc4s3)CC2)c1 InChI=1S/C23H26N6S/c1-16(2)13-17-7-8-18(20-15-24-27-26-20)21(14-17)28-9-11-29(12-10-28)23-25-19-5-3-4-6-22(19)30-23/h3-8,14-16H,9-13H2,1-2H3,(H,24,26,27) UIDHHNSDANBFFN-UHFFFAOYSA-N 703572 2-[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]-1,3-benzo- thiazole::US20240368133, Compound A-49 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 2340 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703572 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703572&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172484097 507747521 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457165 CC(C)Oc1ccc(-c2nn[nH]n2)c(CN2CCN(c3nc4ccccc4s3)CC2)c1 InChI=1S/C22H25N7OS/c1-15(2)30-17-7-8-18(21-24-26-27-25-21)16(13-17)14-28-9-11-29(12-10-28)22-23-19-5-3-4-6-20(19)31-22/h3-8,13,15H,9-12,14H2,1-2H3,(H,24,25,26,27) MLMZSPFKERSACF-UHFFFAOYSA-N 703573 2-[4-[[5-isoprop- oxy-2-(2H-tetrazol- 5-yl)phenyl]meth- yl]piperazin-1-yl]- 1,3-benzothiazole::US20240368133, Compound A-50 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 10500 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703573 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703573&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212159 507747522 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457166 CC(C)Oc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4s3)CC2)c1 InChI=1S/C22H25N7OS/c1-15(2)30-16-7-8-17(22-24-26-27-25-22)19(13-16)29-11-9-28(10-12-29)14-21-23-18-5-3-4-6-20(18)31-21/h3-8,13,15H,9-12,14H2,1-2H3,(H,24,25,26,27) MDAIZCDIYGEDEZ-UHFFFAOYSA-N 703574 2-[[4-[5-isoprop- oxy-2-(2H-tetrazol- 5-yl)phenyl]piper- azin-1-yl]methyl]- 1,3-benzothiazole::US20240368133, Compound A-51 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 2110 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703574 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703574&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 169608613 507747523 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457167 c1ccc2sc(CN3CCN(c4cc(OC5CC5)ccc4-c4nn[nH]n4)CC3)nc2c1 InChI=1S/C22H23N7OS/c1-2-4-20-18(3-1)23-21(31-20)14-28-9-11-29(12-10-28)19-13-16(30-15-5-6-15)7-8-17(19)22-24-26-27-25-22/h1-4,7-8,13,15H,5-6,9-12,14H2,(H,24,25,26,27) OTPBFYHJBVBZGS-UHFFFAOYSA-N 703575 2-[[4-[5-(cyclo- propoxy)-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]-1,3-benzo- thiazole::US20240368133, Compound A-52 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 4420 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703575 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703575&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443754 507747524 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457168 CC(C)COc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4s3)CC2)c1 InChI=1S/C23H27N7OS/c1-16(2)15-31-17-7-8-18(23-25-27-28-26-23)20(13-17)30-11-9-29(10-12-30)14-22-24-19-5-3-4-6-21(19)32-22/h3-8,13,16H,9-12,14-15H2,1-2H3,(H,25,26,27,28) AFAJDSHXDZOJSH-UHFFFAOYSA-N 703576 2-[[4-[5-isobutoxy- 2-(2H-tetrazol-5- yl)phenyl]piperazin- 1-yl]methyl]-1,3- benzothiazole::US20240368133, Compound A-53 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 7600 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703576 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703576&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443939 507747525 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457169 c6ccc5sc(CN4CCN(c2cc(OCC1CC1)ccc2c3nn[nH]n3)CC4)nc5c6 InChI=1S/C23H25N7OS/c1-2-4-21-19(3-1)24-22(32-21)14-29-9-11-30(12-10-29)20-13-17(31-15-16-5-6-16)7-8-18(20)23-25-27-28-26-23/h1-4,7-8,13,16H,5-6,9-12,14-15H2,(H,25,26,27,28) YHPNFQKHWMBHAV-UHFFFAOYSA-N 703577 2-[[4-[5-(cyclo- propylmethoxy)-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-1,3- benzothiazole::US20240368133, Compound A-54 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 2070 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703577 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703577&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212174 507747526 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457170 FC(F)COc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4s3)CC2)c1 InChI=1S/C21H21F2N7OS/c22-19(23)13-31-14-5-6-15(21-25-27-28-26-21)17(11-14)30-9-7-29(8-10-30)12-20-24-16-3-1-2-4-18(16)32-20/h1-6,11,19H,7-10,12-13H2,(H,25,26,27,28) CAUZGOBQNRBRAR-UHFFFAOYSA-N 703578 2-[[4-[5-(2,2- difluoroethoxy)-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-1,3- benzothiazole::US20240368133, Compound A-55 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 2270 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703578 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703578&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443605 507747527 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457171 COCCOc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4s3)CC2)c1 InChI=1S/C22H25N7O2S/c1-30-12-13-31-16-6-7-17(22-24-26-27-25-22)19(14-16)29-10-8-28(9-11-29)15-21-23-18-4-2-3-5-20(18)32-21/h2-7,14H,8-13,15H2,1H3,(H,24,25,26,27) IJIZCRKTPHDIJS-UHFFFAOYSA-N 703579 2-[[4-[5-(2-meth- oxyethoxy)-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]-1,3-benzo- thiazole::US20240368133, Compound A-56 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 61700 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703579 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703579&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443931 507747528 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457172 c6ccc5sc(CN4CCN(c2cc(OC1CCCC1)ccc2c3nn[nH]n3)CC4)nc5c6 InChI=1S/C24H27N7OS/c1-2-6-17(5-1)32-18-9-10-19(24-26-28-29-27-24)21(15-18)31-13-11-30(12-14-31)16-23-25-20-7-3-4-8-22(20)33-23/h3-4,7-10,15,17H,1-2,5-6,11-14,16H2,(H,26,27,28,29) BFWMLGWSNUZGHU-UHFFFAOYSA-N 703580 2-[[4-[5-(cyclo- pentoxy)-2-(2H- tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-1,3- benzothiazole::US20240368133, Compound A-57 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 1900 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703580 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703580&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443729 507747529 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457173 c1ccc2sc(CN3CCN(c4cc(OCC5COC5)ccc4-c4nn[nH]n4)CC3)nc2c1 InChI=1S/C23H25N7O2S/c1-2-4-21-19(3-1)24-22(33-21)12-29-7-9-30(10-8-29)20-11-17(32-15-16-13-31-14-16)5-6-18(20)23-25-27-28-26-23/h1-6,11,16H,7-10,12-15H2,(H,25,26,27,28) RMQGIWMHTIPENP-UHFFFAOYSA-N 703581 2-[[4-[5-(oxetan-3- ylmethoxy)-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]-1,3-benzo- thiazole::US20240368133, Compound A-58 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 17200 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703581 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703581&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443873 507747530 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457174 CCNc5ccc(c1nn[nH]n1)c(N4CCN(Cc3nc2ccccc2s3)CC4)c5 InChI=1S/C21H24N8S/c1-2-22-15-7-8-16(21-24-26-27-25-21)18(13-15)29-11-9-28(10-12-29)14-20-23-17-5-3-4-6-19(17)30-20/h3-8,13,22H,2,9-12,14H2,1H3,(H,24,25,26,27) URBYZKMKXKMFBG-UHFFFAOYSA-N 703582 3-[4-(1,3-benzothi- azol-2-ylmethyl)- piperazin-1-yl]- N-ethyl-4-(2H- tetrazol-5-yl)aniline::US20240368133, Compound A-59 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 4750 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703582 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703582&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212184 507747531 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457175 CC(C)Nc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4s3)CC2)c1 InChI=1S/C22H26N8S/c1-15(2)23-16-7-8-17(22-25-27-28-26-22)19(13-16)30-11-9-29(10-12-30)14-21-24-18-5-3-4-6-20(18)31-21/h3-8,13,15,23H,9-12,14H2,1-2H3,(H,25,26,27,28) RUIKFMWOPRZNKO-UHFFFAOYSA-N 703583 3-[4-(1,3-benzothi- azol-2-ylmethyl)- piperazin-1-yl]- N-isopropyl-4-(2H- tetrazol-5-yl)aniline::US20240368133, Compound A-60 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 3460 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703583 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703583&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443581 507747532 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457176 c1ccc2sc(CN3CCN(c4cc(CC5CC5)ccc4-c4nn[nH]n4)CC3)nc2c1 InChI=1S/C23H25N7S/c1-2-4-21-19(3-1)24-22(31-21)15-29-9-11-30(12-10-29)20-14-17(13-16-5-6-16)7-8-18(20)23-25-27-28-26-23/h1-4,7-8,14,16H,5-6,9-13,15H2,(H,25,26,27,28) ILWFPZWEGMRUGQ-UHFFFAOYSA-N 703584 3-[4-(1,3-benzothi- azol-2-ylmethyl)- piperazin-1-yl]-N- cyclopropyl-4-(2H- tetrazol-5-yl)aniline hydrochloride::US20240368133, Compound A-61 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 14700 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703584 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703584&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172879041 507747533 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457177 c6ccc5sc(CN4CCN(c2cc(NCC1CC1)ccc2c3nn[nH]n3)CC4)nc5c6 InChI=1S/C23H26N8S/c1-2-4-21-19(3-1)25-22(32-21)15-30-9-11-31(12-10-30)20-13-17(24-14-16-5-6-16)7-8-18(20)23-26-28-29-27-23/h1-4,7-8,13,16,24H,5-6,9-12,14-15H2,(H,26,27,28,29) QVPDBIMJZGVSAG-UHFFFAOYSA-N 703585 3-[4-(1,3-benzothi- azol-2-ylmethyl)- piperazin-1-yl]-N- (cyclopropylmeth- yl)-4-(2H-tetrazol- 5-yl)aniline::US20240368133, Compound A-62 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 1680 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703585 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703585&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212161 507747534 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457178 COCCNc5ccc(c1nn[nH]n1)c(N4CCN(Cc3nc2ccccc2s3)CC4)c5 InChI=1S/C22H26N8OS/c1-31-13-8-23-16-6-7-17(22-25-27-28-26-22)19(14-16)30-11-9-29(10-12-30)15-21-24-18-4-2-3-5-20(18)32-21/h2-7,14,23H,8-13,15H2,1H3,(H,25,26,27,28) KWNBWKSYSCLJAQ-UHFFFAOYSA-N 703586 3-[4-(1,3-benzothi- azol-2-ylmethyl)- piperazin-1-yl]-N- (2-methoxyethyl)- 4-(2H-tetrazol-5- yl)aniline::US20240368133, Compound A-63 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 21600 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703586 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703586&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 169609293 507747535 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457179 c6ccc5sc(CN4CCN(c2cc(NC1CCCC1)ccc2c3nn[nH]n3)CC4)nc5c6 InChI=1S/C24H28N8S/c1-2-6-17(5-1)25-18-9-10-19(24-27-29-30-28-24)21(15-18)32-13-11-31(12-14-32)16-23-26-20-7-3-4-8-22(20)33-23/h3-4,7-10,15,17,25H,1-2,5-6,11-14,16H2,(H,27,28,29,30) RXEIGSPLNJGWNF-UHFFFAOYSA-N 703587 3-[4-(1,3-benzothi- azol-2-ylmethyl)- piperazin-1-yl]-N- cyclopentyl-4-(2H- tetrazol-5-yl)aniline::US20240368133, Compound A-64 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 1560 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703587 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703587&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212152 507747536 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457180 c6ccc5sc(CN4CCN(c2cc(N1CCCCC1)ccc2c3nn[nH]n3)CC4)nc5c6 InChI=1S/C24H28N8S/c1-4-10-31(11-5-1)18-8-9-19(24-26-28-29-27-24)21(16-18)32-14-12-30(13-15-32)17-23-25-20-6-2-3-7-22(20)33-23/h2-3,6-9,16H,1,4-5,10-15,17H2,(H,26,27,28,29) RDBVCGCAJMLHRB-UHFFFAOYSA-N 703588 2-[[4-[5-(1-piperid- yl)-2-(2H-tetrazol-5- yl)phenyl]piperazin- 1-yl]methyl]-1,3- benzothiazole::US20240368133, Compound A-65 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 1850 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703588 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703588&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171779919 507747537 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457181 CN1CCN(c2ccc(-c3nn[nH]n3)c(N3CCN(Cc4nc5ccccc5s4)CC3)c2)CC1 InChI=1S/C24H29N9S/c1-30-8-12-32(13-9-30)18-6-7-19(24-26-28-29-27-24)21(16-18)33-14-10-31(11-15-33)17-23-25-20-4-2-3-5-22(20)34-23/h2-7,16H,8-15,17H2,1H3,(H,26,27,28,29) MAVMCWBMFQPORA-UHFFFAOYSA-N 703589 2-[[4-[5-(4-methyl- piperazin-1-yl)-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-1,3- benzothiazole::US20240368133, Compound A-66 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 11800 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703589 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703589&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443725 507747538 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457182 c6ccc5sc(CN4CCN(c2cc(N1CCOCC1)ccc2c3nn[nH]n3)CC4)nc5c6 InChI=1S/C23H26N8OS/c1-2-4-21-19(3-1)24-22(33-21)16-29-7-9-31(10-8-29)20-15-17(30-11-13-32-14-12-30)5-6-18(20)23-25-27-28-26-23/h1-6,15H,7-14,16H2,(H,25,26,27,28) IHPGDUDXQVKZOJ-UHFFFAOYSA-N 703590 4-[3-[4-(1,3-benzo- thiazol-2-ylmethyl)- piperazin-1-yl]-4- (2H-tetrazol-5-yl)- phenyl]morpholine::US20240368133, Compound A-67 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 7110 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703590 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703590&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 169608609 507747539 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457183 COC1CC(Nc2ccc(-c3nn[nH]n3)c(N3CCN(Cc4nc5ccccc5s4)CC3)c2)C1 InChI=1S/C24H28N8OS/c1-33-18-12-17(13-18)25-16-6-7-19(24-27-29-30-28-24)21(14-16)32-10-8-31(9-11-32)15-23-26-20-4-2-3-5-22(20)34-23/h2-7,14,17-18,25H,8-13,15H2,1H3,(H,27,28,29,30) UWIIDJWGFBLYGK-UHFFFAOYSA-N 703591 3-[4-(1,3-benzo- thiazol-2-ylmethyl)- piperazin-1-yl]-N- (3-methoxycyclo- butyl)-4-(2H- tetrazol-5-yl)aniline::US20240368133, Compound A-68 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 8500 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703591 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703591&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443889 507747540 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457184 CC(C)Cc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3nc(=O)c4cnn(C)c4[nH]3)CC2)c1 InChI=1S/C22H28N10O/c1-14(2)10-15-4-5-16(20-26-28-29-27-20)18(11-15)32-8-6-31(7-9-32)13-19-24-21-17(22(33)25-19)12-23-30(21)3/h4-5,11-12,14H,6-10,13H2,1-3H3,(H,24,25,33)(H,26,27,28,29) MNPSRZHQTUEXIJ-UHFFFAOYSA-N 703592 6-[[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-1- methyl-7H-pyr- azolo[3,4-d]pyrimi- din-4-one::US20240368133, Compound A-69 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 10600 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703592 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703592&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212182 507747541 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457185 Cc1ccc2nc(CN3CCN(c4cc(CC(C)C)ccc4-c4nn[nH]n4)CC3)cc(=O)n2c1 InChI=1S/C25H30N8O/c1-17(2)12-19-5-6-21(25-27-29-30-28-25)22(13-19)32-10-8-31(9-11-32)16-20-14-24(34)33-15-18(3)4-7-23(33)26-20/h4-7,13-15,17H,8-12,16H2,1-3H3,(H,27,28,29,30) NMRRFRATTNNKOT-UHFFFAOYSA-N 703593 2-[[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-7- methyl-pyrido[1,2- a]pyrimidin-4-one::US20240368133, Compound A-70 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 1800 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703593 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703593&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212197 507747542 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457186 CC(C)Cc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ncccc4o3)CC2)c1 InChI=1S/C22H26N8O/c1-15(2)12-16-5-6-17(21-25-27-28-26-21)18(13-16)30-10-8-29(9-11-30)14-20-24-22-19(31-20)4-3-7-23-22/h3-7,13,15H,8-12,14H2,1-2H3,(H,25,26,27,28) NBRLGEYEIXXJPH-UHFFFAOYSA-N 703594 2-[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin-1- yl]methyl]oxazolo- [4,5-b]pyridine::US20240368133, Compound A-71 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 18500 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703594 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703594&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443660 507747543 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457187 Cc1ccn2c(=O)cc(CN3CCN(c4cc(CC(C)C)ccc4-c4nn[nH]n4)CC3)nc2c1 InChI=1S/C25H30N8O/c1-17(2)12-19-4-5-21(25-27-29-30-28-25)22(14-19)32-10-8-31(9-11-32)16-20-15-24(34)33-7-6-18(3)13-23(33)26-20/h4-7,13-15,17H,8-12,16H2,1-3H3,(H,27,28,29,30) SGJBIJVAMJUHEF-UHFFFAOYSA-N 703595 2-[[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-8- methyl-pyrido[1,2- a]pyrimidin-4-one::US20240368133, Compound A-72 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 8390 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703595 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703595&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171780043 507747544 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457188 Cc1cccc2nc(CN3CCN(c4cc(CC(C)C)ccc4-c4nn[nH]n4)CC3)cc(=O)n12 InChI=1S/C25H30N8O/c1-17(2)13-19-7-8-21(25-27-29-30-28-25)22(14-19)32-11-9-31(10-12-32)16-20-15-24(34)33-18(3)5-4-6-23(33)26-20/h4-8,14-15,17H,9-13,16H2,1-3H3,(H,27,28,29,30) IEPSPNVOWNJPAG-UHFFFAOYSA-N 703596 2-[[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-6- methyl-pyrido[1,2- a]pyrimidin-4-one-::US20240368133, Compound A-73 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 4300 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703596 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703596&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212155 507747545 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457189 CC(C)Cc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3cc(=O)n4c(ccn4C)n3)CC2)c1 InChI=1S/C23H29N9O/c1-16(2)12-17-4-5-19(23-25-27-28-26-23)20(13-17)31-10-8-30(9-11-31)15-18-14-22(33)32-21(24-18)6-7-29(32)3/h4-7,13-14,16H,8-12,15H2,1-3H3,(H,25,26,27,28) ORKZHKDJYLMXDJ-UHFFFAOYSA-N 703597 5-[[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-1- methyl-pyrazolo- [1,5-a]pyrimidin-7- one::US20240368133, Compound A-74 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 11700 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703597 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703597&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212205 507747546 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457190 Cc1csc2nc(CN3CCN(c4cc(CC(C)C)ccc4-c4nn[nH]n4)CC3)cc(=O)n12 InChI=1S/C23H28N8OS/c1-15(2)10-17-4-5-19(22-25-27-28-26-22)20(11-17)30-8-6-29(7-9-30)13-18-12-21(32)31-16(3)14-33-23(31)24-18/h4-5,11-12,14-15H,6-10,13H2,1-3H3,(H,25,26,27,28) BVUFOUZJTMDTLU-UHFFFAOYSA-N 703598 7-[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-3- methyl-thiazolo[3,2- a]pyrimidin-5-one::US20240368133, Compound A-75 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 5920 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703598 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703598&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171779772 507747547 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457191 CC(C)Cc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3cc(=O)n4ccccc4n3)CC2)c1 InChI=1S/C24H28N8O/c1-17(2)13-18-6-7-20(24-26-28-29-27-24)21(14-18)31-11-9-30(10-12-31)16-19-15-23(33)32-8-4-3-5-22(32)25-19/h3-8,14-15,17H,9-13,16H2,1-2H3,(H,26,27,28,29) PXDGNAWXPNGULG-UHFFFAOYSA-N 703599 2-[[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]pyrido- [1,2-a]pyrimidin-4- one::US20240368133, Compound A-76 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 5570 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703599 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703599&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212160 507747548 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457192 CC(C)Cc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3cc4ccccc4n(C)c3=O)CC2)c1 InChI=1S/C26H31N7O/c1-18(2)14-19-8-9-22(25-27-29-30-28-25)24(15-19)33-12-10-32(11-13-33)17-21-16-20-6-4-5-7-23(20)31(3)26(21)34/h4-9,15-16,18H,10-14,17H2,1-3H3,(H,27,28,29,30) UYHUAHOPOLDEMY-UHFFFAOYSA-N 703600 3-[[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-1- methyl-quinolin-2- one::US20240368133, Compound A-77 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 2910 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703600 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703600&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212224 507747549 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457193 CC(C)Cc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4c(=O)n3C)CC2)c1 InChI=1S/C25H30N8O/c1-17(2)14-18-8-9-20(24-27-29-30-28-24)22(15-18)33-12-10-32(11-13-33)16-23-26-21-7-5-4-6-19(21)25(34)31(23)3/h4-9,15,17H,10-14,16H2,1-3H3,(H,27,28,29,30) OOPCXNVSMSLSQJ-UHFFFAOYSA-N 703601 2-[[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-3- methyl-quinazolin- 4-one::US20240368133, Compound A-78 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 1500 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703601 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703601&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 169608773 507747550 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457194 CC(C)Cc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4n(C)c3=O)CC2)c1 InChI=1S/C25H30N8O/c1-17(2)14-18-8-9-19(24-27-29-30-28-24)23(15-18)33-12-10-32(11-13-33)16-21-25(34)31(3)22-7-5-4-6-20(22)26-21/h4-9,15,17H,10-14,16H2,1-3H3,(H,27,28,29,30) CEHUUZNCKBTXNP-UHFFFAOYSA-N 703602 3-[[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-1- methyl-quinoxalin- 2-one::US20240368133, Compound A-79 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 4720 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703602 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703602&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 169609287 507747551 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457195 CC(C)Cc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3cnc4ccccn34)CC2)c1 InChI=1S/C23H28N8/c1-17(2)13-18-6-7-20(23-25-27-28-26-23)21(14-18)30-11-9-29(10-12-30)16-19-15-24-22-5-3-4-8-31(19)22/h3-8,14-15,17H,9-13,16H2,1-2H3,(H,25,26,27,28) XKLVSLJOMQXWII-UHFFFAOYSA-N 703603 3-[[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]imid- azo[1,2-a]pyridine::US20240368133, Compound A-80 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 222 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703603 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703603&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443912 507747552 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457196 CC(C)Cc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3nn(C)c4ccccc34)CC2)c1 InChI=1S/C24H30N8/c1-17(2)14-18-8-9-20(24-25-28-29-26-24)23(15-18)32-12-10-31(11-13-32)16-21-19-6-4-5-7-22(19)30(3)27-21/h4-9,15,17H,10-14,16H2,1-3H3,(H,25,26,28,29) LOUZYFDGCFIFMQ-UHFFFAOYSA-N 703604 3-[[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-1- methyl-indazole::US20240368133, Compound A-81 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 1840 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703604 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703604&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443874 507747553 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457197 Cc1cc(CN2CCN(c3cc(CC(C)C)ccc3-c3nn[nH]n3)CC2)no1 InChI=1S/C20H27N7O/c1-14(2)10-16-4-5-18(20-21-24-25-22-20)19(12-16)27-8-6-26(7-9-27)13-17-11-15(3)28-23-17/h4-5,11-12,14H,6-10,13H2,1-3H3,(H,21,22,24,25) STNGCOYIIGWMGC-UHFFFAOYSA-N 703605 3-[[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-5- methyl-isoxazole::US20240368133, Compound A-82 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 3200 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703605 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703605&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171779756 507747554 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457198 CC(C)Cc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3nccn3C)CC2)c1 InChI=1S/C20H28N8/c1-15(2)12-16-4-5-17(20-22-24-25-23-20)18(13-16)28-10-8-27(9-11-28)14-19-21-6-7-26(19)3/h4-7,13,15H,8-12,14H2,1-3H3,(H,22,23,24,25) DCPPQXQQHQZDAC-UHFFFAOYSA-N 703606 1-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]-4-[(1-meth- ylimidazol-2-yl)- methyl]piperazine::US20240368133, Compound A-83 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 1780 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703606 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703606&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212218 507747555 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457199 CC(C)Cc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3ccnn3C)CC2)c1 InChI=1S/C20H28N8/c1-15(2)12-16-4-5-18(20-22-24-25-23-20)19(13-16)28-10-8-27(9-11-28)14-17-6-7-21-26(17)3/h4-7,13,15H,8-12,14H2,1-3H3,(H,22,23,24,25) AACFVNRFNGGNFL-UHFFFAOYSA-N 703607 1-[5-isobutyl-2-(2H- tetrazol-5-yl)phen- yl]-4-[(2-methylpyr- azol-3-yl)methyl]- piperazine::US20240368133, Compound A-84 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 2370 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703607 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703607&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171779849 507747556 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457200 CC(C)Cc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3ccc(C(F)(F)F)cn3)CC2)c1 InChI=1S/C22H26F3N7/c1-15(2)11-16-3-6-19(21-27-29-30-28-21)20(12-16)32-9-7-31(8-10-32)14-18-5-4-17(13-26-18)22(23,24)25/h3-6,12-13,15H,7-11,14H2,1-2H3,(H,27,28,29,30) GMJPGTYOORVHSE-UHFFFAOYSA-N 703608 1-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]-4-[[5- (trifluoromethyl)-2- pyridyl]methyl]- piperazine::US20240368133, Compound A-85 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 2030 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703608 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703608&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212209 507747557 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457201 Cc1nc(CN2CCN(c3cc(CC(C)C)ccc3-c3nn[nH]n3)CC2)no1 InChI=1S/C19H26N8O/c1-13(2)10-15-4-5-16(19-21-24-25-22-19)17(11-15)27-8-6-26(7-9-27)12-18-20-14(3)28-23-18/h4-5,11,13H,6-10,12H2,1-3H3,(H,21,22,24,25) KXVZIJGOZNILCE-UHFFFAOYSA-N 703609 3-[[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin-1- yl]methyl]-5-meth- yl-1,2,4-oxadiazole::US20240368133, Compound A-86 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 24900 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703609 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703609&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171779786 507747558 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457202 Cc1nc(CN2CCN(c3cc(CC(C)C)ccc3-c3nn[nH]n3)CC2)cs1 InChI=1S/C20H27N7S/c1-14(2)10-16-4-5-18(20-22-24-25-23-20)19(11-16)27-8-6-26(7-9-27)12-17-13-28-15(3)21-17/h4-5,11,13-14H,6-10,12H2,1-3H3,(H,22,23,24,25) HCHBICNWUBJWNM-UHFFFAOYSA-N 703610 4-[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-2- methyl-thiazole::US20240368133, Compound A-87 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 3810 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703610 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703610&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212219 507747559 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457203 CC(C)Cc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3ncccn3)CC2)c1 InChI=1S/C20H26N8/c1-15(2)12-16-4-5-17(20-23-25-26-24-20)18(13-16)28-10-8-27(9-11-28)14-19-21-6-3-7-22-19/h3-7,13,15H,8-12,14H2,1-2H3,(H,23,24,25,26) MJEWTJHYAKYADI-UHFFFAOYSA-N 703611 2-[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]pyrimi- dine::US20240368133, Compound A-88 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 15500 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703611 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703611&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212171 507747560 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457204 Cc1cc(CN2CCN(c3cc(CC(C)C)ccc3-c3nn[nH]n3)CC2)on1 InChI=1S/C20H27N7O/c1-14(2)10-16-4-5-18(20-21-24-25-22-20)19(12-16)27-8-6-26(7-9-27)13-17-11-15(3)23-28-17/h4-5,11-12,14H,6-10,13H2,1-3H3,(H,21,22,24,25) CSUSRKOHUNOBJA-UHFFFAOYSA-N 703612 5-[[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-3- methyl-isoxazole::US20240368133, Compound A-89 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 9780 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703612 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703612&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212140 507747561 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457205 CC(C)Cc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3cccnn3)CC2)c1 InChI=1S/C20H26N8/c1-15(2)12-16-5-6-18(20-23-25-26-24-20)19(13-16)28-10-8-27(9-11-28)14-17-4-3-7-21-22-17/h3-7,13,15H,8-12,14H2,1-2H3,(H,23,24,25,26) SZKDLFCVEOOVKS-UHFFFAOYSA-N 703613 3-[[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]pyrid- azine::US20240368133, Compound A-90 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 2030 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703613 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703613&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171779734 507747562 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457206 c5cnnc(CN4CCN(c2cc(C1CC1)ccc2c3nn[nH]n3)CC4)c5 InChI=1S/C19H22N8/c1-2-16(21-20-7-1)13-26-8-10-27(11-9-26)18-12-15(14-3-4-14)5-6-17(18)19-22-24-25-23-19/h1-2,5-7,12,14H,3-4,8-11,13H2,(H,22,23,24,25) ZDRKJCTYTXGQAJ-UHFFFAOYSA-N 703614 3-[[4-[5-cycloprop- yl-2-(2H-tetrazol-5- yl)phenyl]piperazin- 1-yl]methyl]pyrid- azine::US20240368133, Compound A-91 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 23700 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703614 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703614&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171780082 507747563 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457207 Cc1nnc(CN2CCN(c3cc(CC(C)C)ccc3-c3nn[nH]n3)CC2)o1 InChI=1S/C19H26N8O/c1-13(2)10-15-4-5-16(19-22-24-25-23-19)17(11-15)27-8-6-26(7-9-27)12-18-21-20-14(3)28-18/h4-5,11,13H,6-10,12H2,1-3H3,(H,22,23,24,25) ZYDLCYVBXHXJKT-UHFFFAOYSA-N 703615 2-[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-5- methyl-1,3,4-oxa- diazole::US20240368133, Compound A-92 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 15600 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703615 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703615&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212164 507747564 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457208 CC(C)Cc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3cnccn3)CC2)c1 InChI=1S/C20H26N8/c1-15(2)11-16-3-4-18(20-23-25-26-24-20)19(12-16)28-9-7-27(8-10-28)14-17-13-21-5-6-22-17/h3-6,12-13,15H,7-11,14H2,1-2H3,(H,23,24,25,26) XZHKERYFAZYIEL-UHFFFAOYSA-N 703616 2-[[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]pyr- azine::US20240368133, Compound A-93 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 6980 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703616 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703616&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212166 507747565 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457209 CC(C)Cc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3nncn3C)CC2)c1 InChI=1S/C19H27N9/c1-14(2)10-15-4-5-16(19-22-24-25-23-19)17(11-15)28-8-6-27(7-9-28)12-18-21-20-13-26(18)3/h4-5,11,13-14H,6-10,12H2,1-3H3,(H,22,23,24,25) STTPJLLXOOWZRB-UHFFFAOYSA-N 703617 1-[5-isobutyl-2-(2H- tetrazol-5-yl)phen- yl]-4-[(4-methyl- 1,2,4-triazol-3-yl)- methyl]piperazine::US20240368133, Compound A-94 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 4770 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703617 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703617&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171779861 507747566 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457210 Cc1nc(=O)cc(CN2CCN(c3cc(CC(C)C)ccc3-c3nn[nH]n3)CC2)[nH]1 InChI=1S/C21H28N8O/c1-14(2)10-16-4-5-18(21-24-26-27-25-21)19(11-16)29-8-6-28(7-9-29)13-17-12-20(30)23-15(3)22-17/h4-5,11-12,14H,6-10,13H2,1-3H3,(H,22,23,30)(H,24,25,26,27) BTQKJINBXCMNHO-UHFFFAOYSA-N 703618 6-[[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-2- methyl-1H-pyrimi- din-4-one::US20240368133, Compound A-95 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 43300 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703618 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703618&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171779794 507747567 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457211 Cc1noc(CN2CCN(c3cc(CC(C)C)ccc3-c3nn[nH]n3)CC2)n1 InChI=1S/C19H26N8O/c1-13(2)10-15-4-5-16(19-21-24-25-22-19)17(11-15)27-8-6-26(7-9-27)12-18-20-14(3)23-28-18/h4-5,11,13H,6-10,12H2,1-3H3,(H,21,22,24,25) KLDYZCZNRTVBEE-UHFFFAOYSA-N 703619 5-[[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-3- methyl-1,2,4-oxa- diazole::US20240368133, Compound A-96 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 13200 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703619 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703619&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212187 507747568 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457212 CC(C)Cc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3nccs3)CC2)c1 InChI=1S/C19H25N7S/c1-14(2)11-15-3-4-16(19-21-23-24-22-19)17(12-15)26-8-6-25(7-9-26)13-18-20-5-10-27-18/h3-5,10,12,14H,6-9,11,13H2,1-2H3,(H,21,22,23,24) CORREKGVQWIDFN-UHFFFAOYSA-N 703620 2-[[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin-1- yl]methyl]thiazole::US20240368133, Compound A-97 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 757 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703620 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703620&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171780086 507747569 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457213 CC(C)Cc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3ncco3)CC2)c1 InChI=1S/C19H25N7O/c1-14(2)11-15-3-4-16(19-21-23-24-22-19)17(12-15)26-8-6-25(7-9-26)13-18-20-5-10-27-18/h3-5,10,12,14H,6-9,11,13H2,1-2H3,(H,21,22,23,24) OOLAABOZZUPRBB-UHFFFAOYSA-N 703621 2-[[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin-1- yl]methyl]oxazole::US20240368133, Compound A-98 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 5690 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703621 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703621&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212145 507747570 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457214 Cc1nccc(CN2CCN(c3cc(CC(C)C)ccc3-c3nn[nH]n3)CC2)n1 InChI=1S/C21H28N8/c1-15(2)12-17-4-5-19(21-24-26-27-25-21)20(13-17)29-10-8-28(9-11-29)14-18-6-7-22-16(3)23-18/h4-7,13,15H,8-12,14H2,1-3H3,(H,24,25,26,27) GJEMJRVFDHBHDR-UHFFFAOYSA-N 703622 4-[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-2- methyl-pyrimidine::US20240368133, Compound A-99 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 33900 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703622 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703622&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212141 507747571 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457215 Cc1cc(=O)nc(CN2CCN(c3cc(CC(C)C)ccc3-c3nn[nH]n3)CC2)[nH]1 InChI=1S/C21H28N8O/c1-14(2)10-16-4-5-17(21-24-26-27-25-21)18(12-16)29-8-6-28(7-9-29)13-19-22-15(3)11-20(30)23-19/h4-5,11-12,14H,6-10,13H2,1-3H3,(H,22,23,30)(H,24,25,26,27) ZWCNZEAHIUCRPJ-UHFFFAOYSA-N 703623 2-[[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-6- methyl-1H-pyrimi- din-4-one::US20240368133, Compound A-100 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 16500 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703623 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703623&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171779764 507747572 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457216 Cc1noc(C)c1CN1CCN(c2cc(CC(C)C)ccc2-c2nn[nH]n2)CC1 InChI=1S/C21H29N7O/c1-14(2)11-17-5-6-18(21-22-25-26-23-21)20(12-17)28-9-7-27(8-10-28)13-19-15(3)24-29-16(19)4/h5-6,12,14H,7-11,13H2,1-4H3,(H,22,23,25,26) RGSCPQMWEDHRTL-UHFFFAOYSA-N 703624 4-[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-3,5- dimethyl-isoxazole::US20240368133, Compound A-101 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 4480 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703624 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703624&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212216 507747573 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457217 CC(C)Cc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3cc(C4CC4)on3)CC2)c1 InChI=1S/C22H29N7O/c1-15(2)11-16-3-6-19(22-23-26-27-24-22)20(12-16)29-9-7-28(8-10-29)14-18-13-21(30-25-18)17-4-5-17/h3,6,12-13,15,17H,4-5,7-11,14H2,1-2H3,(H,23,24,26,27) UAAZLVBYYVFCQQ-UHFFFAOYSA-N 703625 5-cyclopropyl-3-[4- [5-isobutyl-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]isoxazole::US20240368133, Compound A-102 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 7070 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703625 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703625&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171779903 507747574 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457218 Cc1ncc(CN2CCN(c3cc(CC(C)C)ccc3-c3nn[nH]n3)CC2)cn1 InChI=1S/C21H28N8/c1-15(2)10-17-4-5-19(21-24-26-27-25-21)20(11-17)29-8-6-28(7-9-29)14-18-12-22-16(3)23-13-18/h4-5,11-13,15H,6-10,14H2,1-3H3,(H,24,25,26,27) NQKUCHWTUDLESS-UHFFFAOYSA-N 703626 5-[[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-2- methyl-pyrimidine::US20240368133, Compound A-103 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 12200 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703626 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703626&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212195 507747575 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457219 Cc1cc(CN2CCN(c3cc(CC(C)C)ccc3-c3nn[nH]n3)CC2)n(C)n1 InChI=1S/C21H30N8/c1-15(2)11-17-5-6-19(21-22-25-26-23-21)20(13-17)29-9-7-28(8-10-29)14-18-12-16(3)24-27(18)4/h5-6,12-13,15H,7-11,14H2,1-4H3,(H,22,23,25,26) AGDLPOPOTXOFSY-UHFFFAOYSA-N 703627 1-[(2,5-dimethyl- pyrazol-3-yl)meth- yl]-4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazine::US20240368133, Compound A-104 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 6000 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703627 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703627&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212191 507747576 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457220 CC(C)Cc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3cncn3C)CC2)c1 InChI=1S/C20H28N8/c1-15(2)10-16-4-5-18(20-22-24-25-23-20)19(11-16)28-8-6-27(7-9-28)13-17-12-21-14-26(17)3/h4-5,11-12,14-15H,6-10,13H2,1-3H3,(H,22,23,24,25) FTDSCPMLEBEWHO-UHFFFAOYSA-N 703628 1-[5-isobutyl-2-(2H- tetrazol-5-yl)phen- yl]-4-[(3-methyl- imidazol-4-yl)meth- yl]piperazine::US20240368133, Compound A-105 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 2000 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703628 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703628&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171780010 507747577 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457221 Cc1cnc(CN2CCN(c3cc(CC(C)C)ccc3-c3nn[nH]n3)CC2)s1 InChI=1S/C20H27N7S/c1-14(2)10-16-4-5-17(20-22-24-25-23-20)18(11-16)27-8-6-26(7-9-27)13-19-21-12-15(3)28-19/h4-5,11-12,14H,6-10,13H2,1-3H3,(H,22,23,24,25) RNQVIYUSGBXHJD-UHFFFAOYSA-N 703629 2-[[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-5- methyl-thiazole::US20240368133, Compound A-106 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 35.5 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703629 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703629&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171779941 507747578 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457222 CC(C)Cc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3cccc(C#N)n3)CC2)c1 InChI=1S/C22H26N8/c1-16(2)12-17-6-7-20(22-25-27-28-26-22)21(13-17)30-10-8-29(9-11-30)15-19-5-3-4-18(14-23)24-19/h3-7,13,16H,8-12,15H2,1-2H3,(H,25,26,27,28) QFRQFMDTAQXDBR-UHFFFAOYSA-N 703630 6-[[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]pyr- idine-2-carbonitrile::US20240368133, Compound A-107 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 54900 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703630 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703630&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212169 507747579 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457223 CC(C)Cc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3ncon3)CC2)c1 InChI=1S/C18H24N8O/c1-13(2)9-14-3-4-15(18-20-23-24-21-18)16(10-14)26-7-5-25(6-8-26)11-17-19-12-27-22-17/h3-4,10,12-13H,5-9,11H2,1-2H3,(H,20,21,23,24) ZNVBNILUWGXZQG-UHFFFAOYSA-N 703631 3-[[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-1,2,4- oxadiazole::US20240368133, Compound A-108 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 41700 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703631 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703631&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212220 507747580 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457224 CC(C)Cc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3cn(C)cn3)CC2)c1 InChI=1S/C20H28N8/c1-15(2)10-16-4-5-18(20-22-24-25-23-20)19(11-16)28-8-6-27(7-9-28)13-17-12-26(3)14-21-17/h4-5,11-12,14-15H,6-10,13H2,1-3H3,(H,22,23,24,25) KSCIDNNXPWPRRS-UHFFFAOYSA-N 703632 1-[5-isobutyl-2-(2H- tetrazol-5-yl)phen- yl]-4-[(1-methyl- imidazol-4-yl)meth- yl]piperazine::US20240368133, Compound A-109 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 40400 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703632 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703632&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212199 507747581 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457225 CC(C)Cc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3ccn(C)n3)CC2)c1 InChI=1S/C20H28N8/c1-15(2)12-16-4-5-18(20-21-24-25-22-20)19(13-16)28-10-8-27(9-11-28)14-17-6-7-26(3)23-17/h4-7,13,15H,8-12,14H2,1-3H3,(H,21,22,24,25) IKHWVKYWUARYJX-UHFFFAOYSA-N 703633 1-[5-isobutyl-2-(2H- tetrazol-5-yl)phen- yl]-4-[(1-methyl- pyrazol-3-yl)meth- yl]piperazine::US20240368133, Compound A-110 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 17800 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703633 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703633&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212222 507747582 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457226 Cc1scnc1CN1CCN(c2cc(CC(C)C)ccc2-c2nn[nH]n2)CC1 InChI=1S/C20H27N7S/c1-14(2)10-16-4-5-17(20-22-24-25-23-20)19(11-16)27-8-6-26(7-9-27)12-18-15(3)28-13-21-18/h4-5,11,13-14H,6-10,12H2,1-3H3,(H,22,23,24,25) IBJSKBZWOYFZMZ-UHFFFAOYSA-N 703634 4-[[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-5- methyl-thiazole::US20240368133, Compound A-111 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 5430 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703634 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703634&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171779956 507747583 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457227 Cc1cnnc(CN2CCN(c3cc(CC(C)C)ccc3-c3nn[nH]n3)CC2)c1 InChI=1S/C21H28N8/c1-15(2)10-17-4-5-19(21-24-26-27-25-21)20(12-17)29-8-6-28(7-9-29)14-18-11-16(3)13-22-23-18/h4-5,11-13,15H,6-10,14H2,1-3H3,(H,24,25,26,27) QGTCXWIFCQMYQU-UHFFFAOYSA-N 703635 3-[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-5- methyl-pyridazine::US20240368133, Compound A-112 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 697 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703635 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703635&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443476 507747584 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457228 Cc1ccc(CN2CCN(c3cc(CC(C)C)ccc3-c3nn[nH]n3)CC2)nn1 InChI=1S/C21H28N8/c1-15(2)12-17-5-7-19(21-24-26-27-25-21)20(13-17)29-10-8-28(9-11-29)14-18-6-4-16(3)22-23-18/h4-7,13,15H,8-12,14H2,1-3H3,(H,24,25,26,27) SPYAMJBZDOEMAX-UHFFFAOYSA-N 703636 3-[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-6- methyl-pyridazine::US20240368133, Compound A-113 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 7070 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703636 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703636&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443588 507747585 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457229 Cc1ncc(CN2CCN(c3cc(CC(C)C)ccc3-c3nn[nH]n3)CC2)n1C InChI=1S/C21H30N8/c1-15(2)11-17-5-6-19(21-23-25-26-24-21)20(12-17)29-9-7-28(8-10-29)14-18-13-22-16(3)27(18)4/h5-6,12-13,15H,7-11,14H2,1-4H3,(H,23,24,25,26) HYFCKPPJPUYSAI-UHFFFAOYSA-N 703637 1-[(2,3-dimethyl- imidazol-4-yl)meth- yl]-4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazine::US20240368133, Compound A-114 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 18700 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703637 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703637&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212143 507747586 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457230 COc4ccc(CN3CCN(c1cc(CC(C)C)ccc1c2nn[nH]n2)CC3)nn4 InChI=1S/C21H28N8O/c1-15(2)12-16-4-6-18(21-24-26-27-25-21)19(13-16)29-10-8-28(9-11-29)14-17-5-7-20(30-3)23-22-17/h4-7,13,15H,8-12,14H2,1-3H3,(H,24,25,26,27) POKVJFQHBQHNHJ-UHFFFAOYSA-N 703638 3-[[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-6- methoxy-pyridazine::US20240368133, Compound A-115 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 1980 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703638 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703638&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 169608429 507747587 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457231 COc1cc(F)c(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4s3)CC2)c1 InChI=1S/C20H20FN7OS/c1-29-13-10-14(21)19(20-23-25-26-24-20)16(11-13)28-8-6-27(7-9-28)12-18-22-15-4-2-3-5-17(15)30-18/h2-5,10-11H,6-9,12H2,1H3,(H,23,24,25,26) WQIRDCXYANOVGQ-UHFFFAOYSA-N 703639 2-[[4-[3-fluoro-5- methoxy-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]-1,3-benzo- thiazole::US20240368133, Compound A-116 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 8980 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703639 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703639&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443740 507747588 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457232 COc1cc(N2CCN(Cc3nc4ccccc4s3)CC2)c(-c2nn[nH]n2)cc1F InChI=1S/C20H20FN7OS/c1-29-17-11-16(13(10-14(17)21)20-23-25-26-24-20)28-8-6-27(7-9-28)12-19-22-15-4-2-3-5-18(15)30-19/h2-5,10-11H,6-9,12H2,1H3,(H,23,24,25,26) LKVXYQLFIINAGU-UHFFFAOYSA-N 703640 2-[[4-[4-fluoro-5- methoxy-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]-1,3-benzo- thiazole::US20240368133, Compound A-117 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 52600 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703640 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703640&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443806 507747589 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457233 CC(C)Oc1cc(F)c(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4s3)CC2)c1 InChI=1S/C22H24FN7OS/c1-14(2)31-15-11-16(23)21(22-25-27-28-26-22)18(12-15)30-9-7-29(8-10-30)13-20-24-17-5-3-4-6-19(17)32-20/h3-6,11-12,14H,7-10,13H2,1-2H3,(H,25,26,27,28) LHURIVKKIJIPFQ-UHFFFAOYSA-N 703641 2-[[4-[3-fluoro-5- isopropoxy-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]-1,3-benzo- thiazole::US20240368133, Compound A-118 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 1000 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703641 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703641&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443502 507747590 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457234 CCc1cc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4s3)CC2)cc1OC(C)C InChI=1S/C24H29N7OS/c1-4-17-13-18(24-26-28-29-27-24)20(14-21(17)32-16(2)3)31-11-9-30(10-12-31)15-23-25-19-7-5-6-8-22(19)33-23/h5-8,13-14,16H,4,9-12,15H2,1-3H3,(H,26,27,28,29) AVWLSAWRNJSXCL-UHFFFAOYSA-N 703642 2-[[4-[4-ethyl-5- isopropoxy-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]-1,3-benzo- thiazole::US20240368133, Compound A-119 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 9420 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703642 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703642&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443929 507747591 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457235 CCc1cc(OC(C)C)cc(N2CCN(Cc3nc4ccccc4s3)CC2)c1-c1nn[nH]n1 InChI=1S/C24H29N7OS/c1-4-17-13-18(32-16(2)3)14-20(23(17)24-26-28-29-27-24)31-11-9-30(10-12-31)15-22-25-19-7-5-6-8-21(19)33-22/h5-8,13-14,16H,4,9-12,15H2,1-3H3,(H,26,27,28,29) YAZCXDLSXREDIA-UHFFFAOYSA-N 703643 2-[[4-[3-ethyl-5-iso- propoxy-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]-1,3-benzo- thiazole::US20240368133, Compound A-120 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 459 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703643 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703643&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443896 507747592 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457236 CC(C)Oc1cc(N2CCN(Cc3nc4ccccc4s3)CC2)c(-c2nn[nH]n2)cc1C1CC1 InChI=1S/C25H29N7OS/c1-16(2)33-22-14-21(19(25-27-29-30-28-25)13-18(22)17-7-8-17)32-11-9-31(10-12-32)15-24-26-20-5-3-4-6-23(20)34-24/h3-6,13-14,16-17H,7-12,15H2,1-2H3,(H,27,28,29,30) NKVWZVYZVBNTLF-UHFFFAOYSA-N 703644 2-[[4-[4-cycloprop- yl-5-isopropoxy-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-1,3- benzothiazole::US20240368133, Compound A-121 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 2780 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703644 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703644&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443797 507747593 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457237 CC(C)Oc1cc(C2CC2)c(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4s3)CC2)c1 InChI=1S/C25H29N7OS/c1-16(2)33-18-13-19(17-7-8-17)24(25-27-29-30-28-25)21(14-18)32-11-9-31(10-12-32)15-23-26-20-5-3-4-6-22(20)34-23/h3-6,13-14,16-17H,7-12,15H2,1-2H3,(H,27,28,29,30) OYBCYGUEXHXGHQ-UHFFFAOYSA-N 703645 2-[[4-[3-cycloprop- yl-5-isopropoxy-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-1,3- benzothiazole::US20240368133, Compound A-122 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 293 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703645 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703645&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443885 507747594 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457238 CCOc1cc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4s3)CC2)cc1OC(C)C InChI=1S/C24H29N7O2S/c1-4-32-20-13-17(24-26-28-29-27-24)19(14-21(20)33-16(2)3)31-11-9-30(10-12-31)15-23-25-18-7-5-6-8-22(18)34-23/h5-8,13-14,16H,4,9-12,15H2,1-3H3,(H,26,27,28,29) DPSLRNDTSKFNIL-UHFFFAOYSA-N 703646 2-[[4-[4-ethoxy-5- isopropoxy-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]-1,3-benzo- thiazole::US20240368133, Compound A-123 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 4880 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703646 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703646&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443928 507747595 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457239 Fc1cc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4s3)CC2)cc1C1CC1 InChI=1S/C22H22FN7S/c23-17-11-16(22-25-27-28-26-22)19(12-15(17)14-5-6-14)30-9-7-29(8-10-30)13-21-24-18-3-1-2-4-20(18)31-21/h1-4,11-12,14H,5-10,13H2,(H,25,26,27,28) MAVRIVKHLFJXTR-UHFFFAOYSA-N 703647 2-[[4-[5-cycloprop- yl-4-fluoro-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]-1,3-benzo- thiazole::US20240368133, Compound A-124 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 18100 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703647 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703647&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443846 507747596 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457240 Fc1cc(C2CC2)cc(N2CCN(Cc3nc4ccccc4s3)CC2)c1-c1nn[nH]n1 InChI=1S/C22H22FN7S/c23-16-11-15(14-5-6-14)12-18(21(16)22-25-27-28-26-22)30-9-7-29(8-10-30)13-20-24-17-3-1-2-4-19(17)31-20/h1-4,11-12,14H,5-10,13H2,(H,25,26,27,28) PSNOYWPOVUGDAZ-UHFFFAOYSA-N 703648 2-[[4-[5-cycloprop- yl-3-fluoro-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]-1,3-benzo- thiazole::US20240368133, Compound A-125 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 389 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703648 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703648&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443679 507747597 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457241 Cc1cc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4s3)CC2)cc1C1CC1 InChI=1S/C23H25N7S/c1-15-12-18(23-25-27-28-26-23)20(13-17(15)16-6-7-16)30-10-8-29(9-11-30)14-22-24-19-4-2-3-5-21(19)31-22/h2-5,12-13,16H,6-11,14H2,1H3,(H,25,26,27,28) NRFNLJQQRUSVQZ-UHFFFAOYSA-N 703649 2-[[4-[5-cycloprop- yl-4-methyl-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]-1,3-benzo- thiazole::US20240368133, Compound A-126 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 22600 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703649 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703649&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443684 507747598 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457242 Cc1cc(C2CC2)cc(N2CCN(Cc3nc4ccccc4s3)CC2)c1-c1nn[nH]n1 InChI=1S/C23H25N7S/c1-15-12-17(16-6-7-16)13-19(22(15)23-25-27-28-26-23)30-10-8-29(9-11-30)14-21-24-18-4-2-3-5-20(18)31-21/h2-5,12-13,16H,6-11,14H2,1H3,(H,25,26,27,28) BMANYNCFNJQRHW-UHFFFAOYSA-N 703650 2-[[4-[5-cycloprop- yl-3-methyl-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]-1,3-benzo- thiazole::US20240368133, Compound A-127 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 74.4 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703650 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703650&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443719 507747599 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457243 CCc1cc(C2CC2)cc(N2CCN(Cc3nc4ccccc4s3)CC2)c1-c1nn[nH]n1 InChI=1S/C24H27N7S/c1-2-16-13-18(17-7-8-17)14-20(23(16)24-26-28-29-27-24)31-11-9-30(10-12-31)15-22-25-19-5-3-4-6-21(19)32-22/h3-6,13-14,17H,2,7-12,15H2,1H3,(H,26,27,28,29) UFPITGXLLJJHEC-UHFFFAOYSA-N 703651 2-[[4-[5-cycloprop- yl-3-ethyl-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]-1,3-benzo- thiazole::US20240368133, Compound A-128 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 2190 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703651 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703651&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443539 507747600 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457244 c1ccc2sc(CN3CCN(c4cc(C5CC5)cc(C5CC5)c4-c4nn[nH]n4)CC3)nc2c1 InChI=1S/C25H27N7S/c1-2-4-22-20(3-1)26-23(33-22)15-31-9-11-32(12-10-31)21-14-18(16-5-6-16)13-19(17-7-8-17)24(21)25-27-29-30-28-25/h1-4,13-14,16-17H,5-12,15H2,(H,27,28,29,30) WBNKIEFQDUNKJL-UHFFFAOYSA-N 703652 2-[[4-[3,5-dicyclo- propyl-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]-1,3-benzo- thiazole::US20240368133, Compound A-129 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 158 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703652 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703652&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443914 507747601 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457245 CCNc1cc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4s3)CC2)cc1C1CC1 InChI=1S/C24H28N8S/c1-2-25-20-13-18(24-27-29-30-28-24)21(14-17(20)16-7-8-16)32-11-9-31(10-12-32)15-23-26-19-5-3-4-6-22(19)33-23/h3-6,13-14,16,25H,2,7-12,15H2,1H3,(H,27,28,29,30) VFHSWKLKSBQUGB-UHFFFAOYSA-N 703653 4-[4-(1,3-benzothi- azol-2-ylmethyl)- piperazin-1-yl]-2- cyclopropyl-N-eth- yl-5-(2H-tetrazol-5- yl)aniline::US20240368133, Compound A-130 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 28800 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703653 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703653&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443943 507747602 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457246 CC(=O)Nc1cc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4s3)CC2)cc1C1CC1 InChI=1S/C24H26N8OS/c1-15(33)25-20-12-18(24-27-29-30-28-24)21(13-17(20)16-6-7-16)32-10-8-31(9-11-32)14-23-26-19-4-2-3-5-22(19)34-23/h2-5,12-13,16H,6-11,14H2,1H3,(H,25,33)(H,27,28,29,30) AWGZOWJZYITCRN-UHFFFAOYSA-N 703654 N-[4-[4-(1,3-benzo- thiazol-2-ylmethyl)- piperazin-1-yl]-2- cyclopropyl-5-(2H- tetrazol-5-yl)phen- yl]acetamide::US20240368133, Compound A-131 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 13300 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703654 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703654&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443772 507747603 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457247 CC(C)Cc1cc(F)c(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4s3)CC2)c1 InChI=1S/C23H26FN7S/c1-15(2)11-16-12-17(24)22(23-26-28-29-27-23)19(13-16)31-9-7-30(8-10-31)14-21-25-18-5-3-4-6-20(18)32-21/h3-6,12-13,15H,7-11,14H2,1-2H3,(H,26,27,28,29) VRHIUHKZOFLPOD-UHFFFAOYSA-N 703655 2-[[4-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]-1,3-benzo- thiazole::US20240368133, Compound A-132 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 355 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703655 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703655&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443745 507747604 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457248 CC(C)Cc1cc(N2CCN(Cc3nc4ccccc4s3)CC2)c(-c2nn[nH]n2)cc1F InChI=1S/C23H26FN7S/c1-15(2)11-16-12-20(17(13-18(16)24)23-26-28-29-27-23)31-9-7-30(8-10-31)14-22-25-19-5-3-4-6-21(19)32-22/h3-6,12-13,15H,7-11,14H2,1-2H3,(H,26,27,28,29) OISUULUGDDYCKB-UHFFFAOYSA-N 703656 2-[[4-[4-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]-1,3-benzo- thiazole::US20240368133, Compound A-133 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 1190 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703656 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703656&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443880 507747605 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457249 Cc1cc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4s3)CC2)cc1CC(C)C InChI=1S/C24H29N7S/c1-16(2)12-18-14-21(19(13-17(18)3)24-26-28-29-27-24)31-10-8-30(9-11-31)15-23-25-20-6-4-5-7-22(20)32-23/h4-7,13-14,16H,8-12,15H2,1-3H3,(H,26,27,28,29) CXFRFUBJQUXYJQ-UHFFFAOYSA-N 703657 2-[[4-[5-isobutyl-4- methyl-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]-1,3-benzo- thiazole::US20240368133, Compound A-134 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 9660 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703657 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703657&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443932 507747606 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457250 Cc1cc(CC(C)C)cc(N2CCN(Cc3nc4ccccc4s3)CC2)c1-c1nn[nH]n1 InChI=1S/C24H29N7S/c1-16(2)12-18-13-17(3)23(24-26-28-29-27-24)20(14-18)31-10-8-30(9-11-31)15-22-25-19-6-4-5-7-21(19)32-22/h4-7,13-14,16H,8-12,15H2,1-3H3,(H,26,27,28,29) GVMVCLIXSWEFDM-UHFFFAOYSA-N 703658 2-[4-[5-isobutyl-3- methyl-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]-1,3-benzo- thiazole::US20240368133, Compound A-135 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 22.0 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703658 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703658&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443815 507747607 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457251 CCc1cc(CC(C)C)cc(N2CCN(Cc3nc4ccccc4s3)CC2)c1-c1nn[nH]n1 InChI=1S/C25H31N7S/c1-4-19-14-18(13-17(2)3)15-21(24(19)25-27-29-30-28-25)32-11-9-31(10-12-32)16-23-26-20-7-5-6-8-22(20)33-23/h5-8,14-15,17H,4,9-13,16H2,1-3H3,(H,27,28,29,30) ICZQIKJWRANHEY-UHFFFAOYSA-N 703659 2-[[4-[3-ethyl-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]-1,3-benzo- thiazole::US20240368133, Compound A-136 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 12.1 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703659 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703659&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443530 507747608 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457252 CC(C)Cc1cc(C2CC2)c(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4s3)CC2)c1 InChI=1S/C26H31N7S/c1-17(2)13-18-14-20(19-7-8-19)25(26-28-30-31-29-26)22(15-18)33-11-9-32(10-12-33)16-24-27-21-5-3-4-6-23(21)34-24/h3-6,14-15,17,19H,7-13,16H2,1-2H3,(H,28,29,30,31) XOPUKAIAFXQCPN-UHFFFAOYSA-N 703660 2-[[4-[3-cycloprop- yl-5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-1,3- benzothiazole::US20240368133, Compound A-137 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 16.0 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703660 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703660&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443620 507747609 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457253 CC(C)Cc1cc(N2CCN(Cc3nc4ccccc4s3)CC2)c(-c2nn[nH]n2)cc1N InChI=1S/C23H28N8S/c1-15(2)11-16-12-20(17(13-18(16)24)23-26-28-29-27-23)31-9-7-30(8-10-31)14-22-25-19-5-3-4-6-21(19)32-22/h3-6,12-13,15H,7-11,14,24H2,1-2H3,(H,26,27,28,29) JFUHXALLPLTBSM-UHFFFAOYSA-N 703661 4-[4-(1,3-benzo- thiazol-2-ylmethyl)- piperazin-1-yl]-2- isobutyl-5-(2H- tetrazol-5-yl)aniline::US20240368133, Compound A-138 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 4710 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703661 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703661&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443942 507747610 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457254 CNc1cc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4s3)CC2)cc1CC(C)C InChI=1S/C24H30N8S/c1-16(2)12-17-13-21(18(14-20(17)25-3)24-27-29-30-28-24)32-10-8-31(9-11-32)15-23-26-19-6-4-5-7-22(19)33-23/h4-7,13-14,16,25H,8-12,15H2,1-3H3,(H,27,28,29,30) ZQIDCESYPGYZQY-UHFFFAOYSA-N 703662 4-[4-(1,3-benzothi- azol-2-ylmethyl)- piperazin-1-yl]-2- isobutyl-N-methyl- 5-(2H-tetrazol-5- yl)aniline::US20240368133, Compound A-139 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 4960 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703662 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703662&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443641 507747611 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457255 CCNc1cc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4s3)CC2)cc1CC(C)C InChI=1S/C25H32N8S/c1-4-26-21-15-19(25-28-30-31-29-25)22(14-18(21)13-17(2)3)33-11-9-32(10-12-33)16-24-27-20-7-5-6-8-23(20)34-24/h5-8,14-15,17,26H,4,9-13,16H2,1-3H3,(H,28,29,30,31) XYADBGSXMFJHSA-UHFFFAOYSA-N 703663 4-[4-(1,3-benzo- thiazol-2-ylmethyl)- piperazin-1-yl]-N- ethyl-2-isobutyl-5- (2H-tetrazol-5-yl)- aniline::US20240368133, Compound A-140 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 736 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703663 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703663&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443713 507747612 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457256 CCc1cnc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4s3)CC2)c1 InChI=1S/C20H22N8S/c1-2-14-11-16(19(21-12-14)20-23-25-26-24-20)28-9-7-27(8-10-28)13-18-22-15-5-3-4-6-17(15)29-18/h3-6,11-12H,2,7-10,13H2,1H3,(H,23,24,25,26) YHMZAXDVQLQVGK-UHFFFAOYSA-N 703664 2-[4-[5-ethyl-2- (2H-tetrazol-5-yl)- 3-pyridyl]piperazin- 1-yl]methyl]-1,3- benzothiazole::US20240368133, Compound A-141 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 22700 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703664 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703664&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443597 507747613 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457257 CCc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4s3)CC2)n1 InChI=1S/C20H22N8S/c1-2-14-7-8-15(19-23-25-26-24-19)20(21-14)28-11-9-27(10-12-28)13-18-22-16-5-3-4-6-17(16)29-18/h3-8H,2,9-13H2,1H3,(H,23,24,25,26) JGGQTTFZKBTRSH-UHFFFAOYSA-N 703665 2-[[4-[6-ethyl-3- (2H-tetrazol-5-yl)- 2-pyridyl]piperazin- 1-yl]methyl]-1,3- benzothiazole::US20240368133, Compound A-142 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 9110 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703665 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703665&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443631 507747614 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457258 c1ccc2sc(CN3CCN(c4cc(C5CC5)cnc4-c4nn[nH]n4)CC3)nc2c1 InChI=1S/C21H22N8S/c1-2-4-18-16(3-1)23-19(30-18)13-28-7-9-29(10-8-28)17-11-15(14-5-6-14)12-22-20(17)21-24-26-27-25-21/h1-4,11-12,14H,5-10,13H2,(H,24,25,26,27) UCBAYNGLYZTFRW-UHFFFAOYSA-N 703666 2-[[4-[5-cycloprop- yl-2-(2H-tetrazol-5- yl)-3-pyridyl]piper- azin-1-yl]methyl]- 1,3-benzothiazole::US20240368133, Compound A-143 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 5460 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703666 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703666&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443823 507747615 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457259 c1ccc2sc(CN3CCN(c4cc(C5CC5)ncc4-c4nn[nH]n4)CC3)nc2c1 InChI=1S/C21H22N8S/c1-2-4-19-16(3-1)23-20(30-19)13-28-7-9-29(10-8-28)18-11-17(14-5-6-14)22-12-15(18)21-24-26-27-25-21/h1-4,11-12,14H,5-10,13H2,(H,24,25,26,27) KPYQXLSMGFBKRB-UHFFFAOYSA-N 703667 2-[[4-[2-cycloprop- yl-5-(2H-tetrazol-5- yl)-4-pyridyl]piper- azin-1-yl]methyl]- 1,3-benzothiazole::US20240368133, Compound A-144 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 14800 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703667 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703667&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443584 507747616 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457260 c1ccc2sc(CN3CCN(c4nc(C5CC5)ccc4-c4nn[nH]n4)CC3)nc2c1 InChI=1S/C21H22N8S/c1-2-4-18-17(3-1)22-19(30-18)13-28-9-11-29(12-10-28)21-15(20-24-26-27-25-20)7-8-16(23-21)14-5-6-14/h1-4,7-8,14H,5-6,9-13H2,(H,24,25,26,27) ARVMXINEYMYJLX-UHFFFAOYSA-N 703668 2-[[4-[6-cycloprop- yl-3-(2H-tetrazol-5- yl)-2-pyridyl]piper- azin-1-yl]methyl]- 1,3-benzothiazole::US20240368133, Compound A-145 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 8220 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703668 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703668&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443634 507747617 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457261 c1ccc2sc(CN3CCN(c4nc(C5CC5)cnc4-c4nn[nH]n4)CC3)nc2c1 InChI=1S/C20H21N9S/c1-2-4-16-14(3-1)22-17(30-16)12-28-7-9-29(10-8-28)20-18(19-24-26-27-25-19)21-11-15(23-20)13-5-6-13/h1-4,11,13H,5-10,12H2,(H,24,25,26,27) XOQKEGQWCWRUQA-UHFFFAOYSA-N 703669 2-[[4-[6-cycloprop- yl-3-(2H-tetrazol-5- yl)pyrazin-2-yl]- piperazin-1-yl]- methyl]-1,3-benzo- thiazole::US20240368133, Compound A-146 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 9740 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703669 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703669&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443758 507747618 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457262 CC(C)Cc1cnc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4s3)CC2)c1 InChI=1S/C22H26N8S/c1-15(2)11-16-12-18(21(23-13-16)22-25-27-28-26-22)30-9-7-29(8-10-30)14-20-24-17-5-3-4-6-19(17)31-20/h3-6,12-13,15H,7-11,14H2,1-2H3,(H,25,26,27,28) VCZDHKPUDGUAFQ-UHFFFAOYSA-N 703670 2-[[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- 3-pyridyl]piperazin- 1-yl]methyl]-1,3- benzothiazole::US20240368133, Compound A-147 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 1470 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703670 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703670&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443658 507747619 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457263 CC(C)Cc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4s3)CC2)n1 InChI=1S/C22H26N8S/c1-15(2)13-16-7-8-17(21-25-27-28-26-21)22(23-16)30-11-9-29(10-12-30)14-20-24-18-5-3-4-6-19(18)31-20/h3-8,15H,9-14H2,1-2H3,(H,25,26,27,28) DNNPOJZQJGPASB-UHFFFAOYSA-N 703671 2-[[4-[6-isobutyl-3- (2H-tetrazol-5-yl)- 2-pyridyl]piperazin- 1-yl]methyl]-1,3- benzothiazole::US20240368133, Compound A-148 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 6240 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703671 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703671&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443516 507747620 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457264 CC(C)Oc1ccc(-c2nn[nH]n2)c(CN2CCN(c3nc4ccccc4s3)CC2)c1 InChI=1S/C22H25N7OS/c1-15(2)30-17-7-8-18(21-24-26-27-25-21)16(13-17)14-28-9-11-29(12-10-28)22-23-19-5-3-4-6-20(19)31-22/h3-8,13,15H,9-12,14H2,1-2H3,(H,24,25,26,27) MLMZSPFKERSACF-UHFFFAOYSA-N 703672 5-[4-(1,3-benzo- thiazol-2-ylmethyl)- piperazin-1-yl]-N- (cyclopropylmeth- yl)-6-(2H-tetrazol-5- yl)pyridin-3-amine::US20240368133, Compound A-149 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 8400 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703672 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703672&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212159 507747621 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457265 COc1cc(F)c(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4c(=O)[nH]3)CC2)c1 InChI=1S/C21H21FN8O2/c1-32-13-10-15(22)19(20-25-27-28-26-20)17(11-13)30-8-6-29(7-9-30)12-18-23-16-5-3-2-4-14(16)21(31)24-18/h2-5,10-11H,6-9,12H2,1H3,(H,23,24,31)(H,25,26,27,28) KDCVIXXZAKYHJN-UHFFFAOYSA-N 703673 2-[[4-[3-fluoro-5- methoxy-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]-3H-quin- azolin-4-one::US20240368133, Compound A-150 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 33800 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703673 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703673&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212201 507747622 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457266 CC(C)Oc1cc(F)c(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4c(=O)[nH]3)CC2)c1 InChI=1S/C23H25FN8O2/c1-14(2)34-15-11-17(24)21(22-27-29-30-28-22)19(12-15)32-9-7-31(8-10-32)13-20-25-18-6-4-3-5-16(18)23(33)26-20/h3-6,11-12,14H,7-10,13H2,1-2H3,(H,25,26,33)(H,27,28,29,30) YRWDNIBSQSPYJO-UHFFFAOYSA-N 703674 2-[[4-[3-fluoro-5- isopropoxy-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]-3H-quin- azolin-4-one::US20240368133, Compound A-151 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 6790 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703674 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703674&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212207 507747623 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457267 CC(C)Oc1cc(C2CC2)c(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4c(=O)[nH]3)CC2)c1 InChI=1S/C26H30N8O2/c1-16(2)36-18-13-20(17-7-8-17)24(25-29-31-32-30-25)22(14-18)34-11-9-33(10-12-34)15-23-27-21-6-4-3-5-19(21)26(35)28-23/h3-6,13-14,16-17H,7-12,15H2,1-2H3,(H,27,28,35)(H,29,30,31,32) WALAJRDWMVRNKC-UHFFFAOYSA-N 703675 2-[4-[3-cyclopropyl- 5-isopropoxy-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-3H- quinazolin-4-one::US20240368133, Compound A-152 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 2870 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703675 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703675&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 169608628 507747624 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457268 CC(C)Cc1cc(N2CCN(Cc3nc4ccccc4c(=O)[nH]3)CC2)c(-c2nn[nH]n2)cc1F InChI=1S/C24H27FN8O/c1-15(2)11-16-12-21(18(13-19(16)25)23-28-30-31-29-23)33-9-7-32(8-10-33)14-22-26-20-6-4-3-5-17(20)24(34)27-22/h3-6,12-13,15H,7-11,14H2,1-2H3,(H,26,27,34)(H,28,29,30,31) BIWJECFWUZGTEY-UHFFFAOYSA-N 703676 2-[[4-[4-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]-3H-quin- azolin-4-one::US20240368133, Compound A-153 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 8420 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703676 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703676&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 169609330 507747625 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457269 CC(C)Cc1cc(F)c(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4c(=O)[nH]3)CC2)c1 InChI=1S/C24H27FN8O/c1-15(2)11-16-12-18(25)22(23-28-30-31-29-23)20(13-16)33-9-7-32(8-10-33)14-21-26-19-6-4-3-5-17(19)24(34)27-21/h3-6,12-13,15H,7-11,14H2,1-2H3,(H,26,27,34)(H,28,29,30,31) KNGTYFUODJQHMH-UHFFFAOYSA-N 703677 2-[[4-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]-3H-quin- azolin-4-one::US20240368133, Compound A-154 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 160 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703677 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703677&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212176 507747626 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457270 COc1cc(F)c(-c2nn[nH]n2)c(N2CCN(Cc3cccnn3)CC2)c1 InChI=1S/C17H19FN8O/c1-27-13-9-14(18)16(17-21-23-24-22-17)15(10-13)26-7-5-25(6-8-26)11-12-3-2-4-19-20-12/h2-4,9-10H,5-8,11H2,1H3,(H,21,22,23,24) UYWQEGPZFJGJJA-UHFFFAOYSA-N 703678 3-[[4-[3-fluoro-5- methoxy-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]pyridazine::US20240368133, Compound A-155 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 72800 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703678 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703678&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212210 507747627 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457271 CC(C)Oc1cc(F)c(-c2nn[nH]n2)c(N2CCN(Cc3cccnn3)CC2)c1 InChI=1S/C19H23FN8O/c1-13(2)29-15-10-16(20)18(19-23-25-26-24-19)17(11-15)28-8-6-27(7-9-28)12-14-4-3-5-21-22-14/h3-5,10-11,13H,6-9,12H2,1-2H3,(H,23,24,25,26) FOOCOMXDHAMXGS-UHFFFAOYSA-N 703679 3-[[4-[3-fluoro-5- isopropoxy-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]pyridazine::US20240368133, Compound A-156 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 11600 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703679 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703679&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212149 507747628 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457272 CC(C)Oc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3cccnn3)CC2)c1F InChI=1S/C19H23FN8O/c1-13(2)29-16-6-5-15(19-23-25-26-24-19)18(17(16)20)28-10-8-27(9-11-28)12-14-4-3-7-21-22-14/h3-7,13H,8-12H2,1-2H3,(H,23,24,25,26) ONPOIPCVYQXOAD-UHFFFAOYSA-N 703680 3-[[4-[2-fluoro-3- isopropoxy-6-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]pyridazine::US20240368133, Compound A-157 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 34400 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703680 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703680&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212162 507747629 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457273 CCc4cc(c1nn[nH]n1)c(N3CCN(Cc2cccnn2)CC3)cc4OC(C)C InChI=1S/C21H28N8O/c1-4-16-12-18(21-24-26-27-25-21)19(13-20(16)30-15(2)3)29-10-8-28(9-11-29)14-17-6-5-7-22-23-17/h5-7,12-13,15H,4,8-11,14H2,1-3H3,(H,24,25,26,27) FOCHSPHZPQWDQT-UHFFFAOYSA-N 703681 3-[[4-[4-ethyl-5- isopropoxy-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]pyridazine::US20240368133, Compound A-158 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 44000 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703681 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703681&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212221 507747630 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457274 CCc1cc(OC(C)C)cc(N2CCN(Cc3cccnn3)CC2)c1-c1nn[nH]n1 InChI=1S/C21H28N8O/c1-4-16-12-18(30-15(2)3)13-19(20(16)21-24-26-27-25-21)29-10-8-28(9-11-29)14-17-6-5-7-22-23-17/h5-7,12-13,15H,4,8-11,14H2,1-3H3,(H,24,25,26,27) OMMFUDSWGJHZME-UHFFFAOYSA-N 703682 3-[[4-[3-ethyl-5- isopropoxy-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]pyridazine::US20240368133, Compound A-159 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 3080 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703682 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703682&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 169609473 507747631 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457275 CC(C)Oc1cc(N2CCN(Cc3cccnn3)CC2)c(-c2nn[nH]n2)cc1C1CC1 InChI=1S/C22H28N8O/c1-15(2)31-21-13-20(19(22-25-27-28-26-22)12-18(21)16-5-6-16)30-10-8-29(9-11-30)14-17-4-3-7-23-24-17/h3-4,7,12-13,15-16H,5-6,8-11,14H2,1-2H3,(H,25,26,27,28) HAOJQOOOCYHQIJ-UHFFFAOYSA-N 703683 3-[[4-[4-cycloprop- yl-5-isopropoxy-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]pyrid- azine::US20240368133, Compound A-160 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 4940 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703683 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703683&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443777 507747632 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457276 CC(C)Oc1cc(C2CC2)c(-c2nn[nH]n2)c(N2CCN(Cc3cccnn3)CC2)c1 InChI=1S/C22H28N8O/c1-15(2)31-18-12-19(16-5-6-16)21(22-25-27-28-26-22)20(13-18)30-10-8-29(9-11-30)14-17-4-3-7-23-24-17/h3-4,7,12-13,15-16H,5-6,8-11,14H2,1-2H3,(H,25,26,27,28) BVWUTDGQPABMAF-UHFFFAOYSA-N 703684 3-[[4-[3-cycloprop- yl-5-isopropoxy-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]pyrid- azine::US20240368133, Compound A-161 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 1460 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703684 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703684&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212202 507747633 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457277 CCOc4cc(c1nn[nH]n1)c(N3CCN(Cc2cccnn2)CC3)cc4OC(C)C InChI=1S/C21H28N8O2/c1-4-30-19-12-17(21-24-26-27-25-21)18(13-20(19)31-15(2)3)29-10-8-28(9-11-29)14-16-6-5-7-22-23-16/h5-7,12-13,15H,4,8-11,14H2,1-3H3,(H,24,25,26,27) KQLIFSMQCVUAEE-UHFFFAOYSA-N 703685 3-[[4-[4-ethoxy-5- isopropoxy-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]pyridazine::US20240368133, Compound A-162 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 20700 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703685 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703685&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 169609301 507747634 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457278 CC(C)Cc1cc(N2CCN(Cc3cccnn3)CC2)c(-c2nn[nH]n2)cc1F InChI=1S/C20H25FN8/c1-14(2)10-15-11-19(17(12-18(15)21)20-24-26-27-25-20)29-8-6-28(7-9-29)13-16-4-3-5-22-23-16/h3-5,11-12,14H,6-10,13H2,1-2H3,(H,24,25,26,27) TWQMNBYISFIKEB-UHFFFAOYSA-N 703686 3-[[4-[4-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]pyridazine::US20240368133, Compound A-163 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 3320 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703686 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703686&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212179 507747635 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457279 CC(C)Cc1cc(F)c(-c2nn[nH]n2)c(N2CCN(Cc3cccnn3)CC2)c1 InChI=1S/C20H25FN8/c1-14(2)10-15-11-17(21)19(20-24-26-27-25-20)18(12-15)29-8-6-28(7-9-29)13-16-4-3-5-22-23-16/h3-5,11-12,14H,6-10,13H2,1-2H3,(H,24,25,26,27) PYCBHWFJTJYNBA-UHFFFAOYSA-N 703687 3-[[4-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]pyridazine::US20240368133, Compound A-164 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 1300 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703687 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703687&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212192 507747636 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457280 CC(C)Cc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3cccnn3)CC2)c1F InChI=1S/C20H25FN8/c1-14(2)12-15-5-6-17(20-24-26-27-25-20)19(18(15)21)29-10-8-28(9-11-29)13-16-4-3-7-22-23-16/h3-7,14H,8-13H2,1-2H3,(H,24,25,26,27) GEQXGWNOAHRWOP-UHFFFAOYSA-N 703688 3-[[4-[2-fluoro-3- isobutyl-6-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]pyridazine::US20240368133, Compound A-165 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 681 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703688 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703688&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443587 507747637 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457281 Cc1cc(-c2nn[nH]n2)c(N2CCN(Cc3cccnn3)CC2)cc1CC(C)C InChI=1S/C21H28N8/c1-15(2)11-17-13-20(19(12-16(17)3)21-24-26-27-25-21)29-9-7-28(8-10-29)14-18-5-4-6-22-23-18/h4-6,12-13,15H,7-11,14H2,1-3H3,(H,24,25,26,27) CKQYIZLVQODGJE-UHFFFAOYSA-N 703689 3-[[4-[5-isobutyl- 4-methyl-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]pyridazine::US20240368133, Compound A-166 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 22100 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703689 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703689&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443786 507747638 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457282 Cc1cc(CC(C)C)cc(N2CCN(Cc3cccnn3)CC2)c1-c1nn[nH]n1 InChI=1S/C21H28N8/c1-15(2)11-17-12-16(3)20(21-24-26-27-25-21)19(13-17)29-9-7-28(8-10-29)14-18-5-4-6-22-23-18/h4-6,12-13,15H,7-11,14H2,1-3H3,(H,24,25,26,27) XZEHMFUKSDPMGO-UHFFFAOYSA-N 703690 3-[[4-[5-isobutyl-3- methyl-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]pyridazine::US20240368133, Compound A-167 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 32.6 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703690 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703690&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212223 507747639 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457283 CCc1cc(CC(C)C)cc(N2CCN(Cc3cccnn3)CC2)c1-c1nn[nH]n1 InChI=1S/C22H30N8/c1-4-18-13-17(12-16(2)3)14-20(21(18)22-25-27-28-26-22)30-10-8-29(9-11-30)15-19-6-5-7-23-24-19/h5-7,13-14,16H,4,8-12,15H2,1-3H3,(H,25,26,27,28) NHRASJTXLARTNV-UHFFFAOYSA-N 703691 3-[4-[3-ethyl-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]pyridazine::US20240368133, Compound A-168 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 17.7 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703691 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703691&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 169610186 507747640 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457284 CC(C)Cc1cc(C2CC2)c(-c2nn[nH]n2)c(N2CCN(Cc3cccnn3)CC2)c1 InChI=1S/C23H30N8/c1-16(2)12-17-13-20(18-5-6-18)22(23-26-28-29-27-23)21(14-17)31-10-8-30(9-11-31)15-19-4-3-7-24-25-19/h3-4,7,13-14,16,18H,5-6,8-12,15H2,1-2H3,(H,26,27,28,29) AUUPCIJCBJYLEW-UHFFFAOYSA-N 703692 3-[[4-[3-cycloprop- yl-5-isobutyl-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]pyridazine::US20240368133, Compound A-169 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 25.3 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703692 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703692&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443494 507747641 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457285 CNc4cc(c1nn[nH]n1)c(N3CCN(Cc2cccnn2)CC3)cc4CC(C)C InChI=1S/C21H29N9/c1-15(2)11-16-12-20(18(13-19(16)22-3)21-25-27-28-26-21)30-9-7-29(8-10-30)14-17-5-4-6-23-24-17/h4-6,12-13,15,22H,7-11,14H2,1-3H3,(H,25,26,27,28) PYROXLMFQBLBBN-UHFFFAOYSA-N 703693 2-isobutyl-N-meth- yl-4-[4-(pyridazin- 3-ylmethyl)piper- azin-1-yl]-5-(2H- tetrazol-5-yl)aniline::US20240368133, Compound A-170 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 12100 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703693 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703693&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 169609421 507747642 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457286 CNc1cc(CC(C)C)cc(N2CCN(Cc3cccnn3)CC2)c1-c1nn[nH]n1 InChI=1S/C21H29N9/c1-15(2)11-16-12-18(22-3)20(21-25-27-28-26-21)19(13-16)30-9-7-29(8-10-30)14-17-5-4-6-23-24-17/h4-6,12-13,15,22H,7-11,14H2,1-3H3,(H,25,26,27,28) QJPWXNBFWCKLCW-UHFFFAOYSA-N 703694 5-isobutyl-N-meth- yl-3-[4-(pyridazin- 3-ylmethyl)piper- azin-1-yl]-2-(2H- tetrazol-5-yl)aniline::US20240368133, Compound A-171 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 15.8 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703694 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703694&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212170 507747643 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457287 CCNc4cc(c1nn[nH]n1)c(N3CCN(Cc2cccnn2)CC3)cc4CC(C)C InChI=1S/C22H31N9/c1-4-23-20-14-19(22-26-28-29-27-22)21(13-17(20)12-16(2)3)31-10-8-30(9-11-31)15-18-6-5-7-24-25-18/h5-7,13-14,16,23H,4,8-12,15H2,1-3H3,(H,26,27,28,29) NWGKJVIDRVSTNC-UHFFFAOYSA-N 703695 N-ethyl-2-isobutyl- 4-[4-(pyridazin-3- ylmethyl)piperazin- 1-yl]-5-(2H-tetrazol- 5-yl)aniline::US20240368133, Compound A-172 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 3520 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703695 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703695&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 169608633 507747644 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457288 CC(C)Cc1cc(F)c(-c2nn[nH]n2)c(N2CCN(Cc3cccnn3)C(C)C2)c1 InChI=1S/C21H27FN8/c1-14(2)9-16-10-18(22)20(21-25-27-28-26-21)19(11-16)30-8-7-29(15(3)12-30)13-17-5-4-6-23-24-17/h4-6,10-11,14-15H,7-9,12-13H2,1-3H3,(H,25,26,27,28) BHRGLVGWNMTDFE-UHFFFAOYSA-N 703696 3-[[4-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]-2-methyl- piperazin-1-yl]- methyl]pyridazine::US20240368133, Compound A-173 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 16.0 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703696 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703696&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171779930 507747645 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457289 CC(C)Cc1cc(F)c(-c2nn[nH]n2)c(N2CCN(Cc3cccnn3)[C@@H](C)C2)c1 InChI=1S/C21H27FN8/c1-14(2)9-16-10-18(22)20(21-25-27-28-26-21)19(11-16)30-8-7-29(15(3)12-30)13-17-5-4-6-23-24-17/h4-6,10-11,14-15H,7-9,12-13H2,1-3H3,(H,25,26,27,28) BHRGLVGWNMTDFE-UHFFFAOYSA-N 703697 3-[[(2S)-4-[3-fluoro- 5-isobutyl-2-(2H- tetrazol-5-yl)phen- yl]-2-methyl- piperazin-1-yl]- methyl]pyridazine::US20240368133, Compound A-174 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 2.35 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703697 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703697&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171378328 507747646 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457290 CC(C)Cc1cc(F)c(-c2nn[nH]n2)c(N2CCN(Cc3cccnn3)[C@H](C)C2)c1 InChI=1S/C21H27FN8/c1-14(2)9-16-10-18(22)20(21-25-27-28-26-21)19(11-16)30-8-7-29(15(3)12-30)13-17-5-4-6-23-24-17/h4-6,10-11,14-15H,7-9,12-13H2,1-3H3,(H,25,26,27,28) BHRGLVGWNMTDFE-UHFFFAOYSA-N 703698 3-[[(2R)-4-[3- fluoro-5-isobutyl- 2-(2H-tetrazol-5- yl)phenyl]-2-meth- yl-piperazin-1-yl]- methyl]pyridazine::US20240368133, Compound A-175 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 322 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703698 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703698&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443760 507747647 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457291 CC(C)Cc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3cccnn3)[C@@H](C)C2)c1F InChI=1S/C21H27FN8/c1-14(2)11-16-6-7-18(21-25-27-28-26-21)20(19(16)22)30-10-9-29(15(3)12-30)13-17-5-4-8-23-24-17/h4-8,14-15H,9-13H2,1-3H3,(H,25,26,27,28) UFMDFVWLRCYFMI-UHFFFAOYSA-N 703699 3-[[(2S)-4-[2-fluoro- 3-isobutyl-6-(2H- tetrazol-5-yl)phen- yl]-2-methyl- piperazin-1-yl]meth- yl]pyridazine::US20240368133, Compound A-176 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 28.7 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703699 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703699&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443643 507747648 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457292 CC(C)Cc1cnc(-c2nn[nH]n2)c(N2CCN(Cc3cccnn3)[C@@H](C)C2)c1 InChI=1S/C20H27N9/c1-14(2)9-16-10-18(19(21-11-16)20-24-26-27-25-20)29-8-7-28(15(3)12-29)13-17-5-4-6-22-23-17/h4-6,10-11,14-15H,7-9,12-13H2,1-3H3,(H,24,25,26,27) MDRRCUVILAVQEN-UHFFFAOYSA-N 703700 3-[[(2S)-4-[5- isobutyl-2-(2H- tetrazol-5-yl)-3- pyridyl]-2-methyl- piperazin-1-yl]- methyl]pyridazine::US20240368133, Compound A-177 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 585 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703700 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703700&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171779829 507747649 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457293 CCC1CN(c2cc(CC(C)C)cc(F)c2-c2nn[nH]n2)CCN1Cc1cccnn1 InChI=1S/C22H29FN8/c1-4-18-14-31(9-8-30(18)13-17-6-5-7-24-25-17)20-12-16(10-15(2)3)11-19(23)21(20)22-26-28-29-27-22/h5-7,11-12,15,18H,4,8-10,13-14H2,1-3H3,(H,26,27,28,29) APBSLTJWFQLUEV-UHFFFAOYSA-N 703701 3-[[2-ethyl-4-[3- fluoro-5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]pyrid- azine::US20240368133, Compound A-178 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 33.5 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703701 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703701&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171780079 507747650 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457294 CC(C)Cc1cc(F)c(-c2nn[nH]n2)c(N2CCN(Cc3cccnn3)C(C(C)C)C2)c1 InChI=1S/C23H31FN8/c1-15(2)10-17-11-19(24)22(23-27-29-30-28-23)20(12-17)32-9-8-31(21(14-32)16(3)4)13-18-6-5-7-25-26-18/h5-7,11-12,15-16,21H,8-10,13-14H2,1-4H3,(H,27,28,29,30) SOZJONLOTOTWAV-UHFFFAOYSA-N 703702 3-[[4-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]-2-isopropyl- piperazin-1-yl]- methyl]pyridazine::US20240368133, Compound A-179 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 953 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703702 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703702&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171780020 507747651 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457295 COc4c(C)cnc(CN3CCN(c1cc(CC(C)C)cc(F)c1c2nn[nH]n2)CC3)c4C InChI=1S/C24H32FN7O/c1-15(2)10-18-11-19(25)22(24-27-29-30-28-24)21(12-18)32-8-6-31(7-9-32)14-20-17(4)23(33-5)16(3)13-26-20/h11-13,15H,6-10,14H2,1-5H3,(H,27,28,29,30) CBJJPHQXXPWCLM-UHFFFAOYSA-N 703703 3-[[4-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]-3-methyl- piperazin-1-yl]- methyl]pyridazine::US20240368133, Compound A-180 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 3.95 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703703 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703703&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212158 507747652 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457296 CCC1CN(Cc2cccnn2)CCN1c1cc(CC(C)C)cc(F)c1-c1nn[nH]n1 InChI=1S/C22H29FN8/c1-4-18-14-30(13-17-6-5-7-24-25-17)8-9-31(18)20-12-16(10-15(2)3)11-19(23)21(20)22-26-28-29-27-22/h5-7,11-12,15,18H,4,8-10,13-14H2,1-3H3,(H,26,27,28,29) MDOJJLNKRQBYTI-UHFFFAOYSA-N 703704 3-[[3-ethyl-4-[3- fluoro-5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]pyrid- azine::US20240368133, Compound A-181 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 14.8 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703704 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703704&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171780064 507747653 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457297 CC(C)Cc1cc(F)c(-c2nn[nH]n2)c(N2CCN(Cc3cccnn3)C(C)(C)C2)c1 InChI=1S/C22H29FN8/c1-15(2)10-16-11-18(23)20(21-26-28-29-27-21)19(12-16)30-8-9-31(22(3,4)14-30)13-17-6-5-7-24-25-17/h5-7,11-12,15H,8-10,13-14H2,1-4H3,(H,26,27,28,29) DORBRWREIQKUEY-UHFFFAOYSA-N 703705 3-[[4-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]-2,2-dimethyl- piperazin-1-yl]- methyl]pyridazine::US20240368133, Compound A-182 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 18.6 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703705 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703705&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171779938 507747654 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457298 CC(C)Cc1cc(F)c(-c2nn[nH]n2)c(N2CC(C)N(Cc3cccnn3)CC2C)c1 InChI=1S/C22H29FN8/c1-14(2)8-17-9-19(23)21(22-26-28-29-27-22)20(10-17)31-12-15(3)30(11-16(31)4)13-18-6-5-7-24-25-18/h5-7,9-10,14-16H,8,11-13H2,1-4H3,(H,26,27,28,29) UYIZQRPQOVKSBH-UHFFFAOYSA-N 703706 3-[[4-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]-2,5-dimethyl- piperazin-1-yl]- methyl]pyridazine::US20240368133, Compound A-183 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 8.33 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703706 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703706&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443627 507747655 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457299 CC(C)Cc1cc(F)c(-c2nn[nH]n2)c(N2CC(C)N(Cc3cccnn3)C(C)C2)c1 InChI=1S/C22H29FN8/c1-14(2)8-17-9-19(23)21(22-26-28-29-27-22)20(10-17)30-11-15(3)31(16(4)12-30)13-18-6-5-7-24-25-18/h5-7,9-10,14-16H,8,11-13H2,1-4H3,(H,26,27,28,29) DCUNWEFVGRUUQY-UHFFFAOYSA-N 703707 3-[[4-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]-2,6-dimethyl- piperazin-1-yl]- methyl]pyridazine::US20240368133, Compound A-184 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 0.893 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703707 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703707&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212167 507747656 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457300 CC(C)Cc1cc(F)c(-c2nn[nH]n2)c(N2C[C@@H](C)N(Cc3cccnn3)[C@H](C)C2)c1 InChI=1S/C22H29FN8/c1-14(2)8-17-9-19(23)21(22-26-28-29-27-22)20(10-17)30-11-15(3)31(16(4)12-30)13-18-6-5-7-24-25-18/h5-7,9-10,14-16H,8,11-13H2,1-4H3,(H,26,27,28,29) DCUNWEFVGRUUQY-UHFFFAOYSA-N 703708 3-[[(2R,6R)-4-[3- fluoro-5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]-2,6-dimeth- yl-piperazin-1-yl]- methyl]pyridazine::US20240368133, Compound A-185 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 69.6 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703708 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703708&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212172 507747657 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457301 CC(C)Cc1cc(F)c(-c2nn[nH]n2)c(N2C[C@@H](C)N(Cc3cccnn3)[C@@H](C)C2)c1 InChI=1S/C22H29FN8/c1-14(2)8-17-9-19(23)21(22-26-28-29-27-22)20(10-17)30-11-15(3)31(16(4)12-30)13-18-6-5-7-24-25-18/h5-7,9-10,14-16H,8,11-13H2,1-4H3,(H,26,27,28,29) DCUNWEFVGRUUQY-UHFFFAOYSA-N 703709 3-[[(2S,6R)-4-[3- fluoro-5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]-2,6-dimeth- yl-piperazin-1-yl]- methyl]pyridazine::US20240368133, Compound A-186 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 18.3 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703709 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703709&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212163 507747658 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457302 CC(C)Cc1cc(F)c(-c2nn[nH]n2)c(N2C[C@H](C)N(Cc3cccnn3)[C@@H](C)C2)c1 InChI=1S/C22H29FN8/c1-14(2)8-17-9-19(23)21(22-26-28-29-27-22)20(10-17)30-11-15(3)31(16(4)12-30)13-18-6-5-7-24-25-18/h5-7,9-10,14-16H,8,11-13H2,1-4H3,(H,26,27,28,29) DCUNWEFVGRUUQY-UHFFFAOYSA-N 703710 3-[[(2S,6S)-4-[3- fluoro-5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]-2,6-dimeth- yl-piperazin-1-yl]- methyl]pyridazine::US20240368133, Compound A-187 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 7.26 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703710 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703710&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212177 507747659 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457303 CC(C)Cc1cc(F)c(-c2nn[nH]n2)c(N2CCN(Cc3cccnn3)C(C)C2C)c1 InChI=1S/C22H29FN8/c1-14(2)10-17-11-19(23)21(22-26-28-29-27-22)20(12-17)31-9-8-30(15(3)16(31)4)13-18-6-5-7-24-25-18/h5-7,11-12,14-16H,8-10,13H2,1-4H3,(H,26,27,28,29) UWNOJOJUDPAODV-UHFFFAOYSA-N 703711 3-[[4-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]-2,3-dimethyl- piperazin-1-yl]- methyl]pyridazine::US20240368133, Compound A-188 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 13.9 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703711 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703711&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212137 507747660 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457304 CC(C)Cc1cc(F)c(-c2nn[nH]n2)c(N2CC3CC2CN3Cc2cccnn2)c1 InChI=1S/C21H25FN8/c1-13(2)6-14-7-18(22)20(21-25-27-28-26-21)19(8-14)30-12-16-9-17(30)11-29(16)10-15-4-3-5-23-24-15/h3-5,7-8,13,16-17H,6,9-12H2,1-2H3,(H,25,26,27,28) UJSYPEZBHFXNDQ-UHFFFAOYSA-N 703712 2-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]-5-(pyridazin-3- ylmethyl)-2,5-di- azabicyclo[2.2.1]- heptane::US20240368133, Compound A-189 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 2650 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703712 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703712&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 169609464 507747661 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457305 CC(C)Cc1cc(F)c(-c2nn[nH]n2)c(N2CC3CCC(C2)N3Cc2cccnn2)c1 InChI=1S/C22H27FN8/c1-14(2)8-15-9-19(23)21(22-26-28-29-27-22)20(10-15)30-12-17-5-6-18(13-30)31(17)11-16-4-3-7-24-25-16/h3-4,7,9-10,14,17-18H,5-6,8,11-13H2,1-2H3,(H,26,27,28,29) GUHLGNDOTRAGPV-UHFFFAOYSA-N 703713 3-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]-8-(pyridazin-3- ylmethyl)-3,8-diaza- bicyclo[3.2.1]octane::US20240368133, Compound A-190 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 1350 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703713 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703713&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212165 507747662 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457306 CC(C)Cc4cc(F)c(c1nn[nH]n1)c(N3CCN(Cc2cc(Cl)ccn2)CC3)c4 InChI=1S/C21H25ClFN7/c1-14(2)9-15-10-18(23)20(21-25-27-28-26-21)19(11-15)30-7-5-29(6-8-30)13-17-12-16(22)3-4-24-17/h3-4,10-12,14H,5-9,13H2,1-2H3,(H,25,26,27,28) DPCJLPUSECSCQM-UHFFFAOYSA-N 703714 1-[(4-chloro-2- pyridyl)methyl]-4- [3-fluoro-5-isobutyl- 2-(2H-tetrazol-5- yl)phenyl]piperazine::US20240368133, Compound A-191 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 53.1 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703714 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703714&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212144 507747663 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457307 CC(C)Cc4cc(F)c(c1nn[nH]n1)c(N3CCN(Cc2ccc(Cl)cn2)CC3)c4 InChI=1S/C21H25ClFN7/c1-14(2)9-15-10-18(23)20(21-25-27-28-26-21)19(11-15)30-7-5-29(6-8-30)13-17-4-3-16(22)12-24-17/h3-4,10-12,14H,5-9,13H2,1-2H3,(H,25,26,27,28) UFCKWCZNOSRDON-UHFFFAOYSA-N 703715 1-[(5-chloro-2- pyridyl)methyl]-4- [3-fluoro-5-isobutyl- 2-(2H-tetrazol-5- yl)phenyl]piperazine::US20240368133, Compound A-192 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 519 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703715 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703715&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212147 507747664 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457308 CC(C)Cc4cc(F)c(c1nn[nH]n1)c(N3CCN(Cc2ncccc2Cl)CC3)c4 InChI=1S/C21H25ClFN7/c1-14(2)10-15-11-17(23)20(21-25-27-28-26-21)19(12-15)30-8-6-29(7-9-30)13-18-16(22)4-3-5-24-18/h3-5,11-12,14H,6-10,13H2,1-2H3,(H,25,26,27,28) RETKCFFOOZZONX-UHFFFAOYSA-N 703716 1-[(3-chloro-2- pyridyl)methyl]-4- [3-fluoro-5-isobutyl- 2-(2H-tetrazol-5- yl)phenyl]piperazine::US20240368133, Compound A-193 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 389 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703716 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703716&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212153 507747665 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457309 COc4ccc(CN3CCN(c1cc(CC(C)C)cc(F)c1c2nn[nH]n2)CC3)nc4 InChI=1S/C22H28FN7O/c1-15(2)10-16-11-19(23)21(22-25-27-28-26-22)20(12-16)30-8-6-29(7-9-30)14-17-4-5-18(31-3)13-24-17/h4-5,11-13,15H,6-10,14H2,1-3H3,(H,25,26,27,28) IWFLBDLPRGTYAP-UHFFFAOYSA-N 703717 1-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]-4-[(5-methoxy- 2-pyridyl)meth- yl]piperazine::US20240368133, Compound A-194 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 737 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703717 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703717&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171779826 507747666 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457310 CC(C)Cc4cc(F)c(c1nn[nH]n1)c(N3CCN(Cc2ccc(F)cn2)CC3)c4 InChI=1S/C21H25F2N7/c1-14(2)9-15-10-18(23)20(21-25-27-28-26-21)19(11-15)30-7-5-29(6-8-30)13-17-4-3-16(22)12-24-17/h3-4,10-12,14H,5-9,13H2,1-2H3,(H,25,26,27,28) NKKZNVHTTTXHQA-UHFFFAOYSA-N 703718 1-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]-4-[(5-fluoro-2- pyridyl)methyl]- piperazine::US20240368133, Compound A-195 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 537 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703718 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703718&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212151 507747667 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457311 CC(C)Cc4cc(F)c(c1nn[nH]n1)c(N3CCN(Cc2ncccc2F)CC3)c4 InChI=1S/C21H25F2N7/c1-14(2)10-15-11-17(23)20(21-25-27-28-26-21)19(12-15)30-8-6-29(7-9-30)13-18-16(22)4-3-5-24-18/h3-5,11-12,14H,6-10,13H2,1-2H3,(H,25,26,27,28) UKTOMXAHIPQJCJ-UHFFFAOYSA-N 703719 1-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]-4-[(3-fluoro-2- pyridyl)methyl]- piperazine::US20240368133, Compound A-196 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 631 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703719 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703719&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212157 507747668 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457312 Cc4cnc(CN3CCN(c1cc(CC(C)C)cc(F)c1c2nn[nH]n2)CC3)c(C)c4 InChI=1S/C23H30FN7/c1-15(2)9-18-11-19(24)22(23-26-28-29-27-23)21(12-18)31-7-5-30(6-8-31)14-20-17(4)10-16(3)13-25-20/h10-13,15H,5-9,14H2,1-4H3,(H,26,27,28,29) ACTCGZQNMAPARV-UHFFFAOYSA-N 703720 1-[(3,5-dimethyl-2- pyridyl)methyl]-4- [3-fluoro-5-isobutyl- 2-(2H-tetrazol-5- yl)phenyl]piperazine::US20240368133, Compound A-197 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 203 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703720 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703720&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171780023 507747669 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457313 COc1cccnc1CN4CCN(c2cc(CC(C)C)cc(F)c2c3nn[nH]n3)CC4 InChI=1S/C22H28FN7O/c1-15(2)11-16-12-17(23)21(22-25-27-28-26-22)19(13-16)30-9-7-29(8-10-30)14-18-20(31-3)5-4-6-24-18/h4-6,12-13,15H,7-11,14H2,1-3H3,(H,25,26,27,28) FMSYBYRDKTYGQI-UHFFFAOYSA-N 703721 1-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]-4-[(3-methoxy- 2-pyridyl)meth- yl]piperazine::US20240368133, Compound A-198 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 1820 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703721 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703721&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212204 507747670 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457314 COc4ccnc(CN3CCN(c1cc(CC(C)C)cc(F)c1c2nn[nH]n2)CC3)c4 InChI=1S/C22H28FN7O/c1-15(2)10-16-11-19(23)21(22-25-27-28-26-22)20(12-16)30-8-6-29(7-9-30)14-17-13-18(31-3)4-5-24-17/h4-5,11-13,15H,6-10,14H2,1-3H3,(H,25,26,27,28) QNSJOIPBJCFIKJ-UHFFFAOYSA-N 703722 1-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]-4-[(4-methoxy- 2-pyridyl)methyl]- piperazine::US20240368133, Compound A-199 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 176 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703722 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703722&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212193 507747671 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457315 COc4c(C)cnc(CN3CCN(c1cc(CC(C)C)cc(F)c1c2nn[nH]n2)CC3)c4C InChI=1S/C24H32FN7O/c1-15(2)10-18-11-19(25)22(24-27-29-30-28-24)21(12-18)32-8-6-31(7-9-32)14-20-17(4)23(33-5)16(3)13-26-20/h11-13,15H,6-10,14H2,1-5H3,(H,27,28,29,30) CBJJPHQXXPWCLM-UHFFFAOYSA-N 703723 1-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]-4-[(4-methoxy- 3,5-dimethyl-2- pyridyl)methyl]- piperazine::US20240368133, Compound A-200 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 1060 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703723 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703723&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212158 507747672 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457316 Cc4ccc(CN3CCN(c1cc(CC(C)C)cc(F)c1c2nn[nH]n2)CC3)nc4 InChI=1S/C22H28FN7/c1-15(2)10-17-11-19(23)21(22-25-27-28-26-22)20(12-17)30-8-6-29(7-9-30)14-18-5-4-16(3)13-24-18/h4-5,11-13,15H,6-10,14H2,1-3H3,(H,25,26,27,28) QCWRQSGYADKNER-UHFFFAOYSA-N 703724 1-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]-4-[(5-methyl-2- pyridyl)methyl]- piperazine::US20240368133, Compound A-201 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 650 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703724 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703724&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171780070 507747673 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457317 CC(C)Cc4cc(F)c(c1nn[nH]n1)c(N3CCN(Cc2cc(C(F)(F)F)ccn2)CC3)c4 InChI=1S/C22H25F4N7/c1-14(2)9-15-10-18(23)20(21-28-30-31-29-21)19(11-15)33-7-5-32(6-8-33)13-17-12-16(3-4-27-17)22(24,25)26/h3-4,10-12,14H,5-9,13H2,1-2H3,(H,28,29,30,31) NAIYOGPVEYQTSC-UHFFFAOYSA-N 703725 1-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]-4-[[4-(trifluoro- methyl)-2-pyridyl]- methyl]piperazine::US20240368133, Compound A-202 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 824 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703725 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703725&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171779848 507747674 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457318 Cc1cccnc1CN4CCN(c2cc(CC(C)C)cc(F)c2c3nn[nH]n3)CC4 InChI=1S/C22H28FN7/c1-15(2)11-17-12-18(23)21(22-25-27-28-26-22)20(13-17)30-9-7-29(8-10-30)14-19-16(3)5-4-6-24-19/h4-6,12-13,15H,7-11,14H2,1-3H3,(H,25,26,27,28) DOMYEEVXMUPSDR-UHFFFAOYSA-N 703726 1-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]-4-[(3-methyl-2- pyridyl)methyl]- piperazine::US20240368133, Compound A-203 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 155 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703726 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703726&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212154 507747675 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457319 Cc4ccnc(CN3CCN(c1cc(CC(C)C)cc(F)c1c2nn[nH]n2)CC3)c4 InChI=1S/C22H28FN7/c1-15(2)10-17-12-19(23)21(22-25-27-28-26-22)20(13-17)30-8-6-29(7-9-30)14-18-11-16(3)4-5-24-18/h4-5,11-13,15H,6-10,14H2,1-3H3,(H,25,26,27,28) PORFZCVAWYZJCA-UHFFFAOYSA-N 703727 1-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]-4-[(4-methyl-2- pyridyl)methyl]- piperazine::US20240368133, Compound A-204 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 212 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703727 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703727&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212217 507747676 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457320 CC(C)Cc4cc(F)c(c1nn[nH]n1)c(N3CCN(Cc2ncc(Cl)cc2F)CC3)c4 InChI=1S/C21H24ClF2N7/c1-13(2)7-14-8-17(24)20(21-26-28-29-27-21)19(9-14)31-5-3-30(4-6-31)12-18-16(23)10-15(22)11-25-18/h8-11,13H,3-7,12H2,1-2H3,(H,26,27,28,29) OODDBZPWUIYTPT-UHFFFAOYSA-N 703728 1-[(5-chloro-3- fluoro-2-pyridyl)- methyl]-4-[3-fluoro- 5-isobutyl-2-(2H- tetrazol-5-yl)phen- yl]piperazine::US20240368133, Compound A-205 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 379 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703728 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703728&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171780060 507747677 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457321 CC(C)Cc4cc(F)c(c1nn[nH]n1)c(N3CCN(Cc2ncc(F)cc2Cl)CC3)c4 InChI=1S/C21H24ClF2N7/c1-13(2)7-14-8-17(24)20(21-26-28-29-27-21)19(9-14)31-5-3-30(4-6-31)12-18-16(22)10-15(23)11-25-18/h8-11,13H,3-7,12H2,1-2H3,(H,26,27,28,29) UVQPMKSIMLMRGT-UHFFFAOYSA-N 703729 1-[(3-chloro-5- fluoro-2-pyridyl)- methyl]-4-[3-fluoro- 5-isobutyl-2-(2H- tetrazol-5-yl)phen- yl]piperazine::US20240368133, Compound A-206 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 1080 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703729 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703729&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212186 507747678 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457322 COc4cnc(CN3CCN(c1cc(CC(C)C)cc(F)c1c2nn[nH]n2)CC3)cc4OC InChI=1S/C23H30FN7O2/c1-15(2)9-16-10-18(24)22(23-26-28-29-27-23)19(11-16)31-7-5-30(6-8-31)14-17-12-20(32-3)21(33-4)13-25-17/h10-13,15H,5-9,14H2,1-4H3,(H,26,27,28,29) GUOOUUKIUWJDNX-UHFFFAOYSA-N 703730 1-[(4,5-dimethoxy- 2-pyridyl)methyl]- 4-[3-fluoro-5-iso- butyl-2-(2H- tetrazol-5-yl)phen- yl]piperazine::US20240368133, Compound A-207 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 1210 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703730 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703730&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171780040 507747679 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457323 COc4ccnc(CN3CCN(c1cc(CC(C)C)cc(F)c1c2nn[nH]n2)CC3)c4C InChI=1S/C23H30FN7O/c1-15(2)11-17-12-18(24)22(23-26-28-29-27-23)20(13-17)31-9-7-30(8-10-31)14-19-16(3)21(32-4)5-6-25-19/h5-6,12-13,15H,7-11,14H2,1-4H3,(H,26,27,28,29) HUKJOLZYGCADQX-UHFFFAOYSA-N 703731 1-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]-4-[(4-methoxy- 3-methyl-2-pyrid- yl)methyl]piper- azine::US20240368133, Compound A-208 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 1920 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703731 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703731&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212212 507747680 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457324 CC(C)Cc1cc(F)c(-c2nn[nH]n2)c(N2CCN(Cc3ccc(C#N)cn3)CC2)c1 InChI=1S/C22H25FN8/c1-15(2)9-17-10-19(23)21(22-26-28-29-27-22)20(11-17)31-7-5-30(6-8-31)14-18-4-3-16(12-24)13-25-18/h3-4,10-11,13,15H,5-9,14H2,1-2H3,(H,26,27,28,29) ZLMBXGBBLZBJAZ-UHFFFAOYSA-N 703732 6-[[4-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]pyridine-3- carbonitrile::US20240368133, Compound A-209 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 3680 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703732 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703732&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212214 507747681 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457325 CC(C)Cc1cc(F)c(-c2nn[nH]n2)c(N2CCN(Cc3cc(Cl)c(F)cn3)CC2)c1 InChI=1S/C21H24ClF2N7/c1-13(2)7-14-8-17(23)20(21-26-28-29-27-21)19(9-14)31-5-3-30(4-6-31)12-15-10-16(22)18(24)11-25-15/h8-11,13H,3-7,12H2,1-2H3,(H,26,27,28,29) XTIOJJWJVPNUTL-UHFFFAOYSA-N 703733 1-[(4-chloro-5- fluoro-2-pyridyl)- methyl]-4-[3-fluoro- 5-isobutyl-2-(2H- tetrazol-5-yl)phen- yl]piperazine::US20240368133, Compound A-210 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 2010 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703733 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703733&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212183 507747682 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457326 CC(C)Cc1cc(F)c(-c2nn[nH]n2)c(N2CCN(Cc3ncc(F)cc3F)CC2)c1 InChI=1S/C21H24F3N7/c1-13(2)7-14-8-17(24)20(21-26-28-29-27-21)19(9-14)31-5-3-30(4-6-31)12-18-16(23)10-15(22)11-25-18/h8-11,13H,3-7,12H2,1-2H3,(H,26,27,28,29) UAZUPLGGZICSPF-UHFFFAOYSA-N 703734 1-[(3,5-difluoro-2- pyridyl)methyl]-4- [3-fluoro-5-isobutyl- 2-(2H-tetrazol-5-yl)- phenyl]piperazine::US20240368133, Compound A-211 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 1290 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703734 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703734&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171779917 507747683 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457327 CC(C)Cc1ccc(-c2nn[nH]n2)c(N2CCN(C(C)c3cccnn3)CC2)c1 InChI=1S/C21H28N8/c1-15(2)13-17-6-7-18(21-24-26-27-25-21)20(14-17)29-11-9-28(10-12-29)16(3)19-5-4-8-22-23-19/h4-8,14-16H,9-13H2,1-3H3,(H,24,25,26,27) YSGWXVCISZIQOQ-UHFFFAOYSA-N 703735 3-[1-[4-[5-isobutyl- 2-(2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]ethyl]pyrid- azine::US20240368133, Compound A-212 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 434 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703735 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703735&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212138 507747684 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457328 CC(C)Cc4cc(F)c(c1nn[nH]n1)c(N3CCN(C(=O)c2cccnn2)CC3)c4 InChI=1S/C20H23FN8O/c1-13(2)10-14-11-15(21)18(19-24-26-27-25-19)17(12-14)28-6-8-29(9-7-28)20(30)16-4-3-5-22-23-16/h3-5,11-13H,6-10H2,1-2H3,(H,24,25,26,27) WLQXEXPVIMILLL-UHFFFAOYSA-N 703736 [4-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- pyridazin-3-yl- methanone::US20240368133, Compound A-213 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 389 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703736 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703736&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171779801 507747685 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457329 CC(C)Cc1cc(F)c(-c2nn[nH]n2)c(N2CCN(C(C)c3ccccn3)CC2)c1 InChI=1S/C22H28FN7/c1-15(2)12-17-13-18(23)21(22-25-27-28-26-22)20(14-17)30-10-8-29(9-11-30)16(3)19-6-4-5-7-24-19/h4-7,13-16H,8-12H2,1-3H3,(H,25,26,27,28) BUIXOWJFAASEAZ-UHFFFAOYSA-N 703737 1-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]-4-[1-(2-pyridyl)- ethyl]piperazine::US20240368133, Compound A-214 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 38.6 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703737 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703737&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171779775 507747686 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457330 CC(C)Cc1cc(F)c(-c2nn[nH]n2)c(N2CCN(C(=O)c3ccccn3)CC2)c1 InChI=1S/C21H24FN7O/c1-14(2)11-15-12-16(22)19(20-24-26-27-25-20)18(13-15)28-7-9-29(10-8-28)21(30)17-5-3-4-6-23-17/h3-6,12-14H,7-11H2,1-2H3,(H,24,25,26,27) QHEIPULNZCAKMM-UHFFFAOYSA-N 703738 [4-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- (2-pyridyl)meth- anone::US20240368133, Compound A-215 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 300 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703738 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703738&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212208 507747687 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457331 CC(C)Cc1cc(F)c(-c2nn[nH]n2)c(N2CCN(C(=O)c3ccccn3)[C@@H](C)C2)c1 InChI=1S/C22H26FN7O/c1-14(2)10-16-11-17(23)20(21-25-27-28-26-21)19(12-16)29-8-9-30(15(3)13-29)22(31)18-6-4-5-7-24-18/h4-7,11-12,14-15H,8-10,13H2,1-3H3,(H,25,26,27,28) MQCDWPSYCXXZJU-UHFFFAOYSA-N 703739 [(2S)-4-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]-2-methyl- piperazin-1-yl]-(2- pyridyl)methanone::US20240368133, Compound A-216 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 247 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703739 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703739&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443535 507747688 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457332 CC(C)Cc1cc(F)c(-c2nn[nH]n2)c(N2CCN(C(=O)c3ccccn3)[C@@H](C)C2)c1 InChI=1S/C22H26FN7O/c1-14(2)10-16-11-17(23)20(21-25-27-28-26-21)19(12-16)29-8-9-30(15(3)13-29)22(31)18-6-4-5-7-24-18/h4-7,11-12,14-15H,8-10,13H2,1-3H3,(H,25,26,27,28) MQCDWPSYCXXZJU-UHFFFAOYSA-N 703740 (2S)-4-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]-2-methyl-1-(2- pyridylmethyl)piper- azine::US20240368133, Compound A-217 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 2.79 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703740 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703740&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443535 507747689 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457333 CC(C)Cc1cc(F)c(-c2nn[nH]n2)c(N2CCN(C(C)c3ccccn3)[C@@H](C)C2)c1 InChI=1S/C23H30FN7/c1-15(2)11-18-12-19(24)22(23-26-28-29-27-23)21(13-18)30-9-10-31(16(3)14-30)17(4)20-7-5-6-8-25-20/h5-8,12-13,15-17H,9-11,14H2,1-4H3,(H,26,27,28,29) VZMDIFIFLISIMD-UHFFFAOYSA-N 703741 (2S)-4-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]-2-methyl-1-[1- (2-pyridyl)ethyl]- piperazine::US20240368133, Compound A-218 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 122 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703741 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703741&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171779800 507747690 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457334 Cc4cnc(CN3CCN(c1c(F)c(CC(C)C)ccc1c2nn[nH]n2)CC3)s4 InChI=1S/C20H26FN7S/c1-13(2)10-15-4-5-16(20-23-25-26-24-20)19(18(15)21)28-8-6-27(7-9-28)12-17-22-11-14(3)29-17/h4-5,11,13H,6-10,12H2,1-3H3,(H,23,24,25,26) WNJOTNCGHHHCLL-UHFFFAOYSA-N 703742 2-[[4-[2-fluoro-3- isobutyl-6-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]-5-methyl- thiazole::US20240368133, Compound A-219 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 681 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703742 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703742&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212185 507747691 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457335 Cc4cnc(CN3CCN(c1cc(CC(C)C)cc(F)c1c2nn[nH]n2)CC3)s4 InChI=1S/C20H26FN7S/c1-13(2)8-15-9-16(21)19(20-23-25-26-24-20)17(10-15)28-6-4-27(5-7-28)12-18-22-11-14(3)29-18/h9-11,13H,4-8,12H2,1-3H3,(H,23,24,25,26) PKIGWZUIEFFVRS-UHFFFAOYSA-N 703743 2-[[4-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]-5-methyl- thiazole::US20240368133, Compound A-220 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 80.7 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703743 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703743&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212181 507747692 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457336 Cc1cnc(CN2CCN(c3cc(CC(C)C)cnc3-c3nn[nH]n3)CC2)s1 InChI=1S/C19H26N8S/c1-13(2)8-15-9-16(18(21-11-15)19-22-24-25-23-19)27-6-4-26(5-7-27)12-17-20-10-14(3)28-17/h9-11,13H,4-8,12H2,1-3H3,(H,22,23,24,25) ZSJMBJJZIUZTLX-UHFFFAOYSA-N 703744 2-[[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- 3-pyridyl]piperazin- 1-yl]methyl]-5- methyl-thiazole::US20240368133, Compound A-221 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 2740 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703744 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703744&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171780008 507747693 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457337 Cc4cnc(CN3CCN(c1cc(CC(C)C)cc(F)c1c2nn[nH]n2)CC3C)s4 InChI=1S/C21H28FN7S/c1-13(2)7-16-8-17(22)20(21-24-26-27-25-21)18(9-16)29-6-5-28(14(3)11-29)12-19-23-10-15(4)30-19/h8-10,13-14H,5-7,11-12H2,1-4H3,(H,24,25,26,27) RRDWSZMZEOTZGJ-UHFFFAOYSA-N 703745 2-[[4-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]-2-methyl- piperazin-1-yl]- methyl]-5-methyl- thiazole::US20240368133, Compound A-222 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 9.47 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703745 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703745&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171779957 507747694 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457338 Cc1cnc(CN2CCN(c3cc(CC(C)C)cc(F)c3C3=NCN=N3)C[C@@H]2C)s1 InChI=1S/C22H29FN6S/c1-14(2)7-17-8-18(23)21(22-25-13-26-27-22)19(9-17)29-6-5-28(15(3)11-29)12-20-24-10-16(4)30-20/h8-10,14-15H,5-7,11-13H2,1-4H3 CPSNZVPANPJINF-UHFFFAOYSA-N 703746 2-[[(2S)-4-[3-fluoro- 5-isobutyl-2-(2H- tetrazol-5-yl)phen- yl]-2-methyl-piper- azin-1-yl]methyl]- 5-methyl-thiazole::US20240368133, Compound A-223 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 6.00 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703746 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703746&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172879042 507747695 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457339 Cc4cnc(C(C)N3C(C)CN(c1cc(CC(C)C)cc(F)c1c2nn[nH]n2)CC3C)s4 InChI=1S/C23H32FN7S/c1-13(2)7-18-8-19(24)21(22-26-28-29-27-22)20(9-18)30-11-14(3)31(15(4)12-30)17(6)23-25-10-16(5)32-23/h8-10,13-15,17H,7,11-12H2,1-6H3,(H,26,27,28,29) OWNUXBULJVZZKN-UHFFFAOYSA-N 703747 2-[[4-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]-2,6-dimethyl- piperazin-1-yl]- methyl]-5-methyl- thiazole::US20240368133, Compound A-224 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 92.2 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703747 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703747&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172484118 507747696 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457340 Cc4cnc(C(C)N3CCN(c1cc(CC(C)C)cc(F)c1c2nn[nH]n2)CC3)s4 InChI=1S/C21H28FN7S/c1-13(2)9-16-10-17(22)19(20-24-26-27-25-20)18(11-16)29-7-5-28(6-8-29)15(4)21-23-12-14(3)30-21/h10-13,15H,5-9H2,1-4H3,(H,24,25,26,27) AKHATAQDINXUIE-UHFFFAOYSA-N 703748 2-[1-[4-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- ethyl]-5-methyl- thiazole::US20240368133, Compound A-225 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 54.1 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703748 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703748&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212188 507747697 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457341 Cc1cnc(C(C)N2CCN(c3cc(CC(C)C)cc(F)c3-c3nn[nH]n3)C[C@@H]2C)s1 InChI=1S/C22H30FN7S/c1-13(2)8-17-9-18(23)20(21-25-27-28-26-21)19(10-17)29-6-7-30(14(3)12-29)16(5)22-24-11-15(4)31-22/h9-11,13-14,16H,6-8,12H2,1-5H3,(H,25,26,27,28) AUPWVUVSQKOZSY-UHFFFAOYSA-N 703749 2-[1-[(2S)-4-[3- fluoro-5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]-2-methyl- piperazin-1-yl]- ethyl]-5-methyl- thiazole::US20240368133, Compound A-226 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 37.2 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703749 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703749&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171779845 507747698 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457342 COc1ccnc(CN2CCN(c3cc(CC(C)C)cc(F)c3-c3nn[nH]n3)C[C@@H]2C)c1 InChI=1S/C23H30FN7O/c1-15(2)9-17-10-20(24)22(23-26-28-29-27-23)21(11-17)31-8-7-30(16(3)13-31)14-18-12-19(32-4)5-6-25-18/h5-6,10-12,15-16H,7-9,13-14H2,1-4H3,(H,26,27,28,29) BQAJFIQJLWDXOE-UHFFFAOYSA-N 703750 (2S)-4-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]-1-[(4-methoxy- 2-pyridyl)methyl]-2- methyl-piperazine::US20240368133, Compound A-227 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 8.75 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703750 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703750&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443674 507747699 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457343 Cc1cccnc1CN1CCN(c2cc(CC(C)C)cc(F)c2-c2nn[nH]n2)C[C@@H]1C InChI=1S/C23H30FN7/c1-15(2)10-18-11-19(24)22(23-26-28-29-27-23)21(12-18)31-9-8-30(17(4)13-31)14-20-16(3)6-5-7-25-20/h5-7,11-12,15,17H,8-10,13-14H2,1-4H3,(H,26,27,28,29) OHDGYZFWUNUEDU-UHFFFAOYSA-N 703751 (2S)-4-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]-2-methyl-1-[(3- methyl-2-pyridyl)- methyl]piperazine::US20240368133, Compound A-228 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 14.9 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703751 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703751&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 169608630 507747700 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457344 Cc1ccnc(CN2CCN(c3cc(CC(C)C)cc(F)c3-c3nn[nH]n3)C[C@@H]2C)c1 InChI=1S/C23H30FN7/c1-15(2)9-18-11-20(24)22(23-26-28-29-27-23)21(12-18)31-8-7-30(17(4)13-31)14-19-10-16(3)5-6-25-19/h5-6,10-12,15,17H,7-9,13-14H2,1-4H3,(H,26,27,28,29) UKWNQISTUDOBIW-UHFFFAOYSA-N 703752 (2S)-4-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]-2-methyl-1-[(4- methyl-2-pyridyl)- methyl]piperazine::US20240368133, Compound A-229 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 7.98 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703752 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703752&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171779936 507747701 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457345 CC(C)Cc1ccc(-c2nn[nH]n2)c(N2CCCN(Cc3cccnn3)CC2)c1 InChI=1S/C21H28N8/c1-16(2)13-17-6-7-19(21-24-26-27-25-21)20(14-17)29-10-4-9-28(11-12-29)15-18-5-3-8-22-23-18/h3,5-8,14,16H,4,9-13,15H2,1-2H3,(H,24,25,26,27) KJJYDEILBVKXMG-UHFFFAOYSA-N 703753 1-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]-4-(pyrid- azin-3-ylmethyl)- 1,4-diazepane::US20240368133, Compound A-230 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 1230 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703753 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703753&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212213 507747702 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457346 CC(C)Cc1cc(F)c(-c2nn[nH]n2)c(N2CCCN(Cc3cccnn3)CC2)c1 InChI=1S/C21H27FN8/c1-15(2)11-16-12-18(22)20(21-25-27-28-26-21)19(13-16)30-8-4-7-29(9-10-30)14-17-5-3-6-23-24-17/h3,5-6,12-13,15H,4,7-11,14H2,1-2H3,(H,25,26,27,28) NOLQPQAGHYYPLB-UHFFFAOYSA-N 703754 1-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]-4-(pyridazin-3- ylmethyl)-1,4- diazepane::US20240368133, Compound A-231 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 368 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703754 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703754&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171780054 507747703 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457347 CC(C)Cc1ccc(-c2nn[nH]n2)c(N2CC3CN(Cc4cccnn4)CC3C2)c1 InChI=1S/C22H28N8/c1-15(2)8-16-5-6-20(22-25-27-28-26-22)21(9-16)30-12-17-10-29(11-18(17)13-30)14-19-4-3-7-23-24-19/h3-7,9,15,17-18H,8,10-14H2,1-2H3,(H,25,26,27,28) AMSXPYZBQUNFNV-UHFFFAOYSA-N 703755 5-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]-2-(pyrid- azin-3-ylmethyl)- 1,3,3a,4,6,6a- hexahydropyrrolo- [3,4-c]pyrrole::US20240368133, Compound A-232 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 2670 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703755 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703755&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212168 507747704 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457348 CC(C)Cc1cc(F)c(-c2nn[nH]n2)c(N2CC3CN(Cc4cccnn4)CC3C2)c1 InChI=1S/C22H27FN8/c1-14(2)6-15-7-19(23)21(22-26-28-29-27-22)20(8-15)31-11-16-9-30(10-17(16)12-31)13-18-4-3-5-24-25-18/h3-5,7-8,14,16-17H,6,9-13H2,1-2H3,(H,26,27,28,29) MBNUMRJGRLRYAA-UHFFFAOYSA-N 703756 5-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]-2-(pyridazin- 3-ylmethyl)- 1,3,3a,4,6,6a- hexahydropyrrolo- [3,4-c]pyrrole::US20240368133, Compound A-233 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 1310 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703756 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703756&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 169608438 507747705 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457349 CC(C)Cc1ccc(-c2nn[nH]n2)c(C2CCN(Cc3cccnn3)CC2)c1 InChI=1S/C21H27N7/c1-15(2)12-16-5-6-19(21-24-26-27-25-21)20(13-16)17-7-10-28(11-8-17)14-18-4-3-9-22-23-18/h3-6,9,13,15,17H,7-8,10-12,14H2,1-2H3,(H,24,25,26,27) ISTLQTZWXWOGOI-UHFFFAOYSA-N 703757 3-[[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]-1-piperid- yl]methyl]pyrid- azine::US20240368133, Compound A-234 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 2020 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703757 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703757&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212146 507747706 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457350 CC(C)Cc1ccc(-c2nn[nH]n2)c(C2CCN(Cc3cccnn3)C2)c1 InChI=1S/C20H25N7/c1-14(2)10-15-5-6-18(20-23-25-26-24-20)19(11-15)16-7-9-27(12-16)13-17-4-3-8-21-22-17/h3-6,8,11,14,16H,7,9-10,12-13H2,1-2H3,(H,23,24,25,26) AYQAGYJSMJQKLH-UHFFFAOYSA-N 703758 3-[[3-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]pyrrolidin- 1-yl]methyl]pyrid- azine::US20240368133, Compound A-235 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 6890 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703758 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703758&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212196 507747707 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457351 CC(C)Cc4ccc(c1nn[nH]n1)c(N3CC(NCc2cccnn2)C3)c4 InChI=1S/C19H24N8/c1-13(2)8-14-5-6-17(19-23-25-26-24-19)18(9-14)27-11-16(12-27)20-10-15-4-3-7-21-22-15/h3-7,9,13,16,20H,8,10-12H2,1-2H3,(H,23,24,25,26) KJVLCJHSMLXTNH-UHFFFAOYSA-N 703759 1-(5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl)-N-(pyrid- azin-3-ylmethyl)- azetidin-3-amine::US20240368133, Compound A-236 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 1010 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703759 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703759&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212198 507747708 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457352 CC(C)Cc1cc(F)c(-c2nn[nH]n2)c(N2CCC(Cc3ccccn3)CC2)c1 InChI=1S/C22H27FN6/c1-15(2)11-17-13-19(23)21(22-25-27-28-26-22)20(14-17)29-9-6-16(7-10-29)12-18-5-3-4-8-24-18/h3-5,8,13-16H,6-7,9-12H2,1-2H3,(H,25,26,27,28) KHUVEWKLJJICBM-UHFFFAOYSA-N 703760 2-((1-(3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl)piperidin-4-yl)- methyl)pyridine::US20240368133, Compound A-237 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 442 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703760 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703760&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171780005 507747709 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457353 CC(C)Cc4ccc(c1nn[nH]n1)c(CN3CCN(Cc2cccnn2)CC3)c4 InChI=1S/C21H28N8/c1-16(2)12-17-5-6-20(21-24-26-27-25-21)18(13-17)14-28-8-10-29(11-9-28)15-19-4-3-7-22-23-19/h3-7,13,16H,8-12,14-15H2,1-2H3,(H,24,25,26,27) OXEGXDFQFHWBJQ-UHFFFAOYSA-N 703761 3-[[4-[[5-isobutyl- 2-(2H-tetrazol-5- yl)phenyl]methyl]- piperazin-1-yl]- methyl]pyridazine::US20240368133, Compound A-238 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 18800 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703761 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703761&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212178 507747710 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457354 CC(C)Cc4ccc(c1nn[nH]n1)c(C(=O)N3CCN(Cc2cccnn2)CC3)c4 InChI=1S/C21H26N8O/c1-15(2)12-16-5-6-18(20-24-26-27-25-20)19(13-16)21(30)29-10-8-28(9-11-29)14-17-4-3-7-22-23-17/h3-7,13,15H,8-12,14H2,1-2H3,(H,24,25,26,27) SHLPZDOIIGYILK-UHFFFAOYSA-N 703762 (5-isobutyl-2-(2H- tetrazol-5-yl)phen- yl)(4-(pyridazin-3- ylmethyl)piperazin- 1-yl)methanone::US20240368133, Compound A-239 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 2570 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703762 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703762&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171779873 507747711 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457355 CCc1nc2ccccc2c(=O)n1CC1CCN(c2ccccc2-c2nn[nH]n2)CC1 InChI=1S/C23H25N7O/c1-2-21-24-19-9-5-3-7-17(19)23(31)30(21)15-16-11-13-29(14-12-16)20-10-6-4-8-18(20)22-25-27-28-26-22/h3-10,16H,2,11-15H2,1H3,(H,25,26,27,28) LKLBHEJATUVRNR-UHFFFAOYSA-N 703763 2-ethyl-3-[[1-[2- (2H-tetrazol-5-yl)- phenyl]-4-piperid- yl]methyl]quin- azolin-4-one::US20240368133, Compound A-240 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 36200 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703763 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703763&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 169610194 507747712 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457356 CCc1nc2ccccc2c(=O)n1CC1CCN(c2ccccc2C(=O)NS(=O)(=O)CC)CC1 InChI=1S/C25H30N4O4S/c1-3-23-26-21-11-7-5-9-19(21)25(31)29(23)17-18-13-15-28(16-14-18)22-12-8-6-10-20(22)24(30)27-34(32,33)4-2/h5-12,18H,3-4,13-17H2,1-2H3,(H,27,30) UNLRVGVUPFJUAZ-UHFFFAOYSA-N 703764 2-[4-[(2-ethyl-4- oxo-quinazolin-3- yl)methyl]-1- piperidyl]-N-ethyl- sulfonyl-benzamide::US20240368133, Compound A-241 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 42500 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703764 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703764&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 169608770 507747713 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457357 CCc1nc2ccc([N+](=O)[O-])cc2c(=O)n1CC1CCN(c2ccccc2-c2nn[nH]n2)CC1 InChI=1S/C23H24N8O3/c1-2-21-24-19-8-7-16(31(33)34)13-18(19)23(32)30(21)14-15-9-11-29(12-10-15)20-6-4-3-5-17(20)22-25-27-28-26-22/h3-8,13,15H,2,9-12,14H2,1H3,(H,25,26,27,28) VBPBDQVCNNJDMO-UHFFFAOYSA-N 703765 2-ethyl-6-nitro-3- [[1-[2-(2H-tetrazol- 5-yl)phenyl]-4- piperidyl]methyl]- quinazolin-4-one::US20240368133, Compound A-242 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 27700 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703765 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703765&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171779871 507747714 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457358 CCCN(C(=O)c1cccs1)c1ccc2nc(CC)n(CC3CCN(c4ccccc4-c4nn[nH]n4)CC3)c(=O)c2c1 InChI=1S/C31H34N8O2S/c1-3-15-38(31(41)27-10-7-18-42-27)22-11-12-25-24(19-22)30(40)39(28(4-2)32-25)20-21-13-16-37(17-14-21)26-9-6-5-8-23(26)29-33-35-36-34-29/h5-12,18-19,21H,3-4,13-17,20H2,1-2H3,(H,33,34,35,36) KYKORMOBINELNF-UHFFFAOYSA-N 703766 N-[2-ethyl-4-oxo- 3-[[1-[2-(2H- tetrazol-5-yl)phen- yl]-4-piperidyl]- methyl]quinazolin- 6-yl]-N-propyl- thiophene-2-carbox- amide::US20240368133, Compound A-243 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 159 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703766 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703766&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212190 507747715 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457359 CCc1nc2ccc(N(Cc3cccnc3)C(=O)c3cccs3)cc2c(=O)n1CC1CCN(c2ccccc2-c2nn[nH]n2)CC1 InChI=1S/C34H33N9O2S/c1-2-31-36-28-12-11-25(42(22-24-7-5-15-35-20-24)34(45)30-10-6-18-46-30)19-27(28)33(44)43(31)21-23-13-16-41(17-14-23)29-9-4-3-8-26(29)32-37-39-40-38-32/h3-12,15,18-20,23H,2,13-14,16-17,21-22H2,1H3,(H,37,38,39,40) WFZCSDITNSGCIN-UHFFFAOYSA-N 703767 N-[2-ethyl-4-oxo-3- [1-[2-(2H-tetrazol- 5-yl)phenyl]-4- piperidyl]methyl]- quinazolin-6-yl]-N- (3-pyridylmethyl)- thiophene-2-carbox- amide::US20240368133, Compound A-244 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 104 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703767 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703767&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171779973 507747716 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457360 CCc1nc2ccc(NC(=O)c3ccccc3)cc2c(=O)n1CC1CCN(c2ccccc2-c2nn[nH]n2)CC1 InChI=1S/C30H30N8O2/c1-2-27-32-25-13-12-22(31-29(39)21-8-4-3-5-9-21)18-24(25)30(40)38(27)19-20-14-16-37(17-15-20)26-11-7-6-10-23(26)28-33-35-36-34-28/h3-13,18,20H,2,14-17,19H2,1H3,(H,31,39)(H,33,34,35,36) YVSWZSZBUIKTBK-UHFFFAOYSA-N 703768 N-[2-ethyl-4-oxo-3- [1-[2-(2H-tetrazol- 5-yl)phenyl]-4- piperidyl]methyl]- quinazolin-6-yl]- benzamide::US20240368133, Compound A-245 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 9970 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703768 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703768&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212180 507747717 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457361 CCc1nc2ccc(N(Cc3ccccc3)C(=O)c3cccs3)cc2c(=O)n1CC1CCN(c2ccccc2-c2nn[nH]n2)CC1 InChI=1S/C35H34N8O2S/c1-2-32-36-29-15-14-26(42(22-24-9-4-3-5-10-24)35(45)31-13-8-20-46-31)21-28(29)34(44)43(32)23-25-16-18-41(19-17-25)30-12-7-6-11-27(30)33-37-39-40-38-33/h3-15,20-21,25H,2,16-19,22-23H2,1H3,(H,37,38,39,40) WUAOVPRYOIGVEK-UHFFFAOYSA-N 703769 N-benzyl-N-[2- ethyl-4-oxo-3-[[1- [2-(2H-tetrazol-5- yl)phenyl]-4-piper- idyl]methyl]quin- azolin-6-yl]thio- phene-2-carbox- amide::US20240368133, Compound A-246 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 102 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703769 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703769&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212189 507747718 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457362 CCc1nc2ccc(NC(=O)C3CC3)cc2c(=O)n1CC1CCN(c2ccccc2-c2nn[nH]n2)CC1 InChI=1S/C27H30N8O2/c1-2-24-29-22-10-9-19(28-26(36)18-7-8-18)15-21(22)27(37)35(24)16-17-11-13-34(14-12-17)23-6-4-3-5-20(23)25-30-32-33-31-25/h3-6,9-10,15,17-18H,2,7-8,11-14,16H2,1H3,(H,28,36)(H,30,31,32,33) HFFQIDDEGGJLDK-UHFFFAOYSA-N 703770 N-[2-ethyl-4-oxo-3- [[1-[2-(2H-tetrazol- 5-yl)phenyl]-4- piperidyl]methyl]- quinazolin-6-yl]- cyclopropane- carboxamide::US20240368133, Compound A-247 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 35300 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703770 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703770&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 169609340 507747719 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457363 CCc1nc2ccc(N(Cc3ccccc3Cl)C(=O)c3cccs3)cc2c(=O)n1CC1CCN(c2ccccc2-c2nn[nH]n2)CC1 InChI=1S/C35H33ClN8O2S/c1-2-32-37-29-14-13-25(43(35(46)31-12-7-19-47-31)22-24-8-3-5-10-28(24)36)20-27(29)34(45)44(32)21-23-15-17-42(18-16-23)30-11-6-4-9-26(30)33-38-40-41-39-33/h3-14,19-20,23H,2,15-18,21-22H2,1H3,(H,38,39,40,41) ZNQNVNHBGOBZQE-UHFFFAOYSA-N 703771 N-[(2-chlorophen- yl)-methyl]-N-[2- ethyl-4-oxo-3-[[1- [2-(2H-tetrazol-5- yl)phenyl]-4-piper- idyl]methyl]quin- azolin-6-yl]thio- phene-2-carbox- amide::US20240368133, Compound A-248 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 48.0 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703771 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703771&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 171779926 507747720 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457364 O=c1c2ccccc2nc(-c2ccccc2)n1CC1CCN(c2ccccc2-c2nnn[nH]2)CC1 InChI=1S/C27H25N7O/c35-27-21-10-4-6-12-23(21)28-26(20-8-2-1-3-9-20)34(27)18-19-14-16-33(17-15-19)24-13-7-5-11-22(24)25-29-31-32-30-25/h1-13,19H,14-18H2,(H,29,30,31,32) PCCBWKOLNAJDIK-UHFFFAOYSA-N 703772 2-phenyl-3-[1-[2- (1H-tetrazol-5-yl)- phenyl]-4-piperid- yl]methyl]quin- azolin-4-one::US20240368133, Compound A-249 Type-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor Homo sapiens 79000 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703772 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=423&target=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703772&enzyme=Type-2+angiotensin+II+receptor%2FLow+affinity+immunoglobulin+epsilon+Fc+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443867 507747721 2 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 MEEGQYSEIEELPRRRCCRRGTQIVLLGLVTAALWAGLLTLLLLWHWDTTQSLKQLEERAARNVSQVSKNLESHHGDQMAQKSQSTQISQELEELRAEQQRLKSQDLELSWNLNGLQADLSSFKSQELNERNEASDLLERLREEVTKLRMELQVSSGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRPDPDGRLPTPSAPLHS 4KI1,4J6Q,4J6P,4J6N,4J6M,4J6L,4J6K,4J6J,4GKO,4G9A,4G96,4EZM,1T8D,1T8C,5LGK Low affinity immunoglobulin epsilon Fc receptor FCER2_HUMAN P06734 1457365 c5ccc(N3CCN(Cc2nc1ccccc1s2)CC3)c(c4nn[nH]n4)c5 InChI=1S/C19H19N7S/c1-3-7-16(14(5-1)19-21-23-24-22-19)26-11-9-25(10-12-26)13-18-20-15-6-2-4-8-17(15)27-18/h1-8H,9-13H2,(H,21,22,23,24) OVPLDUIIXKGXTP-UHFFFAOYSA-N 703528 2-[[4-[2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]-1,3-benzo- thiazole::US20240368133, Compound A-05 Type-1 angiotensin II receptor Homo sapiens 49900 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703528 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703528&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 169609282 507747477 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457366 c5ccc(N3CCC(Cc2nc1ccccc1s2)CC3)c(c4nn[nH]n4)c5 InChI=1S/C20H20N6S/c1-3-7-17(15(5-1)20-22-24-25-23-20)26-11-9-14(10-12-26)13-19-21-16-6-2-4-8-18(16)27-19/h1-8,14H,9-13H2,(H,22,23,24,25) INKVQZJQAUZJOH-UHFFFAOYSA-N 703529 2-[[1-[2-(2H- tetrazol-5-yl)phen- yl]-4-piperidyl]- methyl]-1,3-benzo- thiazole::US20240368133, Compound A-06 Type-1 angiotensin II receptor Homo sapiens 25400 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703529 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703529&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 169609277 507747478 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457367 CCOC(=O)NS(=O)(=O)c1ccc(C(F)(F)F)cc1N1CCN(Cc2nc3ccccc3n2C)CC1 InChI=1S/C23H26F3N5O4S/c1-3-35-22(32)28-36(33,34)20-9-8-16(23(24,25)26)14-19(20)31-12-10-30(11-13-31)15-21-27-17-6-4-5-7-18(17)29(21)2/h4-9,14H,3,10-13,15H2,1-2H3,(H,28,32) BYORFRFOHVYBLR-UHFFFAOYSA-N 703531 ethyl N-[2-[4-[(1- methylbenzimid- azol-2-yl)methyl]- piperazin-1-yl]-4- (trifluoromethyl)- phenyl]sulfonyl- carbamate::US20240368133, Compound A-08 Type-1 angiotensin II receptor Homo sapiens 92100 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703531 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703531&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 171779851 507747480 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457368 CCCCOC(=O)NS(=O)(=O)c1ccc(C(F)(F)F)cc1N1CCN(Cc2nc3ccccc3n2C)CC1 InChI=1S/C25H30F3N5O4S/c1-3-4-15-37-24(34)30-38(35,36)22-10-9-18(25(26,27)28)16-21(22)33-13-11-32(12-14-33)17-23-29-19-7-5-6-8-20(19)31(23)2/h5-10,16H,3-4,11-15,17H2,1-2H3,(H,30,34) HPYLEWGHDCANII-UHFFFAOYSA-N 703532 butyl N-[2-[4-[(1- methylbenzimid- azol-2-yl)methyl]- piperazin-1-yl]-4- (trifluoromethyl)- phenyl]sulfonyl- carbamate::US20240368133, Compound A-09 Type-1 angiotensin II receptor Homo sapiens 36500 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703532 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703532&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 169609259 507747481 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457369 CCCCNC(=O)NS(=O)(=O)c1ccc(C(F)(F)F)cc1N1CCN(Cc2nc3ccccc3n2C)CC1 InChI=1S/C25H31F3N6O3S/c1-3-4-11-29-24(35)31-38(36,37)22-10-9-18(25(26,27)28)16-21(22)34-14-12-33(13-15-34)17-23-30-19-7-5-6-8-20(19)32(23)2/h5-10,16H,3-4,11-15,17H2,1-2H3,(H2,29,31,35) SCISZPMVSUUSMT-UHFFFAOYSA-N 703533 1-butyl-3-[2-[4-[(1- methylbenzimid- azol-2-yl)methyl]- piperazin-1-yl]-4- (trifluoromethyl)- phenyl]sulfonyl- urea::US20240368133, Compound A-10 Type-1 angiotensin II receptor Homo sapiens 70000 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703533 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703533&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 169609290 507747482 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457370 CCCCOC(=O)NS(=O)c1ccc(C)cc1N1CCN(Cc2nc3ccccc3n2C)CC1 InChI=1S/C25H33N5O3S/c1-4-5-16-33-25(31)27-34(32)23-11-10-19(2)17-22(23)30-14-12-29(13-15-30)18-24-26-20-8-6-7-9-21(20)28(24)3/h6-11,17H,4-5,12-16,18H2,1-3H3,(H,27,31) FLFLETBETIJBMS-UHFFFAOYSA-N 703534 butyl N-[4-methyl- 2-[4-[(1-methyl- benzimidazol-2-yl)- methyl]piperazin- 1-yl]phenyl]sulfon- ylcarbamate::US20240368133, Compound A-11 Type-1 angiotensin II receptor Homo sapiens 37700 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703534 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703534&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 172484127 507747483 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457371 CCCc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4n3C)CC2)c1 InChI=1S/C23H28N8/c1-3-6-17-9-10-18(23-25-27-28-26-23)21(15-17)31-13-11-30(12-14-31)16-22-24-19-7-4-5-8-20(19)29(22)2/h4-5,7-10,15H,3,6,11-14,16H2,1-2H3,(H,25,26,27,28) ZDKFGDQGEPGOSO-UHFFFAOYSA-N 703542 1-methyl-2-[[4-[5- propyl-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]benzimid- azole::US20240368133, Compound A-19 Type-1 angiotensin II receptor Homo sapiens 47400 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703542 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703542&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 169608599 507747491 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457372 CC(C)Cc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4n3C)CC2)c1 InChI=1S/C24H30N8/c1-17(2)14-18-8-9-19(24-26-28-29-27-24)22(15-18)32-12-10-31(11-13-32)16-23-25-20-6-4-5-7-21(20)30(23)3/h4-9,15,17H,10-14,16H2,1-3H3,(H,26,27,28,29) AMJXFNRPXIVNKH-UHFFFAOYSA-N 703543 2-[[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin-1- yl]methyl]-1-meth- yl-benzimidazole::US20240368133, Compound A-20 Type-1 angiotensin II receptor Homo sapiens 49700 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703543 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703543&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 169609389 507747492 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457373 CC(C)=Cc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4n3C)CC2)c1 InChI=1S/C24H28N8/c1-17(2)14-18-8-9-19(24-26-28-29-27-24)22(15-18)32-12-10-31(11-13-32)16-23-25-20-6-4-5-7-21(20)30(23)3/h4-9,14-15H,10-13,16H2,1-3H3,(H,26,27,28,29) ZKWNCTZOUCUQCJ-UHFFFAOYSA-N 703544 1-methyl-2-[[4-[5- (2-methylprop-1- enyl)-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]benzimid- azole::US20240368133, Compound A-21 Type-1 angiotensin II receptor Homo sapiens 41700 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703544 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703544&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212156 507747493 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457374 CCS(=O)(=O)NC(=O)c1ccc(C2CC2)cc1N1CCN(Cc2nc3ccccc3s2)CC1 InChI=1S/C24H28N4O3S2/c1-2-33(30,31)26-24(29)19-10-9-18(17-7-8-17)15-21(19)28-13-11-27(12-14-28)16-23-25-20-5-3-4-6-22(20)32-23/h3-6,9-10,15,17H,2,7-8,11-14,16H2,1H3,(H,26,29) DLSDWPNWRABIQA-UHFFFAOYSA-N 703558 2-[4-(1,3-benzo- thiazol-2-ylmethyl)- piperazin-1-yl]-4- cyclopropyl-N-eth- ylsulfonyl-benz- amide::US20240368133, Compound A-35 Type-1 angiotensin II receptor Homo sapiens 31400 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703558 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703558&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443922 507747507 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457375 CCOc1ccc(C(=O)NS(=O)(=O)CC)c(N2CCN(Cc3nc4ccccc4s3)CC2)c1 InChI=1S/C23H28N4O4S2/c1-3-31-17-9-10-18(23(28)25-33(29,30)4-2)20(15-17)27-13-11-26(12-14-27)16-22-24-19-7-5-6-8-21(19)32-22/h5-10,15H,3-4,11-14,16H2,1-2H3,(H,25,28) QSKBNIRZFMWKEO-UHFFFAOYSA-N 703561 2-[4-(1,3-benzo- thiazol-2-ylmethyl)- piperazin-1-yl]-4- ethoxy-N-ethyl- sulfonyl-benzamide::US20240368133, Compound A-38 Type-1 angiotensin II receptor Homo sapiens 13600 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703561 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703561&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443467 507747510 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457376 CCS(=O)(=O)NC(=O)c1ccc(OC(C)C)cc1N1CCN(Cc2nc3ccccc3s2)CC1 InChI=1S/C24H30N4O4S2/c1-4-34(30,31)26-24(29)19-10-9-18(32-17(2)3)15-21(19)28-13-11-27(12-14-28)16-23-25-20-7-5-6-8-22(20)33-23/h5-10,15,17H,4,11-14,16H2,1-3H3,(H,26,29) BXVNGEGLPDZKLD-UHFFFAOYSA-N 703563 2-[4-(1,3-benzo- thiazol-2-ylmethyl)- piperazin-1-yl]-N- ethylsulfonyl-4- isopropoxy-benz- amide::US20240368133, Compound A-40 Type-1 angiotensin II receptor Homo sapiens 36600 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703563 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703563&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443755 507747512 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457377 CCS(=O)(=O)NC(=O)c1ccc(OC2CC2)cc1N1CCN(Cc2nc3ccccc3s2)CC1 InChI=1S/C24H28N4O4S2/c1-2-34(30,31)26-24(29)19-10-9-18(32-17-7-8-17)15-21(19)28-13-11-27(12-14-28)16-23-25-20-5-3-4-6-22(20)33-23/h3-6,9-10,15,17H,2,7-8,11-14,16H2,1H3,(H,26,29) ADQPYVOOAUWHBU-UHFFFAOYSA-N 703564 2-[4-(1,3-benzo- thiazol-2-ylmethyl)- piperazin-1-yl]-4- (cyclopropoxy)-N- ethylsulfonyl-benz- amide::US20240368133, Compound A-41 Type-1 angiotensin II receptor Homo sapiens 16500 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703564 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703564&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443570 507747513 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457378 CCCOc1ccc(C(=O)NS(=O)(=O)CC)c(N2CCN(Cc3nc4ccccc4s3)CC2)c1 InChI=1S/C24H30N4O4S2/c1-3-15-32-18-9-10-19(24(29)26-34(30,31)4-2)21(16-18)28-13-11-27(12-14-28)17-23-25-20-7-5-6-8-22(20)33-23/h5-10,16H,3-4,11-15,17H2,1-2H3,(H,26,29) DCOVRGFZJRCJDF-UHFFFAOYSA-N 703565 2-[4-(1,3-benzo- thiazol-2-ylmeth- yl)piperazin-1-yl]- N-ethylsulfonyl-4- propoxy-benzamide::US20240368133, Compound A-42 Type-1 angiotensin II receptor Homo sapiens 26300 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703565 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703565&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443946 507747514 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457379 CCNc1ccc(C(=O)NS(=O)(=O)CC)c(N2CCN(Cc3nc4ccccc4s3)CC2)c1 InChI=1S/C23H29N5O3S2/c1-3-24-17-9-10-18(23(29)26-33(30,31)4-2)20(15-17)28-13-11-27(12-14-28)16-22-25-19-7-5-6-8-21(19)32-22/h5-10,15,24H,3-4,11-14,16H2,1-2H3,(H,26,29) YVYYDNRQBORTGU-UHFFFAOYSA-N 703567 2-[4-(1,3-benzo- thiazol-2-ylmethyl)- piperazin-1-yl]-4- (ethylamino)-N- ethylsulfonyl-benz- amide::US20240368133, Compound A-44 Type-1 angiotensin II receptor Homo sapiens 34900 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703567 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703567&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443732 507747516 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457380 CCc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4s3)CC2)c1 InChI=1S/C21H23N7S/c1-2-15-7-8-16(21-23-25-26-24-21)18(13-15)28-11-9-27(10-12-28)14-20-22-17-5-3-4-6-19(17)29-20/h3-8,13H,2,9-12,14H2,1H3,(H,23,24,25,26) SLGKSHCWFZUZAX-UHFFFAOYSA-N 703568 2-[[4-[5-ethyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-1,3- benzothiazole::US20240368133, Compound A-45 Type-1 angiotensin II receptor Homo sapiens 30000 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703568 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703568&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443728 507747517 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457381 CC(C)Cc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4s3)CC2)c1 InChI=1S/C23H27N7S/c1-16(2)13-17-7-8-18(23-25-27-28-26-23)20(14-17)30-11-9-29(10-12-30)15-22-24-19-5-3-4-6-21(19)31-22/h3-8,14,16H,9-13,15H2,1-2H3,(H,25,26,27,28) QQSNIEJIUAYEPP-UHFFFAOYSA-N 703571 2-[[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-1,3- benzothiazole::US20240368133, Compound A-48 Type-1 angiotensin II receptor Homo sapiens 27800 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703571 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703571&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443945 507747520 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457382 CC(C)Cc1ccc(-c2c[nH]nn2)c(N2CCN(c3nc4ccccc4s3)CC2)c1 InChI=1S/C23H26N6S/c1-16(2)13-17-7-8-18(20-15-24-27-26-20)21(14-17)28-9-11-29(12-10-28)23-25-19-5-3-4-6-22(19)30-23/h3-8,14-16H,9-13H2,1-2H3,(H,24,26,27) UIDHHNSDANBFFN-UHFFFAOYSA-N 703572 2-[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]-1,3-benzo- thiazole::US20240368133, Compound A-49 Type-1 angiotensin II receptor Homo sapiens 20300 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703572 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703572&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 172484097 507747521 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457383 CC(C)Oc1ccc(-c2nn[nH]n2)c(CN2CCN(c3nc4ccccc4s3)CC2)c1 InChI=1S/C22H25N7OS/c1-15(2)30-17-7-8-18(21-24-26-27-25-21)16(13-17)14-28-9-11-29(12-10-28)22-23-19-5-3-4-6-20(19)31-22/h3-8,13,15H,9-12,14H2,1-2H3,(H,24,25,26,27) MLMZSPFKERSACF-UHFFFAOYSA-N 703573 2-[4-[[5-isoprop- oxy-2-(2H-tetrazol- 5-yl)phenyl]meth- yl]piperazin-1-yl]- 1,3-benzothiazole::US20240368133, Compound A-50 Type-1 angiotensin II receptor Homo sapiens 28800 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703573 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703573&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212159 507747522 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457384 CC(C)Oc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4s3)CC2)c1 InChI=1S/C22H25N7OS/c1-15(2)30-16-7-8-17(22-24-26-27-25-22)19(13-16)29-11-9-28(10-12-29)14-21-23-18-5-3-4-6-20(18)31-21/h3-8,13,15H,9-12,14H2,1-2H3,(H,24,25,26,27) MDAIZCDIYGEDEZ-UHFFFAOYSA-N 703574 2-[[4-[5-isoprop- oxy-2-(2H-tetrazol- 5-yl)phenyl]piper- azin-1-yl]methyl]- 1,3-benzothiazole::US20240368133, Compound A-51 Type-1 angiotensin II receptor Homo sapiens 55000 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703574 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703574&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 169608613 507747523 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457385 CC(C)COc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4s3)CC2)c1 InChI=1S/C23H27N7OS/c1-16(2)15-31-17-7-8-18(23-25-27-28-26-23)20(13-17)30-11-9-29(10-12-30)14-22-24-19-5-3-4-6-21(19)32-22/h3-8,13,16H,9-12,14-15H2,1-2H3,(H,25,26,27,28) AFAJDSHXDZOJSH-UHFFFAOYSA-N 703576 2-[[4-[5-isobutoxy- 2-(2H-tetrazol-5- yl)phenyl]piperazin- 1-yl]methyl]-1,3- benzothiazole::US20240368133, Compound A-53 Type-1 angiotensin II receptor Homo sapiens 45600 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703576 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703576&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443939 507747525 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457386 c6ccc5sc(CN4CCN(c2cc(OCC1CC1)ccc2c3nn[nH]n3)CC4)nc5c6 InChI=1S/C23H25N7OS/c1-2-4-21-19(3-1)24-22(32-21)14-29-9-11-30(12-10-29)20-13-17(31-15-16-5-6-16)7-8-18(20)23-25-27-28-26-23/h1-4,7-8,13,16H,5-6,9-12,14-15H2,(H,25,26,27,28) YHPNFQKHWMBHAV-UHFFFAOYSA-N 703577 2-[[4-[5-(cyclo- propylmethoxy)-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-1,3- benzothiazole::US20240368133, Compound A-54 Type-1 angiotensin II receptor Homo sapiens 31000 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703577 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703577&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212174 507747526 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457387 FC(F)COc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4s3)CC2)c1 InChI=1S/C21H21F2N7OS/c22-19(23)13-31-14-5-6-15(21-25-27-28-26-21)17(11-14)30-9-7-29(8-10-30)12-20-24-16-3-1-2-4-18(16)32-20/h1-6,11,19H,7-10,12-13H2,(H,25,26,27,28) CAUZGOBQNRBRAR-UHFFFAOYSA-N 703578 2-[[4-[5-(2,2- difluoroethoxy)-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-1,3- benzothiazole::US20240368133, Compound A-55 Type-1 angiotensin II receptor Homo sapiens 39700 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703578 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703578&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443605 507747527 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457388 c6ccc5sc(CN4CCN(c2cc(OC1CCCC1)ccc2c3nn[nH]n3)CC4)nc5c6 InChI=1S/C24H27N7OS/c1-2-6-17(5-1)32-18-9-10-19(24-26-28-29-27-24)21(15-18)31-13-11-30(12-14-31)16-23-25-20-7-3-4-8-22(20)33-23/h3-4,7-10,15,17H,1-2,5-6,11-14,16H2,(H,26,27,28,29) BFWMLGWSNUZGHU-UHFFFAOYSA-N 703580 2-[[4-[5-(cyclo- pentoxy)-2-(2H- tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-1,3- benzothiazole::US20240368133, Compound A-57 Type-1 angiotensin II receptor Homo sapiens 34500 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703580 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703580&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443729 507747529 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457389 c6ccc5sc(CN4CCN(c2cc(NC1CCCC1)ccc2c3nn[nH]n3)CC4)nc5c6 InChI=1S/C24H28N8S/c1-2-6-17(5-1)25-18-9-10-19(24-27-29-30-28-24)21(15-18)32-13-11-31(12-14-32)16-23-26-20-7-3-4-8-22(20)33-23/h3-4,7-10,15,17,25H,1-2,5-6,11-14,16H2,(H,27,28,29,30) RXEIGSPLNJGWNF-UHFFFAOYSA-N 703587 3-[4-(1,3-benzothi- azol-2-ylmethyl)- piperazin-1-yl]-N- cyclopentyl-4-(2H- tetrazol-5-yl)aniline::US20240368133, Compound A-64 Type-1 angiotensin II receptor Homo sapiens 39700 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703587 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703587&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212152 507747536 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457390 c6ccc5sc(CN4CCN(c2cc(N1CCCCC1)ccc2c3nn[nH]n3)CC4)nc5c6 InChI=1S/C24H28N8S/c1-4-10-31(11-5-1)18-8-9-19(24-26-28-29-27-24)21(16-18)32-14-12-30(13-15-32)17-23-25-20-6-2-3-7-22(20)33-23/h2-3,6-9,16H,1,4-5,10-15,17H2,(H,26,27,28,29) RDBVCGCAJMLHRB-UHFFFAOYSA-N 703588 2-[[4-[5-(1-piperid- yl)-2-(2H-tetrazol-5- yl)phenyl]piperazin- 1-yl]methyl]-1,3- benzothiazole::US20240368133, Compound A-65 Type-1 angiotensin II receptor Homo sapiens 60800 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703588 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703588&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 171779919 507747537 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457391 Cc1ccc2nc(CN3CCN(c4cc(CC(C)C)ccc4-c4nn[nH]n4)CC3)cc(=O)n2c1 InChI=1S/C25H30N8O/c1-17(2)12-19-5-6-21(25-27-29-30-28-25)22(13-19)32-10-8-31(9-11-32)16-20-14-24(34)33-15-18(3)4-7-23(33)26-20/h4-7,13-15,17H,8-12,16H2,1-3H3,(H,27,28,29,30) NMRRFRATTNNKOT-UHFFFAOYSA-N 703593 2-[[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-7- methyl-pyrido[1,2- a]pyrimidin-4-one::US20240368133, Compound A-70 Type-1 angiotensin II receptor Homo sapiens 61200 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703593 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703593&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212197 507747542 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457392 CC(C)Cc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3cc4ccccc4n(C)c3=O)CC2)c1 InChI=1S/C26H31N7O/c1-18(2)14-19-8-9-22(25-27-29-30-28-25)24(15-19)33-12-10-32(11-13-33)17-21-16-20-6-4-5-7-23(20)31(3)26(21)34/h4-9,15-16,18H,10-14,17H2,1-3H3,(H,27,28,29,30) UYHUAHOPOLDEMY-UHFFFAOYSA-N 703600 3-[[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-1- methyl-quinolin-2- one::US20240368133, Compound A-77 Type-1 angiotensin II receptor Homo sapiens 13500 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703600 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703600&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212224 507747549 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457393 CC(C)Cc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4c(=O)n3C)CC2)c1 InChI=1S/C25H30N8O/c1-17(2)14-18-8-9-20(24-27-29-30-28-24)22(15-18)33-12-10-32(11-13-33)16-23-26-21-7-5-4-6-19(21)25(34)31(23)3/h4-9,15,17H,10-14,16H2,1-3H3,(H,27,28,29,30) OOPCXNVSMSLSQJ-UHFFFAOYSA-N 703601 2-[[4-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-3- methyl-quinazolin- 4-one::US20240368133, Compound A-78 Type-1 angiotensin II receptor Homo sapiens 12200 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703601 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703601&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 169608773 507747550 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457394 CC(C)Cc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3ccc(C(F)(F)F)cn3)CC2)c1 InChI=1S/C22H26F3N7/c1-15(2)11-16-3-6-19(21-27-29-30-28-21)20(12-16)32-9-7-31(8-10-32)14-18-5-4-17(13-26-18)22(23,24)25/h3-6,12-13,15H,7-11,14H2,1-2H3,(H,27,28,29,30) GMJPGTYOORVHSE-UHFFFAOYSA-N 703608 1-[5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]-4-[[5- (trifluoromethyl)-2- pyridyl]methyl]- piperazine::US20240368133, Compound A-85 Type-1 angiotensin II receptor Homo sapiens 45000 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703608 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703608&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212209 507747557 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457395 CC(C)Cc1ccc(-c2nn[nH]n2)c(N2CCN(Cc3nncn3C)CC2)c1 InChI=1S/C19H27N9/c1-14(2)10-15-4-5-16(19-22-24-25-23-19)17(11-15)28-8-6-27(7-9-28)12-18-21-20-13-26(18)3/h4-5,11,13-14H,6-10,12H2,1-3H3,(H,22,23,24,25) STTPJLLXOOWZRB-UHFFFAOYSA-N 703617 1-[5-isobutyl-2-(2H- tetrazol-5-yl)phen- yl]-4-[(4-methyl- 1,2,4-triazol-3-yl)- methyl]piperazine::US20240368133, Compound A-94 Type-1 angiotensin II receptor Homo sapiens 14200 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703617 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703617&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 171779861 507747566 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457396 COc1cc(F)c(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4s3)CC2)c1 InChI=1S/C20H20FN7OS/c1-29-13-10-14(21)19(20-23-25-26-24-20)16(11-13)28-8-6-27(7-9-28)12-18-22-15-4-2-3-5-17(15)30-18/h2-5,10-11H,6-9,12H2,1H3,(H,23,24,25,26) WQIRDCXYANOVGQ-UHFFFAOYSA-N 703639 2-[[4-[3-fluoro-5- methoxy-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]-1,3-benzo- thiazole::US20240368133, Compound A-116 Type-1 angiotensin II receptor Homo sapiens 18100 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703639 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703639&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443740 507747588 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457397 CC(C)Oc1cc(F)c(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4s3)CC2)c1 InChI=1S/C22H24FN7OS/c1-14(2)31-15-11-16(23)21(22-25-27-28-26-22)18(12-15)30-9-7-29(8-10-30)13-20-24-17-5-3-4-6-19(17)32-20/h3-6,11-12,14H,7-10,13H2,1-2H3,(H,25,26,27,28) LHURIVKKIJIPFQ-UHFFFAOYSA-N 703641 2-[[4-[3-fluoro-5- isopropoxy-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]-1,3-benzo- thiazole::US20240368133, Compound A-118 Type-1 angiotensin II receptor Homo sapiens 41500 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703641 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703641&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443502 507747590 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457398 CC(C)Oc1cc(N2CCN(Cc3nc4ccccc4s3)CC2)c(-c2nn[nH]n2)cc1C1CC1 InChI=1S/C25H29N7OS/c1-16(2)33-22-14-21(19(25-27-29-30-28-25)13-18(22)17-7-8-17)32-11-9-31(10-12-32)15-24-26-20-5-3-4-6-23(20)34-24/h3-6,13-14,16-17H,7-12,15H2,1-2H3,(H,27,28,29,30) NKVWZVYZVBNTLF-UHFFFAOYSA-N 703644 2-[[4-[4-cycloprop- yl-5-isopropoxy-2- (2H-tetrazol-5-yl)- phenyl]piperazin- 1-yl]methyl]-1,3- benzothiazole::US20240368133, Compound A-121 Type-1 angiotensin II receptor Homo sapiens 11700 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703644 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703644&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443797 507747593 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457399 CCc1cc(C2CC2)cc(N2CCN(Cc3nc4ccccc4s3)CC2)c1-c1nn[nH]n1 InChI=1S/C24H27N7S/c1-2-16-13-18(17-7-8-17)14-20(23(16)24-26-28-29-27-24)31-11-9-30(10-12-31)15-22-25-19-5-3-4-6-21(19)32-22/h3-6,13-14,17H,2,7-12,15H2,1H3,(H,26,27,28,29) UFPITGXLLJJHEC-UHFFFAOYSA-N 703651 2-[[4-[5-cycloprop- yl-3-ethyl-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]-1,3-benzo- thiazole::US20240368133, Compound A-128 Type-1 angiotensin II receptor Homo sapiens 18200 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703651 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703651&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443539 507747600 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457400 CCNc1cc(-c2nn[nH]n2)c(N2CCN(Cc3nc4ccccc4s3)CC2)cc1CC(C)C InChI=1S/C25H32N8S/c1-4-26-21-15-19(25-28-30-31-29-25)22(14-18(21)13-17(2)3)33-11-9-32(10-12-33)16-24-27-20-7-5-6-8-23(20)34-24/h5-8,14-15,17,26H,4,9-13,16H2,1-3H3,(H,28,29,30,31) XYADBGSXMFJHSA-UHFFFAOYSA-N 703663 4-[4-(1,3-benzo- thiazol-2-ylmethyl)- piperazin-1-yl]-N- ethyl-2-isobutyl-5- (2H-tetrazol-5-yl)- aniline::US20240368133, Compound A-140 Type-1 angiotensin II receptor Homo sapiens 24700 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703663 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703663&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443713 507747612 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457401 CC(C)Cc1cc(F)c(-c2nn[nH]n2)c(N2CC(C)N(Cc3cccnn3)C(C)C2)c1 InChI=1S/C22H29FN8/c1-14(2)8-17-9-19(23)21(22-26-28-29-27-22)20(10-17)30-11-15(3)31(16(4)12-30)13-18-6-5-7-24-25-18/h5-7,9-10,14-16H,8,11-13H2,1-4H3,(H,26,27,28,29) DCUNWEFVGRUUQY-UHFFFAOYSA-N 703707 3-[[4-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]-2,6-dimethyl- piperazin-1-yl]- methyl]pyridazine::US20240368133, Compound A-184 Type-1 angiotensin II receptor Homo sapiens 33600 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703707 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703707&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212167 507747656 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457402 CC(C)Cc1cc(F)c(-c2nn[nH]n2)c(N2CCN(Cc3ccc(C#N)cn3)CC2)c1 InChI=1S/C22H25FN8/c1-15(2)9-17-10-19(23)21(22-26-28-29-27-22)20(11-17)31-7-5-30(6-8-31)14-18-4-3-16(12-24)13-25-18/h3-4,10-11,13,15H,5-9,14H2,1-2H3,(H,26,27,28,29) ZLMBXGBBLZBJAZ-UHFFFAOYSA-N 703732 6-[[4-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]pyridine-3- carbonitrile::US20240368133, Compound A-209 Type-1 angiotensin II receptor Homo sapiens 6740 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703732 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703732&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212214 507747681 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457403 CC(C)Cc1cc(F)c(-c2nn[nH]n2)c(N2CCN(C(=O)c3ccccn3)[C@@H](C)C2)c1 InChI=1S/C22H26FN7O/c1-14(2)10-16-11-17(23)20(21-25-27-28-26-21)19(12-16)29-8-9-30(15(3)13-29)22(31)18-6-4-5-7-24-18/h4-7,11-12,14-15H,8-10,13H2,1-3H3,(H,25,26,27,28) MQCDWPSYCXXZJU-UHFFFAOYSA-N 703740 (2S)-4-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]-2-methyl-1-(2- pyridylmethyl)piper- azine::US20240368133, Compound A-217 Type-1 angiotensin II receptor Homo sapiens 17500 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703740 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703740&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 167443535 507747689 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457404 Cc4cnc(CN3CCN(c1c(F)c(CC(C)C)ccc1c2nn[nH]n2)CC3)s4 InChI=1S/C20H26FN7S/c1-13(2)10-15-4-5-16(20-23-25-26-24-20)19(18(15)21)28-8-6-27(7-9-28)12-17-22-11-14(3)29-17/h4-5,11,13H,6-10,12H2,1-3H3,(H,23,24,25,26) WNJOTNCGHHHCLL-UHFFFAOYSA-N 703742 2-[[4-[2-fluoro-3- isobutyl-6-(2H- tetrazol-5-yl)phen- yl]piperazin-1-yl]- methyl]-5-methyl- thiazole::US20240368133, Compound A-219 Type-1 angiotensin II receptor Homo sapiens 55200 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703742 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703742&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212185 507747691 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457405 CC(C)Cc1cc(F)c(-c2nn[nH]n2)c(N2CCCN(Cc3cccnn3)CC2)c1 InChI=1S/C21H27FN8/c1-15(2)11-16-12-18(22)20(21-25-27-28-26-21)19(13-16)30-8-4-7-29(9-10-30)14-17-5-3-6-23-24-17/h3,5-6,12-13,15H,4,7-11,14H2,1-2H3,(H,25,26,27,28) NOLQPQAGHYYPLB-UHFFFAOYSA-N 703754 1-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]-4-(pyridazin-3- ylmethyl)-1,4- diazepane::US20240368133, Compound A-231 Type-1 angiotensin II receptor Homo sapiens 18900 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703754 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703754&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 171780054 507747703 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457406 CCCN(C(=O)c1cccs1)c1ccc2nc(CC)n(CC3CCN(c4ccccc4-c4nn[nH]n4)CC3)c(=O)c2c1 InChI=1S/C31H34N8O2S/c1-3-15-38(31(41)27-10-7-18-42-27)22-11-12-25-24(19-22)30(40)39(28(4-2)32-25)20-21-13-16-37(17-14-21)26-9-6-5-8-23(26)29-33-35-36-34-29/h5-12,18-19,21H,3-4,13-17,20H2,1-2H3,(H,33,34,35,36) KYKORMOBINELNF-UHFFFAOYSA-N 703766 N-[2-ethyl-4-oxo- 3-[[1-[2-(2H- tetrazol-5-yl)phen- yl]-4-piperidyl]- methyl]quinazolin- 6-yl]-N-propyl- thiophene-2-carbox- amide::US20240368133, Compound A-243 Type-1 angiotensin II receptor Homo sapiens 11500 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703766 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703766&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212190 507747715 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457407 CCc1nc2ccc(N(Cc3cccnc3)C(=O)c3cccs3)cc2c(=O)n1CC1CCN(c2ccccc2-c2nn[nH]n2)CC1 InChI=1S/C34H33N9O2S/c1-2-31-36-28-12-11-25(42(22-24-7-5-15-35-20-24)34(45)30-10-6-18-46-30)19-27(28)33(44)43(31)21-23-13-16-41(17-14-23)29-9-4-3-8-26(29)32-37-39-40-38-32/h3-12,15,18-20,23H,2,13-14,16-17,21-22H2,1H3,(H,37,38,39,40) WFZCSDITNSGCIN-UHFFFAOYSA-N 703767 N-[2-ethyl-4-oxo-3- [1-[2-(2H-tetrazol- 5-yl)phenyl]-4- piperidyl]methyl]- quinazolin-6-yl]-N- (3-pyridylmethyl)- thiophene-2-carbox- amide::US20240368133, Compound A-244 Type-1 angiotensin II receptor Homo sapiens 6620 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703767 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703767&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 171779973 507747716 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457408 CCc1nc2ccc(N(Cc3ccccc3)C(=O)c3cccs3)cc2c(=O)n1CC1CCN(c2ccccc2-c2nn[nH]n2)CC1 InChI=1S/C35H34N8O2S/c1-2-32-36-29-15-14-26(42(22-24-9-4-3-5-10-24)35(45)31-13-8-20-46-31)21-28(29)34(44)43(32)23-25-16-18-41(19-17-25)30-12-7-6-11-27(30)33-37-39-40-38-33/h3-15,20-21,25H,2,16-19,22-23H2,1H3,(H,37,38,39,40) WUAOVPRYOIGVEK-UHFFFAOYSA-N 703769 N-benzyl-N-[2- ethyl-4-oxo-3-[[1- [2-(2H-tetrazol-5- yl)phenyl]-4-piper- idyl]methyl]quin- azolin-6-yl]thio- phene-2-carbox- amide::US20240368133, Compound A-246 Type-1 angiotensin II receptor Homo sapiens 26700 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703769 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703769&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 172212189 507747718 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4 1457409 CCc1nc2ccc(N(Cc3ccccc3Cl)C(=O)c3cccs3)cc2c(=O)n1CC1CCN(c2ccccc2-c2nn[nH]n2)CC1 InChI=1S/C35H33ClN8O2S/c1-2-32-37-29-14-13-25(43(35(46)31-12-7-19-47-31)22-24-8-3-5-10-28(24)36)20-27(29)34(45)44(32)21-23-15-17-42(18-16-23)30-11-6-4-9-26(30)33-38-40-41-39-33/h3-14,19-20,23H,2,15-18,21-22H2,1H3,(H,38,39,40,41) ZNQNVNHBGOBZQE-UHFFFAOYSA-N 703771 N-[(2-chlorophen- yl)-methyl]-N-[2- ethyl-4-oxo-3-[[1- [2-(2H-tetrazol-5- yl)phenyl]-4-piper- idyl]methyl]quin- azolin-6-yl]thio- phene-2-carbox- amide::US20240368133, Compound A-248 Type-1 angiotensin II receptor Homo sapiens 40100 US Patent 10.7270/Q25D8XB0 aid2060556 US20240368133 DE BLIECK, A; MENET, CJ 11/7/2024 3/14/2025 Confo Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703771 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5550&target=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703771&enzyme=Type-1+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 171779926 507747720 1 MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE 8TH4,6OS2,6OS1,6OS0,6DO1,8TH3,9EAJ,9EAI,9EAH Type-1 angiotensin II receptor AGTR1_HUMAN P30556 Q13725 Q8TBK4